
<html lang="en"     class="pb-page"  data-request-id="56e9c582-a32a-4b56-85d2-66f2299283ce"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2008.51.issue-19;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/jm800600v;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Structure−Activity Relationships of Novel Insulin Receptor Tyrosine Kinase Activators" /></meta><meta name="dc.Creator" content="Robert T.  Lum" /></meta><meta name="dc.Creator" content="Mingshan  Cheng" /></meta><meta name="dc.Creator" content="Cristina P.  Cristobal" /></meta><meta name="dc.Creator" content="Ira D.  Goldfine" /></meta><meta name="dc.Creator" content="Joseph L.  Evans" /></meta><meta name="dc.Creator" content="James G.  Keck" /></meta><meta name="dc.Creator" content="Robert W.  Macsata" /></meta><meta name="dc.Creator" content="Vara Prasad  Manchem" /></meta><meta name="dc.Creator" content="Yukiharu  Matsumoto" /></meta><meta name="dc.Creator" content="Sophia J.  Park" /></meta><meta name="dc.Creator" content="Sandhya S.  Rao" /></meta><meta name="dc.Creator" content="Louise  Robinson" /></meta><meta name="dc.Creator" content="Songyuan  Shi" /></meta><meta name="dc.Creator" content="Wayne R.  Spevak" /></meta><meta name="dc.Creator" content="Steven R.  Schow" /></meta><meta name="dc.Description" content="A novel series of symmetrical ureas of [(7-amino(2-naphthyl))sulfonyl]phenylamines were designed, synthesized, and tested for their ability to increase glucose transport in mouse 3T3-L1 adipocytes,..." /></meta><meta name="Description" content="A novel series of symmetrical ureas of [(7-amino(2-naphthyl))sulfonyl]phenylamines were designed, synthesized, and tested for their ability to increase glucose transport in mouse 3T3-L1 adipocytes,..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 13, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm800600v" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm800600v" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm800600v" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm800600v" /></link>
        
    
    

<title>Design, Synthesis, and Structure−Activity Relationships of Novel Insulin Receptor Tyrosine Kinase Activators | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm800600v" /></meta><meta property="og:title" content="Design, Synthesis, and Structure−Activity Relationships of Novel Insulin Receptor Tyrosine Kinase Activators" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0010.jpeg" /></meta><meta property="og:description" content=" A novel series of symmetrical ureas of [(7-amino(2-naphthyl))sulfonyl]phenylamines were designed, synthesized, and tested for their ability to increase glucose transport in mouse 3T3-L1 adipocytes, a surrogate readout for activation of the insulin receptor (IR) tyrosine kinase (IRTK). A structure−activity relationship was established that indicated glucose transport activity was dependent on the presence of two acidic functionalities, two sulfonamide linkages, and a central urea or 2-imidazolidinone core. Compound 30 was identified as a potent and selective IRTK activator. At low concentrations, 30 was able to increase the tyrosine phosphorylation of the IR stimulated by submaximal insulin. At higher concentrations, 30 was able to increase tyrosine the phosphorylation levels of the IR in the absence of insulin. When administered intraperitoneally (ip) and orally (po), 30 improved glucose tolerance in hypoinsulinemic, streptozotocin-treated rats. These data provide pharmacological validation that small molecule IRTK activators represent a potential new class of antidiabetic agents." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm800600v"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm800600v">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm800600v&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm800600v&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm800600v&amp;href=/doi/10.1021/jm800600v" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 6173-6187</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm800557d" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm800621x" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Structure−Activity Relationships of Novel Insulin Receptor Tyrosine Kinase Activators</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+T.++Lum">Robert T. Lum</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mingshan++Cheng">Mingshan Cheng</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cristina+P.++Cristobal">Cristina P. Cristobal</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ira+D.++Goldfine">Ira D. Goldfine</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+L.++Evans">Joseph L. Evans</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+G.++Keck">James G. Keck</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+W.++Macsata">Robert W. Macsata</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vara+Prasad++Manchem">Vara Prasad Manchem</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yukiharu++Matsumoto">Yukiharu Matsumoto</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sophia+J.++Park">Sophia J. Park</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandhya+S.++Rao">Sandhya S. Rao</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Louise++Robinson">Louise Robinson</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Songyuan++Shi">Songyuan Shi</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wayne+R.++Spevak">Wayne R. Spevak</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+R.++Schow">Steven R. Schow</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Telik, Inc., 3165 Porter Drive, Palo Alto, California 94304, University of California at San Francisco, Mount Zion Medical Center, San Francisco, California 94115, ReceptorBio, Inc., 1155 Chess Drive, Suite 116, Foster City, California 95051, and Sanwa Kaguku Kenkyusho Co. Ltd., Nagoya 461-8631, Japan</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: 650-255-5806. Fax: 309-406-8212. E-mail: <a href="/cdn-cgi/l/email-protection#d8b2bdaeb9b6aba8b0bc98bdb9aaacb0b4b1b6b3f6b6bdac"><span class="__cf_email__" data-cfemail="0d67687b6c637e7d65694d686c7f79656164636623636879">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Telik, Inc.</div><div class="corresp-fn" id="afn2">§University of California at San Francisco.</div><div class="corresp-fn" id="afn3">#ReceptorBio, Inc.</div><div class="corresp-fn" id="afn4">‡Sanwa Kaguku Kenkyusho Co. Ltd.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm800600v&amp;href=/doi/10.1021%2Fjm800600v" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 6173–6187</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 13, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 May 2008</li><li><span class="item_label"><b>Published</b> online</span>13 September 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 October 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm800600v" title="DOI URL">https://doi.org/10.1021/jm800600v</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6173%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRobert%2BT.%2BLum%252C%2BMingshan%2BCheng%252C%2BCristina%2BP.%2BCristobal%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D19%26contentID%3Djm800600v%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BStructure%25E2%2588%2592Activity%2BRelationships%2Bof%2BNovel%2BInsulin%2BReceptor%2BTyrosine%2BKinase%2BActivators%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6187%26publicationDate%3DOctober%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm800600v"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2017</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm800600v" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Structure−Activity Relationships of Novel Insulin Receptor Tyrosine Kinase Activators&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;T. Lum&quot;},{&quot;first_name&quot;:&quot;Mingshan&quot;,&quot;last_name&quot;:&quot;Cheng&quot;},{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;P. Cristobal&quot;},{&quot;first_name&quot;:&quot;Ira&quot;,&quot;last_name&quot;:&quot;D. Goldfine&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;L. Evans&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;G. Keck&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;W. Macsata&quot;},{&quot;first_name&quot;:&quot;Vara&quot;,&quot;last_name&quot;:&quot;Prasad Manchem&quot;},{&quot;first_name&quot;:&quot;Yukiharu&quot;,&quot;last_name&quot;:&quot;Matsumoto&quot;},{&quot;first_name&quot;:&quot;Sophia&quot;,&quot;last_name&quot;:&quot;J. Park&quot;},{&quot;first_name&quot;:&quot;Sandhya&quot;,&quot;last_name&quot;:&quot;S. Rao&quot;},{&quot;first_name&quot;:&quot;Louise&quot;,&quot;last_name&quot;:&quot;Robinson&quot;},{&quot;first_name&quot;:&quot;Songyuan&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Wayne&quot;,&quot;last_name&quot;:&quot;R. Spevak&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;R. Schow&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;6173-6187&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm800600v&quot;},&quot;abstract&quot;:&quot;A novel series of symmetrical ureas of [(7-amino(2-naphthyl))sulfonyl]phenylamines were designed, synthesized, and tested for their ability to increase glucose transport in mouse 3T3-L1 adipocytes, a surrogate readout for activation of the insulin receptor (IR) tyrosine kinase (IRTK). A structure−activity relationship was established that indicated glucose transport activity was dependent on the presence of two acidic functionalities, two sulfonamide linkages, and a central urea or 2-imidazolidinone core. Compound 30 was identified as a potent and selective IRTK activator. At low concentrations, 30 was able to increase the tyrosine phosphorylation of the IR stimulated by submaximal insulin. At higher concentrations, 30 was able to increase tyrosine the phosphorylation levels of the IR in the absence of insulin. When administered intraperitoneally (ip) and orally (po), 30 improved glucose tolerance in hypoinsulinemic, streptozotocin-treated rats. These data provide pharmacological validation that small molecul&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800600v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800600v" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800600v&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800600v" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800600v&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800600v" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm800600v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800600v&amp;href=/doi/10.1021/jm800600v" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm800600v" /></input><a href="/doi/pdf/10.1021/jm800600v" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (313 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm800600v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm800600v%26sid%3Dliteratum%253Aachs%26pmid%3D18788731%26genre%3Darticle%26aulast%3DLum%26date%3D2008%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BStructure%25E2%2588%2592Activity%2BRelationships%2Bof%2BNovel%2BInsulin%2BReceptor%2BTyrosine%2BKinase%2BActivators%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D19%26spage%3D6173%26epage%3D6187%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291456" title="Hydrocarbons">Hydrocarbons</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290925" title="Carbohydrates">Carbohydrates</a>,</li><li><a href="/action/doSearch?ConceptID=292271" title="Urea">Urea</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A novel series of symmetrical ureas of [(7-amino(2-naphthyl))sulfonyl]phenylamines were designed, synthesized, and tested for their ability to increase glucose transport in mouse 3T3-L1 adipocytes, a surrogate readout for activation of the insulin receptor (IR) tyrosine kinase (IRTK). A structure−activity relationship was established that indicated glucose transport activity was dependent on the presence of two acidic functionalities, two sulfonamide linkages, and a central urea or 2-imidazolidinone core. Compound <b>30</b> was identified as a potent and selective IRTK activator. At low concentrations, <b>30</b> was able to increase the tyrosine phosphorylation of the IR stimulated by submaximal insulin. At higher concentrations, <b>30</b> was able to increase tyrosine the phosphorylation levels of the IR in the absence of insulin. When administered intraperitoneally (ip) and orally (po), <b>30</b> improved glucose tolerance in hypoinsulinemic, streptozotocin-treated rats. These data provide pharmacological validation that small molecule IRTK activators represent a potential new class of antidiabetic agents.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84841" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84841" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Diabetes mellitus is a serious and growing worldwide medical problem. In 2000, 171 million people were estimated to be affected by the disease, and that number is expected to more than double to 366 million by 2030.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Two major clinically distinct types of diabetes have been described. Type 1 diabetes is caused by an autoimmune-mediated destruction of the insulin producing β cells of the pancreas leading to an absolute insulin deficiency. It is managed by administering exogenous insulin. Type 2 diabetes is, by far, the most common form of diabetes and accounts for greater than 90% of all cases. This form of the disease is characterized by insulin resistance, which is a reduced sensitivity of the target tissues (liver, skeletal muscle, adipose) to insulin, along with abnormal secretion of insulin.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Initially, the body is able to compensate for insulin resistance by secreting more insulin, and this state of hyperinsulinemia is often an early indicator of the disease.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Eventually, the pancreas will be unable to secrete enough insulin to maintain glucose homeostasis, and consequently oral antidiabetic agents will be needed.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">Current oral antidiabetic agents exert their glucose lowering effects by five main modes of action.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The sulfonylureas and meglitinides stimulate insulin secretion by the pancreatic β cells.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Metformin, a biguanide, decreases hepatic glucose production,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> although it is likely that its ability to stimulate AMP-activated protein kinase also contributes to its antihyperglycemic activity.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The α-glucosidase inhibitors reduce gastrointestinal absorption of carbohydrates.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The thiazolidinediones increase glucose utilization in muscle and liver.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Activation of the peroxisome proliferator-activated receptor-γ (PPARγ<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: CKD, cytoplasmic kinase domain; DPP-IV, dipeptidyl peptidase IV; EGFR, epidermal growth factor receptor; GLP-1, glucagon-like peptide-1; GLUT4, insulin-sensitive glucose transporter; HIV, human immunodeficiency virus; IGF-1R, insulin-like growth factor-1 receptor; IR, insulin receptor; IRS-1/2, insulin receptor substrates 1 and 2; IRTK, insulin receptor tyrosine kinase; PI 3-kinase, phosphatidylinositol 3-kinase; PPARγ, peroxisome proliferator-activated receptor-γ; SAR, structure−activity relationship; SEM, standard error of the mean; STZ, streptozotocin; TK, tyrosine kinase; TRAP, target-related affinity profiling.</p></div> in adipose tissue by this class of drugs directs changes in adipose gene expression including the increased production of adiponectin, which in turn elicits insulin sensitizing effects in the target tissues.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> Mostly recently, inhibitors of dipeptidyl peptidase IV (DPP-IV), a promiscuous enzyme responsible for the abbreviated plasma half-life of glucagon-like peptide-1 (GLP-1), have been developed.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> These compounds serve to elevate circulating GLP-1 levels, enhance insulin secretion, and improve glycemic control. Unfortunately, these agents do not work in all patients, and some have potentially serious side effects.<a onclick="showRef(event, 'ref7 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref7 ref17 ref18 ref19">(7, 17-19)</a> For example, the sulfonylureas, meglitinides, and thiazolidinediones all have a tendency to cause weight gain. This is undesirable in a population already at risk for cardiovascular disease.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> In addition, the U.S. Food and Drug Administration removed the thiazolidinedione, troglitazone, from the market because of its liver toxicity. Such problems illustrate the need to develop new treatments for diabetes with novel mechanisms of action.</div><div class="NLM_p">The insulin receptor (IR) is a large transmembrane glycoprotein found in insulin sensitive target cells (liver, muscle, and fat).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> It comprises two extracellular α-subunits that contain the insulin-binding domain and two membrane spanning β-subunits that contain a ligand activated tyrosine kinase, which will be referred to as the insulin receptor tyrosine kinase (IRTK). Insulin acts by binding to the extracellular domain of the IR, thus inducing autophosphorylation and activation of the IRTK. A cascade of signaling events is initiated leading to increased tyrosine phosphorylation of multiple intracellular substrates, including the insulin receptor substrates 1 and 2 (IRS-1/2), and the activation of second messenger systems such as phosphatidylinositol 3-kinase (PI 3-kinase).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> These pathways act to trigger the translocation of GLUT4 to the cell surface.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> GLUT4 is one of a family of membrane proteins responsible for glucose uptake in mammalian cells and is the major isoform responsive to insulin stimulation.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">Given the essential and early role the IR plays in insulin action, it represents an important and unexploited target for drug development. A family of quinones has been reported as the first selective activators of the IRTK.<a onclick="showRef(event, 'ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29">(26-29)</a> These compounds exhibit antihyperglycemic activity in several animal models of type 2 diabetes<a onclick="showRef(event, 'ref26 ref27 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref29 ref30">(26, 27, 29, 30)</a> and thus provide pharmacological validation that small molecule IRTK activators represent a potential new class of antidiabetic agents. By use of our proprietary drug discovery target-related affinity profiling (TRAP) technology,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> the azonaphthylurea <b>1</b> (TLK16998) was discovered. This compound functions as an IR sensitizer both in vitro and in vivo.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Compound <b>1</b> increases tyrosine phosphorylation of the IRTK, with subsequent enhancement of downstream signaling events including IRS-1 phosphorylation and GLUT4 translocation, resulting increased in cellular glucose transport. Compound <b>1</b> is also efficacious at lowering glucose in two mouse models of type 2 diabetes.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Compound <b>1</b> is also effective at increasing IRTK in several cellular models of impaired insulin receptor function.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> A novel series of IRTK activators that are exemplified by general structure <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) were designed using the azonaphthyl urea <b>1</b> as a starting point. The design, synthesis, and SAR of this series of novel antidiabetic agents are reported here.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Summary of changes made to compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16716" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16716" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The naphthylureas, as exemplified by <b>2</b>, were prepared by one of two general methods. Method A (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) represents the most direct approach and was used for the majority of compounds that were prepared. Reaction of the 7-amino-2-naphthalenesulfonic acids with triphosgene afforded the corresponding ureas, which were converted to the bis-sulfonyl chlorides <b>44</b> and <b>45</b> on treatment with phosphorus oxychloride. Coupling of these intermediates with the appropriate aniline furnished, after any necessary deprotection steps, the sulfonamides <b>4</b>−<b>22</b> and <b>24</b>−<b>28</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Incomplete reaction at the final stage provided the monoaddition products <b>31</b> and <b>32</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), which were readily separable from their symmetrical analogues.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0017.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) triphosgene, THF/aqueous NaOH; (b) POCl<sub>3</sub>; (c) pyridine, THF.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Glucose Uptake Data and Experimental Methods for Ureas <b>3</b>−<b>30</b><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0005.gif" alt="" id="gr4" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">R<sub>1</sub></th><th align="center" valign="middle">R<sub>2</sub></th><th align="center" valign="middle">R<sub>3</sub></th><th align="center" valign="middle">R<sub>4</sub></th><th align="center" valign="middle">method</th><th align="center" valign="middle">EC<sub>50</sub> (μM)</th><th align="center" valign="middle" char=".">no. of assays</th><th align="center" valign="middle"><i>P</i></th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b></td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">90</td><td align="char" char=".">1</td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>3</b></td><td align="left">OH</td><td align="left">H</td><td align="left">SO<sub>3</sub>Na</td><td align="left">H</td><td align="left">B</td><td align="left">26 ± 5.6</td><td align="char" char=".">6</td><td align="left"><0.001 vs <b>1</b></td></tr><tr valign="top"><td align="left"><b>4</b></td><td align="left">H</td><td align="left">H</td><td align="left">SO<sub>3</sub>Na</td><td align="left">H</td><td align="left">A</td><td align="left">22</td><td align="char" char=".">2</td><td align="left">ns vs <b>3</b></td></tr><tr valign="top"><td align="left"><b>5</b></td><td align="left">H</td><td align="left">H</td><td align="left">H</td><td align="left">H</td><td align="left">A</td><td align="left">>200</td><td align="char" char=".">1</td><td align="left">inactive compound</td></tr><tr valign="top"><td align="left"><b>6</b></td><td align="left">H</td><td align="left">H</td><td align="left">NO<sub>2</sub></td><td align="left">H</td><td align="left">A</td><td align="left">>200</td><td align="char" char=".">1</td><td align="left">inactive compound</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="left">H</td><td align="left">H</td><td align="left">CN</td><td align="left">H</td><td align="left">A</td><td align="left">>200</td><td align="char" char=".">1</td><td align="left">inactive compound</td></tr><tr valign="top"><td align="left"><b>8</b></td><td align="left">OH</td><td align="left">H</td><td align="left">CF<sub>3</sub></td><td align="left">H</td><td align="left">A</td><td align="left">>200</td><td align="char" char=".">1</td><td align="left">inactive compound</td></tr><tr valign="top"><td align="left"><b>9</b></td><td align="left">OH</td><td align="left">H</td><td align="left">CO<sub>2</sub>H</td><td align="left">H</td><td align="left">A</td><td align="left">43</td><td align="char" char=".">1</td><td align="left"><0.05 vs <b>3</b></td></tr><tr valign="top"><td align="left"><b>10</b></td><td align="left">H</td><td align="left">H</td><td align="left">CO<sub>2</sub>H</td><td align="left">H</td><td align="left">A</td><td align="left">24</td><td align="char" char=".">1</td><td align="left">ns vs <b>4</b></td></tr><tr valign="top"><td align="left"><b>11</b></td><td align="left">OH</td><td align="left">H</td><td align="left">tetrazole</td><td align="left">H</td><td align="left">A</td><td align="left">73</td><td align="char" char=".">2</td><td align="left"><0.012 vs <b>3</b></td></tr><tr valign="top"><td align="left"><b>12</b></td><td align="left">H</td><td align="left">H</td><td align="left">tetrazole</td><td align="left">H</td><td align="left">A</td><td align="left">54</td><td align="char" char=".">2</td><td align="left"><0.05 vs <b>4</b></td></tr><tr valign="top"><td align="left"><b>13</b></td><td align="left">OH</td><td align="left">H</td><td align="left">CH<sub>2</sub>OH</td><td align="left">H</td><td align="left">A</td><td align="left">>200</td><td align="char" char=".">1</td><td align="left">inactive compound</td></tr><tr valign="top"><td align="left"><b>14</b></td><td align="left">H</td><td align="left">H</td><td align="left">OH</td><td align="left">H</td><td align="left">A</td><td align="left">>200</td><td align="char" char=".">1</td><td align="left">inactive compound</td></tr><tr valign="top"><td align="left"><b>15</b></td><td align="left">H</td><td align="left">H</td><td align="left">SO<sub>2</sub>NH<sub>2</sub></td><td align="left">H</td><td align="left">A</td><td align="left">>200</td><td align="char" char=".">1</td><td align="left">inactive compound</td></tr><tr valign="top"><td align="left"><b>16</b></td><td align="left">OH</td><td align="left">H</td><td align="left">CH<sub>2</sub>CO<sub>2</sub>H</td><td align="left">H</td><td align="left">A</td><td align="left">>200</td><td align="char" char=".">1</td><td align="left">inactive compound</td></tr><tr valign="top"><td align="left"><b>17</b></td><td align="left">H</td><td align="left">H</td><td align="left">H</td><td align="left">SO<sub>3</sub>Na</td><td align="left">A</td><td align="left">94</td><td align="char" char=".">1</td><td align="left"><0.01 vs <b>4</b></td></tr><tr valign="top"><td align="left"><b>18</b></td><td align="left">OH</td><td align="left">H</td><td align="left">H</td><td align="left">CO<sub>2</sub>H</td><td align="left">A</td><td align="left">103</td><td align="char" char=".">2</td><td align="left"><0.001 vs <b>9</b></td></tr><tr valign="top"><td align="left"><b>19</b></td><td align="left">OH</td><td align="left">CO<sub>2</sub>H</td><td align="left">H</td><td align="left">H</td><td align="left">A</td><td align="left">93</td><td align="char" char=".">2</td><td align="left"><0.001 vs <b>9</b></td></tr><tr valign="top"><td align="left"><b>20</b></td><td align="left">H</td><td align="left">H</td><td align="left">H</td><td align="left">CO<sub>2</sub>H</td><td align="left">A</td><td align="left">183</td><td align="char" char=".">1</td><td align="left"><0.001 vs <b>10</b></td></tr><tr valign="top"><td align="left"><b>21</b></td><td align="left">H</td><td align="left">CO<sub>2</sub>H</td><td align="left">H</td><td align="left">H</td><td align="left">A</td><td align="left">41</td><td align="char" char=".">1</td><td align="left"><0.001 vs 10</td></tr><tr valign="top"><td align="left"><b>22</b></td><td align="left">OH</td><td align="left">H</td><td align="left">CO<sub>2</sub>H</td><td align="left">Cl</td><td align="left">A</td><td align="left">18 ± 8.7</td><td align="char" char=".">3</td><td align="left"><0.001 vs <b>9</b></td></tr><tr valign="top"><td align="left"><b>23</b></td><td align="left">H</td><td align="left">H</td><td align="left">CO<sub>2</sub>H</td><td align="left">Cl</td><td align="left">B</td><td align="left">16</td><td align="char" char=".">2</td><td align="left"><0.001 vs <b>10</b></td></tr><tr valign="top"><td align="left"><b>24</b></td><td align="left">OH</td><td align="left">H</td><td align="left">CO<sub>2</sub>H</td><td align="left">OH</td><td align="left">A</td><td align="left">43</td><td align="char" char=".">2</td><td align="left">ns vs <b>9</b></td></tr><tr valign="top"><td align="left"><b>25</b></td><td align="left">H</td><td align="left">H</td><td align="left">CO<sub>2</sub>H</td><td align="left">OH</td><td align="left">A</td><td align="left">9</td><td align="char" char=".">2</td><td align="left"><0.001 vs <b>10</b></td></tr><tr valign="top"><td align="left"><b>26</b></td><td align="left">H</td><td align="left">H</td><td align="left">CO<sub>2</sub>H</td><td align="left">NO<sub>2</sub></td><td align="left">A</td><td align="left">40</td><td align="char" char=".">1</td><td align="left">ns vs <b>10</b></td></tr><tr valign="top"><td align="left"><b>27</b></td><td align="left">H</td><td align="left">OH</td><td align="left">CO<sub>2</sub>H</td><td align="left">H</td><td align="left">A</td><td align="left">150</td><td align="char" char=".">1</td><td align="left"><0.001 vs <b>9</b></td></tr><tr valign="top"><td align="left"><b>28</b></td><td align="left">OH</td><td align="left">Cl</td><td align="left">CO<sub>2</sub>H</td><td align="left">H</td><td align="left">A</td><td align="left">121</td><td align="char" char=".">1</td><td align="left"><0.05 vs <b>22</b></td></tr><tr valign="top"><td align="left"><b>29</b></td><td align="left">H</td><td align="left">H</td><td align="left">SO<sub>3</sub>Na</td><td align="left">Cl</td><td align="left">B</td><td align="left">6 ± 1.0</td><td align="char" char=".">4</td><td align="left"><0.015 vs <b>4</b>; <0.05 vs <b>23</b></td></tr><tr valign="top"><td align="left"><b>30</b></td><td align="left">OH</td><td align="left">H</td><td align="left">SO<sub>3</sub>Na</td><td align="left">Cl</td><td align="left">B</td><td align="left">5 ± 1.2</td><td align="char" char=".">7</td><td align="left"><0.002 vs <b>3</b>; <0.03 vs <b>22</b></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Test compounds were evaluated in each screening assay at four concentrations using triplicate incubations in the presence of 5.6 nM insulin, a submaximally effective concentration, as described in <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. The EC<sub>50</sub> value was calculated using nonlinear regression analysis of the best-fit curve of the untransformed data. Values shown are the mean ± SEM [when <i>n</i> (number of independent assays) ≥ 3]. Under the conditions employed, the % coefficient of variation for this screening assay was typically ≤15%. For statistical comparison of test compounds when <i>n</i> ≥ 2, an unpaired <i>t</i> test was used to compare the EC<sub>50</sub> of two compounds. For statistical comparisons of a panel of compounds when <i>n</i> = 1, an ANOVA (repeated measures) was used to compare the counts per minute data (four concentrations, triplicate incubations) followed by the Newman−Keuls multiple comparison test. Significance was accepted at <i>P</i> < 0.05. Typically, 2-fold differences in EC<sub>50</sub> values were statistically significant, while differences less than 2-fold were not. All analyses were performed using GraphPad Prism (MS Windows, version 4.03), GraphPad Software, San Diego, CA (<a href="http://www.graphpad.com" class="extLink">www.graphpad.com</a>). ns, not significant.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Glucose Uptake Data For Truncated Analogues <b>31</b> and <b>32</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0006.gif" alt="" id="gr5" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">R</th><th align="center" valign="middle" char=".">EC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>31</b></td><td align="left">3-SO<sub>3</sub>Na, 4-Cl</td><td align="char" char=".">>200</td></tr><tr valign="top"><td align="left"><b>32</b></td><td align="left">3-CO<sub>2</sub>H, 4-OH</td><td align="char" char=".">>200</td></tr></tbody></table></div></div><div class="NLM_p">Method B, although requiring an additional synthetic step, was more convenient on a large scale (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). In this procedure, the 7-amino-2-naphthalenesulfonic acids were acetylated prior to formation of the sulfonyl chlorides <b>46</b> and <b>47</b>. Coupling with the appropriate anilines yielded the sulfonamides <b>48</b> and <b>49</b>, which after deprotection were treated with triphosgene to afford symmetrical ureas <b>52</b> and <b>53</b>. In this manner, symmetrical ureas <b>3</b>, <b>23</b>, <b>29</b>, and <b>30</b> were prepared.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0018.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Ac<sub>2</sub>O, pyridine; (b) POCl<sub>3</sub>; (c) pyridine, THF; (d) 5 N NaOH, 60°C; (e) triphosgene, THF, 1 M NaOAc buffer, pH 4.7.</p></p></figure><div class="NLM_p">For sulfonic acid containing anilines, it proved convenient to couple them as their sulfonate esters. This allowed for the facile chromatographic separation (method A) or extractive separation (methods A and B) of any unreacted naphthalenesulfonic acid. The <i>p</i>-cresolaniline sulfonates <b>54</b>, <b>55</b>, and <b>56</b> were prepared from the corresponding nitrobenzenesulfonyl chlorides by esterification with <i>p</i>-cresol followed by reduction of the nitro group (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). 3-(1<i>H</i>-1,2,3,4-Tetrazol-5-yl)phenylamine <b>57</b> was prepared in one step from 3-aminobenzonitrile and sodium azide.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0019.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>p</i>-cresol, pyridine, THF; (b) SnCl<sub>2</sub>, HCl; (c) POCl<sub>3</sub>, DMA; (d) NaN<sub>3</sub>, Et<sub>3</sub>NHCl, toluene, 100°C.</p></p></figure><div class="NLM_p">The amides <b>33</b> and <b>34</b> were prepared according to the procedure described in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, starting from the known aminonaphthalenecarboxylic acid <b>58</b>.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Protection of the amine followed by acid chloride formation and amidation with the appropriate aniline yielded carboxamides <b>59</b> and <b>60</b>. After Fmoc removal and reaction with triphosgene, protected ureas <b>61</b>and <b>62</b> were obtained. Basic hydrolysis provided the desired diacids <b>33</b> and <b>34</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0001.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Fmoc-Cl, NaOH; (b) SOCl<sub>2</sub>, pyridine; (c) methyl 3-aminobenzoate or <b>54</b>; (d) piperidine, CH<sub>2</sub>Cl<sub>2</sub>; (e) triphosgene, THF/aqueous NaOH; (f) NaOMe, THF/H<sub>2</sub>O.</p></p></figure><div class="NLM_p">The <i>N</i>-methylsulfonamide <b>35</b> was simply prepared by methylation of sulfonamide <b>4</b> (method A, R<sub>1</sub> = H, R<sub>2</sub> = 3-SO<sub>3</sub>Na) using potassium carbonate and iodomethane.</div><div class="NLM_p">Compounds <b>36</b> and <b>37</b>, which contain a flexible ethyl linker, and the constrained 2-imidazolidinone <b>43</b> were prepared as described in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. 1,2-Dibromoethane was alkylated with excess 7-amino-2-naphthalenesulfonic acid, and the nitrogen atoms were then acetylated prior to sulfonyl chloride formation. The resulting sulfonyl chloride <b>63</b> was coupled to 5-amino-2-chlorobenzoic acid followed by liberation of the amines by basic hydrolysis to give the ethyl linked analogue <b>37</b>. Triphosgene induced cyclization afforded the 2-imidazolidinone <b>43</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0002.jpeg" id="gs5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 1,2-Dibromoethane, K<sub>2</sub>CO<sub>3</sub>, DMF; (b) Ac<sub>2</sub>O, pyridine; (c) POCl<sub>3</sub>; (d) 5-amino-2-chlorobenzoic acid, pyridine; (e) 5 N NaOH; (f) triphosgene THF/aqueous Na<sub>2</sub>CO<sub>3</sub>.</p></p></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a> shows the synthesis of the <i>N</i>,<i>N</i>′-dimethylurea <b>42</b>. Triphosgene mediated ureidation of 7-amino-2-naphthalenesulfonic acid (method A, Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) was followed by methylation of the urea nitrogens. Conversion to the bis-sulfonyl chloride, coupling to methyl 5-amino-2-chlorobenzoate, and subsequent ester hydrolysis gave the desired <i>N</i>,<i>N</i>′-dimethylurea <b>42</b>.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0003.jpeg" id="gs6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) NaH, MeI, DMF, 70 °C; (b) POCl<sub>3</sub>; (c) methyl 2-amino-5-chlorobenzoate, pyridine; (d) NaOH.</p></p></figure><div class="NLM_p">The importance of the central urea linker was further explored by the synthesis of thiourea <b>38</b> and guanidine analogues <b>39</b>−<b>41</b> as depicted in Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>. The 7-aminonaphthalene <b>64</b> was obtained by esterification of intermediate <b>51</b> (method B, Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, R<sub>2</sub> = 3-CO<sub>2</sub>H, 4-Cl). It was then converted to the thioisocyanate <b>65</b> using 1,1′-thiocarbonyldiimidazole. This thioisocyanate was treated with 7-aminonaphthalene <b>64</b> to afford the thiourea <b>66</b>, which was subsequently hydrolyzed to furnish the dicarboxylic acid <b>38</b>. The thiourea <b>66</b> also gave access to a series of guanidine isosteres by initial S-methylation followed by reaction with the appropriate amine in a sealed tube. Basic hydrolysis of the resulting esters <b>67</b>−<b>69</b> gave the desired guanidines <b>39</b>−<b>41</b>.</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0004.jpeg" id="gs7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 1,1′-Thiocarbonyldiimidazole; (b) <b>64</b>, CH<sub>2</sub>Cl<sub>2</sub>; (c) 1 N NaOH; (d) MeI; (e) R<sub>1</sub>NH<sub>2</sub>, sealed tube, 70−80 °C.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54513" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54513" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The azonaphthylurea <b>1</b> contains a number of undesirable features for a drug candidate. In particular, the elimination of the six sulfonic acids and four azo linkages and reduction of the high molecular weight were targeted as early goals for the improvement of our lead structure. The initial SAR work with the azo analogues of <b>1</b> focused on the role of the benzenesulfonic acids. It was found that the distal benzenesulfonic acid groups were not required for activity (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). However, the sulfonic acids on the benzene rings directly attached to the central naphthalene urea core were found to be essential for activity. Replacement of the inner azo linkages of <b>1</b> with another type of linker to the requisite benzenesulfonic acid groups was next examined. A subsequent set of compounds using the sulfonic acids on the naphthalenes as a handle for the formation of sulfonamide linkages was explored. Changing the linker eliminated the undesirable azo linkages and incorporated neutral sulfonamides. This strategy provided compounds of the general structure <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), many of which retained the IRTK activation activity of <b>1</b>. In order to establish the SAR of these IRTK activators, an expanded series of analogues was designed and synthesized.</div><div class="NLM_p">Compounds <b>1</b> and <b>3</b> were initially compared by their effect on autophosphorylation of the cytoplasmic kinase domain of the human insulin receptor. Both compounds demonstrated a dose dependent activation of the autophosphorylation activity (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The biphasic dose−response curve is likely a consequence of incubation conditions associated with the in vitro (enzymatic) assay. Importantly, neither compound (<b>1</b> or <b>3</b>; data not shown) nor <b>30</b> exhibited a biphasic dose−response in a cellular assay measuring insulin receptor tyrosine phosphorylation (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) or other cellular assays (data not shown).</div><figure id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effects of compounds <b>1</b> and <b>3</b> on the autophosphorylation of the insulin receptor cytoplasmic kinase domain (CKD). Results are mean ± SEM values of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of compound <b>30</b> on insulin receptor tyrosine phosphorylation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A downstream consequence of IRTK activation in the cell is the stimulation of glucose transport. This whole-cell functional assay provides a measure of the ability of test compounds to activate the insulin receptor and for that activation to lead to a quantifiable signal reflecting the cellular uptake of glucose.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> This assay uses differentiated mouse 3T3-L1 adipocytes and measures the ability of test compounds to increase (i.e., stimulate) glucose transport in the absence and presence of insulin using 2-deoxy-<span class="smallcaps smallerCapital">d</span>-[<sup>14</sup>C]glucose. Compound <b>3</b> stimulated glucose transport (EC<sub>50</sub> = 26 μM) in the presence of 5.6 nM insulin relative to compound <b>1</b> (EC<sub>50</sub> = 90 μM). The increased potency of <b>3</b> in the glucose transport assay agrees with the observed relative potencies of compounds <b>1</b> and <b>3</b> in the phosphorylation assay. At high concentrations, <b>3</b> increased glucose transport in the absence of insulin; this was not observed for compound <b>1</b>. Therefore, at higher concentrations, <b>3</b> acts as an insulin receptor agonist in 3T3-L1 adipocytes, while at lower concentrations, the presence of insulin is required to observe an increase in glucose transport. The cellular activity of <b>3</b> demonstrated that this simplified scaffold was a good starting point to begin SAR studies.</div><div class="NLM_p">The importance of the naphthalene hydroxyls of <b>3</b> on its glucose transport activity was first addressed. The <i>des</i>-hydroxyl analogue <b>4</b> (EC<sub>50</sub> = 22 μM) was prepared and was shown to be equipotent to <b>3</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), thus showing that these hydroxyl groups are not essential for glucose transport activity.</div><div class="NLM_p">The need for acidic functionalities on the terminal benzene rings was established as exemplified by compounds <b>5</b>−<b>8</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, suggesting that the sulfonic acid groups are playing a critical role in activating the IRTK. In order to determine if other acidic groups could take the place of the sulfonic acids, analogues containing carboxylic acids, <b>9</b> and <b>10</b>, tetrazoles, <b>11</b> and <b>12</b>, alcohols, <b>13</b> and <b>14</b>, and sulfonamide <b>15</b> at the 3-position of the terminal benzene rings were prepared. The alcohols and sulfonamide were inactive in the glucose transport assay. The carboxylic acids <b>9</b> (EC<sub>50</sub> = 43 μM) and <b>10</b> (EC<sub>50</sub> = 24 μM) were slightly less potent than the corresponding sulfonic acids, and the tetrazoles <b>11</b> (EC<sub>50</sub> = 73 μM) and <b>12</b> (EC<sub>50</sub> = 54 μM) were weaker still. In addition, a derivative in which the terminal rings were phenylacetic acids (<b>16)</b> was prepared; this analogue proved to be inactive. As had been observed previously, the naphthalene hydroxyl groups had little effect on activity.</div><div class="NLM_p">The effect of the position of the acidic groups on the terminal benzene rings was next explored. When the sulfonic acid was moved to the 4-position, <b>17</b>, the activity was reduced by 4-fold. Attempts to prepare analogues with the sulfonic acid in the 2-position were unsuccessful, and this was postulated to be due to steric crowding. However, in the case of the carboxylic acid series, both the 2- and 4-substituted analogues <b>18</b>−<b>21</b> could be prepared. These analogues were again less active (2- to 8-fold) than the corresponding 3-substituted carboxylic acid analogues <b>9</b> and <b>10</b>.</div><div class="NLM_p">After establishment of a preference for acidic functionality at the 3-position of the terminal ring, exploration of the effects of additional substituents on that ring was initiated. For synthetic reasons the 3-substituted carboxylic acids <b>9</b> and <b>10</b> were chosen as models for this series. Incorporation of a chlorine at the 4-position of the terminal ring resulted in compounds <b>22</b> and <b>23</b> with increased potency, and this trend was also observed by the incorporation of a hydroxyl group at the same 4-position giving salicylic acid <b>25</b>. The analogous salicylic acid derivative containing the naphthalene hydroxyl groups (<b>24)</b> was an outlier in this series, being only equipotent to its analogue <b>9</b>. Introduction of a chlorine or hydroxyl substituent between the acidic functionality and the sulfonamide linker gave compounds <b>27</b> and <b>28</b>; however, both exhibited a reduction in potency. The increased potency observed with chlorine substitution in the 4-position in the 3-benzoic acid series was also observed with the 3-sulfonic acid analogues <b>29</b> and <b>30</b>. These two compounds had EC<sub>50</sub> values of 6 and 5 μM, respectively, and are the most potent analogues in this series.</div><div class="NLM_p">To confirm the requirement for acidic functionalities on the terminal benzene rings, carboxylate and sulfonate ester intermediates of the active compounds were tested in the glucose uptake assay; all were inactive. In addition, two truncated analogues, <b>31</b> and <b>32</b>, which lack one of the acid functionalized terminal benzene rings were also tested; both showed a dramatic reduction in glucose uptake activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_p">The 2,7-substitution pattern of the naphthalene rings was found to be critical to activity. A number of analogues containing 2,6-substituted naphthalenes were synthesized, and all proved to have little or no activity.</div><div class="NLM_p">The importance of the sulfonamide linkages was examined next. Amide analogues <b>33</b> and <b>34</b> both exhibited a loss in activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), showing that the sulfonamide linkage could not be replaced by this spatially dissimilar linker. The <i>N</i>-methylsulfonamide <b>35</b> showed a reduction in activity, perhaps indicating that the sulfonamide proton is also important.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Glucose Uptake Data for Analogues with Changes to the Sulfonamide Linker<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0007.gif" alt="" id="gr14" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">linker (A → B)</th><th align="center" valign="middle">R</th><th align="center" valign="middle" char=".">EC<sub>50</sub> (μM)</th><th align="center" valign="middle" char=".">no. of assays</th><th align="center" valign="middle"><i>P</i></th></tr></thead><tbody><tr valign="top"><td align="left"><b>10</b></td><td align="left">−SO<sub>2</sub>NH−</td><td align="left">CO<sub>2</sub>H</td><td align="char" char=".">24</td><td align="char" char=".">1</td><td align="left">ns vs <b>4</b></td></tr><tr valign="top"><td align="left"><b>4</b></td><td align="left">−SO<sub>2</sub>NH−</td><td align="left">SO<sub>3</sub>Na</td><td align="char" char=".">22</td><td align="char" char=".">2</td><td align="left">ns vs <b>3</b></td></tr><tr valign="top"><td align="left"><b>33</b></td><td align="left">−CONH−</td><td align="left">CO<sub>2</sub>H</td><td align="char" char=".">>200</td><td align="char" char=".">1</td><td align="left">inactive compound</td></tr><tr valign="top"><td align="left"><b>34</b></td><td align="left">−CONH−</td><td align="left">SO<sub>3</sub>Na</td><td align="char" char=".">>200</td><td align="char" char=".">1</td><td align="left">inactive compound</td></tr><tr valign="top"><td align="left"><b>35</b></td><td align="left">−SO<sub>2</sub>N(CH<sub>3</sub>)−</td><td align="left">SO<sub>3</sub>Na</td><td align="char" char=".">91</td><td align="char" char=".">1</td><td align="left"><0.001 vs <b>10</b>; <0.001 vs <b>4</b></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Test compounds were evaluated in each screening assay at four concentrations using triplicate incubations in the presence of 5.6 nM insulin, a submaximally effective concentration, as described in <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. The EC<sub>50</sub> value was calculated using nonlinear regression analysis of the best-fit curve of the untransformed data. Values shown are the mean ± SEM [when <i>n</i> (number of independent assays) ≥ 3]. Under the conditions employed, the % coefficient of variation for this screening assay was typically ≤15%. For statistical comparison of test compounds when <i>n</i> ≥ 2, an unpaired <i>t</i> test was used to compare the EC<sub>50</sub> of two compounds. For statistical comparisons of a panel of compounds when <i>n</i> = 1, an ANOVA (repeated measures) was used to compare the counts per minute data (four concentrations, triplicate incubations) followed by the Newman−Keuls multiple comparison test. Significance was accepted at <i>P</i> < 0.05. Typically, 2-fold differences in EC<sub>50</sub> values were statistically significant, while differences less than 2-fold were not. All analyses were performed using GraphPad Prism (MS Windows, version 4.03), GraphPad Software, San Diego, CA (<a href="http://www.graphpad.com" class="extLink">www.graphpad.com</a>). ns, not significant.</p></div></div></div><div class="NLM_p">To assess the importance of the central linkage, the urea linker was modified using compound <b>23</b> as the comparator (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Compounds <b>36</b> and <b>37</b>, which contain a flexible ethyl linker, were both inactive. Replacement of the urea with a thiourea <b>38</b>, guanidine <b>39</b>, or substituted guanidines <b>40</b> and <b>41</b> resulted in compounds with vastly diminished or no activity. Methylation of the urea nitrogens gave <b>42</b>, which was also inactive. The only modification to the urea linker that retained moderate activity was the cyclic 2-imidazolidinone <b>43</b>, which had an EC<sub>50</sub> of 56 μM. These data suggest that it is not the urea protons that are critical for activity, but perhaps it is the trans, trans conformation<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> adopted by the urea linker that is important. It is known that <i>N</i>,<i>N</i>′-dimethyldiphenylureas adopt a cis,cis conformation,<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> while for thioureas<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and guanidines<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> the mixed cis,trans conformation may predominate. Since the urea linkage acts as a hinge in the center of the molecule, even subtle changes in orientation can cause large movements in the relative positions of the outer rings.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Glucose Uptake Data for Analogues with Changes to the Urea Linker</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0008.gif" alt="" id="gr15" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0009.gif" alt="" id="gr16" /></img></td></tr></tbody></table></div></div><div class="NLM_p">Compound <b>30</b> was chosen for further characterization as a representative example from this series. At this stage, it is unknown with certainty if the pharmacological properties of <b>30</b> differed compared to <b>29</b>. This is currently under investigation. In mouse 3T3-HIR cells that overexpress the human IR, <b>30</b> (10 μM) significantly potentiated the effects of 2.5 nM insulin to increase the tyrosine phosphorylation of the IR (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). At 3 μM <b>30</b> + 2.5 nM insulin, there was a trend toward increasing in IR phosphotyrosine (∼75%) vs ∼50% with 2.5 nM insulin alone. At 10 μM, <b>30</b> plus insulin increased IR tyrosine phosphorylation to a degree similar to 100 nM insulin alone. Compound <b>30</b>, at concentrations 18 μM or greater, was able to increase tyrosine phosphorylation of the IR in the absence of insulin.</div><div class="NLM_p">The effects of <b>30</b> on glucose transport has been evaluated in 3T3-L1 adipocytes.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> In the absence of insulin, 30 and 50 μM <b>30</b> produced a significant increase in glucose transport by approximately 340% and 875%, respectively. Additional experiments evaluating the effects of <b>30</b> on insulin-stimulated glucose transport in 3T3-L1 adipocytes were also performed using additional concentrations of insulin. In the presence of 10 and 30 μM <b>30</b>, the insulin concentration−response curve was significantly left-shifted, indicative of an IR sensitizing effect.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Taken together, these results indicate that at concentrations of ≥30 μM, compound <b>30</b> increases glucose transport in the absence of insulin but functions more potently to enhance insulin stimulated glucose transport (i.e., functions as a cellular insulin sensitizer).</div><div class="NLM_p">Compound <b>30</b> also increased plasma membrane GLUT4 content by ∼85% in adipocytes stimulated with 50 nM insulin (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). This is consistent with the increase in glucose transport activity observed with compound <b>30</b> and the expected translocation of GLUT4 from intracellular stores to the cell membrane following IRTK activation.</div><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0014.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. GLUT4 content at the plasma membrane is increased by treatment with compound <b>30</b>: (∗) <i>p</i> < 0.05; (∗∗) <i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To illustrate the selectivity for the IR, compound <b>30</b> was tested for its ability to enhance tyrosine phosphorylation of the related insulin-like growth factor-1 (IGF-1R) and epidermal growth factor (EGFR) receptors. At concentrations up to 30 μM, <b>30</b> had no effect on either IGF-1-stimulated tyrosine phosphorylation of the IGF-1R or EGF-stimulated phosphorylation of the EGFR.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">Compound <b>30</b> was also tested in vivo for its ability to improve glucose tolerance in an oral glucose tolerance test in hypoinsulinemic rats. A single ip dose of <b>30</b> (50 mg/kg) was able to lower blood glucose (<i>p</i> = 0.014) by approximately 25% by 30 min after glucose loading (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><figure id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0015.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of a single intraperitoneal (ip) dose of compound <b>30</b> in an oral glucose tolerance test in STZ-diabetic rats. Glucose load was administered 15 min postdose (50 mg/kg): (∗) <i>p</i> = 0.014 (<i>t</i> test, unpaired).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>30</b> (1000 mg/kg) was also orally active in this model and produced an approximate 32% reduction in blood glucose (<i>p</i> < 0.05) by 30 min after glucose loading (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</div><figure id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0016.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of a single oral (po) dose of compound <b>30</b> in an oral glucose tolerance test in STZ-diabetic rats. Glucose load was administered 15 min postdose (1000 mg/kg): (∗) <i>p</i> < 0.05 (<i>t</i> test, unpaired).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Protease inhibitor therapy is known to reduce the morbidity and mortality associated with HIV infection. However, protease inhibitors are also associated with metabolic abnormalities including insulin resistance, hyperglycemia, and hypertriglyceridemia.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> In normal rats made insulin resistant by the HIV protease inhibitor indinavir, oral administration of <b>30</b> (10 mg/kg) resulted in improved glucose tolerance and reduced plasma insulin levels 30 min after the glucose challenge.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Streptozotocin (STZ)-treated rats are hyperglycemic and hypoinsulinemic and are significantly more insulin resistant than indinavir-treated rats. In addition, the hyperglycemia that is a consequence of STZ treatment further exacerbates the insulin resistance, a condition commonly referred to as glucotoxicity. In contrast, indinavir-treated rats are normoglycemic with normal insulin levels. Hence, it is not unexpected that the efficacious dose of <b>30</b> was higher in STZ-treated rats compared to indinavir-treated rats.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37031" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37031" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A series of compounds based upon the symmetrical ureas of [(7-amino(2-naphthyl))sulfonyl]phenylamines were designed and synthesized. The presence of an acidic functionality on the terminal benzene rings was shown to be critical for activity. The relative positioning of these two acidic groups was also important because changes to the central urea linker cause conformation changes in the central hinge of the molecule, and therefore, changes in the relative positions of the two acidic groups invariably gave analogues with little or no activity.</div><div class="NLM_p last">Many compounds in the series stimulated the activity of the IRTK, leading to an increase in glucose uptake in cells. In addition several analogues showed activity in animal models of type 2 diabetes. These data demonstrate that interaction of these small molecules with the IR is able to elicit a similar response both in vitro and in vivo as the interaction of insulin with the IR. Therefore, our data provide pharmacological validation that small molecule IRTK activators represent a potential new class of antidiabetic agent.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> General</h3><div class="NLM_p last">Unless otherwise noted, materials were obtained from commercial suppliers and were used without further purification. 7-Amino-2-naphthalenesulfonic acid (TCI America) and 7-amino-4-hydroxy-2-naphthalenesulfonic acid (Fluka) were purified prior to use by filtration (0.2 μm nylon filter) of a 1 N NaOH solution followed by precipitation of the zwitterion after acidification with HCl. The silica gel used in column chromatography was 230−400 mesh from EM Science. Reverse-phase HPLC (RP-HPLC) was performed with a C18 stationary phase and a solvent system of CH<sub>3</sub>CN/H<sub>2</sub>O and 0.5%TFA or CH<sub>3</sub>CN/H<sub>2</sub>O and NH<sub>4</sub>OAc. Melting points (Pyrex capillary) were determined on a Mel-Temp apparatus and are uncorrected. <sup>1</sup>H (300 Mhz) and <sup>13</sup>C (75 Mhz) NMR spectra were recorded on a Varian XL-300 spectrometer. Chemical shifts for <sup>1</sup>H spectra are reported as δ values in parts per million (ppm) relative to DMSO at 2.51 ppm, CD<sub>3</sub>OD at 3.31 ppm, or TMS at 0.00 ppm in CDCl<sub>3</sub>. Chemical shifts for <sup>13</sup>C spectra are reported as δ values in ppm relative to DMSO at 39.5 ppm or CDCl<sub>3</sub> at 77.0 ppm. Coupling constants (<i>J</i>) are reported in hertz (Hz). The splitting pattern abbreviations are designated as follows: s = singlet, d = doublet; dd = doublet of doublets, t = triplet, q = quartet, br = broad, m = multiplet, app = apparent. Matrix assisted laser desorption ionization (MALDI) mass spectra were obtained using a Finnigan Lasermat. Electospray ionization (ES) mass spectra were obtained using a Hewlett-Packard series 1100 MSD. Elemental analyses were performed by Quantitative Technologies Inc. (Whitehouse, NJ).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> 3-{[(4-Hydroxy-7-{[(5-hydroxy-7-{[(3-sulfophenyl)amino]sulfonyl}(2-naphthyl))amino]carbonylamino}-2-naphthyl)sulfonyl]amino}benzenesulfonic Acid, Disodium Salt (<b>3</b>)</h3><div class="NLM_p last">The title compound was prepared as described for compound <b>23</b> from compound <b>47</b> and 4-methylphenyl 3-aminobenzenesulfonate (<b>54</b>) in 55% overall yield as a tan solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.83 (2H, s), 10.42 (2H, s), 9.53 (2H, s), 8.13 (2H, d, <i>J</i> = 1.6 Hz), 8.07 (2H, d, <i>J</i> = 9.0 Hz), 7.74 (2H, s), 7.66 (2H, dd, <i>J</i> = 1.9 Hz, <i>J</i> = 9.2 Hz), 7.46 (2H, s), 7.13−7.24 (6H, m), 7.01 (2H, d, <i>J</i> = 1.6 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 154.2, 152.7, 148.9, 139.1, 138.0, 137.4, 133.9, 128.3, 123.1, 122.1, 121.1, 120.8, 119.6, 117.6, 117.4, 114.3, 102.5; MS (MALDI(−)) <i>m</i>/<i>z</i> 835 (M − Na). Anal. (C<sub>33</sub>H<sub>24</sub>N<sub>4</sub>Na<sub>2</sub>O<sub>13</sub>S<sub>4</sub>) C, H, N.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Method A (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>)</h3><div class="NLM_p last">To compound <b>44</b> or <b>45</b> dissolved in THF was added a solution of 2.2 equiv of the aniline as a solution in THF with 5 equiv of pyridine. The mixture was allowed to stir at ambient temperature for 16 h. The products were purified by RP-HPLC, silica gel flash chromatography, or extraction followed by chromatography.</div></div><div id="sec5_4a" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 3-{[(7-{[(7-{[(3-Sulfophenyl)amino]sulfonyl}-2-naphthyl)amino]carbonylamino}-2-naphthyl)sulfonyl]amino}benzenesulfonic Acid, Disodium Salt (<b>4</b>)</h3><div class="NLM_p">The reaction of <b>44</b> with 4-methylphenyl 3-aminobenzenesulfonate (<b>54</b>) according to general method A gave 4-methylphenyl 3-[({7-[({7-[({3-[(4-methylphenyl)oxysulfonyl] phenyl}amino)sulfonyl]-2-naphthyl}amino)carbonylamino]-2-naphthyl}sulfonyl)amino]benzenesulfonate in 84% yield as an off-white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.94 (2H, s), 9.23 (2H, s), 8.31 (2H, s), 8.26 (2H, s), 8.05 (2H, d, <i>J</i> = 8.8 Hz), 7.98 (2H, d, <i>J</i> = 9.1 Hz), 7.76 (2H, dd, <i>J</i> = 2.0 Hz, <i>J</i> = 8.9 Hz), 7.63 (2H, dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.7 Hz), 7.57−7.59 (4H, m), 7.50 (2H, app t, <i>J</i> = 8.2 Hz), 7.35 (2H, d, <i>J</i> = 7.8 Hz), 6.84 (4H, d, <i>J</i> = 8.4 Hz), 6.51 (4H, d, <i>J</i> = 8.6 Hz), 2.12 (6H, s); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 152.2, 146.5, 138.8, 138.7, 136.5, 136.3, 135.2, 132.2, 130.4, 130.3, 129.8, 129.0, 128.4, 126.7, 125.2, 123.0, 122.5, 120.9, 119.5, 118.1, 114.4, 19.9; MS (MALDI(−)) <i>m</i>/<i>z</i> 962 (M − H).</div><div class="NLM_p last">This material was hydrolyzed in a 1:1 mixture of aqueous 2 N NaOH and methanol at 50 °C for 6 h. Purification by RP-HPLC gave the title compound in 98% yield as a tan solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.38 (2H, br s), 9.31 (2H, s), 8.28 (2H, s), 8.19 (2H, s), 7.97 (2H, d, <i>J</i> = 8.7 Hz), 7.93 (2H, d, <i>J</i> = 9.2 Hz), 7.77 (2H, dd, <i>J</i> = 1.9 Hz, <i>J</i> = 9.0 Hz), 7.60 (2H, dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.7 Hz), 7.43 (2H, s), 7.12−7.21 (6H, m); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 152.5, 149.1, 138.8, 137.2, 137.1, 132.4, 130.2, 128.9, 128.5, 128.3, 126.6, 122.2, 121.1, 119.9, 119.5, 117.4 114.2; MS (MALDI(−)) <i>m</i>/<i>z</i> 802 (M − Na). Anal. (C<sub>33</sub>H<sub>24</sub>N<sub>4</sub>Na<sub>2</sub>O<sub>11</sub>S<sub>4</sub>) C, H, N.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 5-{[(7-{[(7-{[(3-Carboxy-4-chlorophenyl)amino]sulfonyl}-5-hydroxy(2-naphthyl))amino]carbonylamino}-4-hydroxy(2-naphthyl))sulfonyl]amino}-2-chlorobenzoic Acid (<b>22</b>)</h3><div class="NLM_p last">The title compound was prepared by method A from compound <b>45</b> and 5-amino-2-chlorobenzoic acid in 63% yield as a brown solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.41 (2H, br s), 10.84 (2H, s), 10.71 (2H, s), 9.17 (2H, s), 8.15 (2H, s), 8.09 (2H, d, <i>J</i> = 9.2 Hz), 7.75 (2H, s), 7.67 (2H, dd, <i>J</i> = 1.8 Hz, <i>J</i> = 9.1 Hz), 7.55 (2H, d, <i>J</i> = 2.7 Hz), 7.42 (2H, d, <i>J</i> = 8.8 Hz), 7.29 (2H, dd, <i>J</i> = 2.6 Hz, <i>J</i> = 8.7 Hz), 6.97 (2H, d, <i>J</i> = 1.5 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 165.9, 154.2, 152.4, 139.0, 137.1, 136.9, 133.7, 131.7, 131.4, 126.3, 123.04, 123.01, 122.0, 121.4, 120.9, 117.5, 114.4, 101.9; MS (ES(−) <i>m</i>/<i>z</i> 811 (M − H). Anal. (C<sub>35</sub>H<sub>24</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>11</sub>S<sub>2</sub>) C, H, N.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Representative Example of Method B (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). 5-{[(7-{[(7-{[(3-Carboxy-4-chlorophenyl)amino]sulfonyl}(2-naphthyl))amino]carbonylamino}(2-naphthyl))sulfonyl]amino}-2-chlorobenzoic Acid (<b>23</b>)</h3><div class="NLM_p">To 4.98 g (22.4 mmol) of methyl 5-amino-2-chlorobenzoate hydrochloride was added 50 mL of THF followed by 11 mL (0.136 mol) of pyridine. The stirred suspension was cooled in an ice bath, and then 5.30 g (18.7 mmol) of <i>N</i>-[7-(chlorosulfonyl)-2-naphthyl]acetamide (<b>46</b>) was added as a suspension in 50 mL of THF. The mixture was allowed to warm to ambient temperature and to stir for 16 h. All volatiles were removed by rotary evaporation, and the resulting residue was extracted with ethyl acetate and 1 N HCl. The organic layer was dried (MgSO<sub>4</sub>) and filtered and volatiles were removed to provide 6.63 g (82%) of methyl 5-({[7-(acetylamino)(2-naphthyl)]sulfonyl}amino)-2-chlorobenzoate as a faint yellow solid: mp = 165−172 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.77 (1H, s), 10.31 (1H, s), 8.42 (1H, s), 8.31 (1H, s), 8.01 (1H, d, <i>J</i> = 8.5 Hz), 7.95 (1H, d, <i>J</i> = 8.9 Hz), 7.74 (1H, dd, <i>J</i> = 1.8 Hz, <i>J</i> = 8.9 Hz), 7.63 (1H, dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.6 Hz), 7.56 (1H, d, <i>J</i> = 2.6 Hz), 7.43 (1H, d, <i>J</i> = 8.7 Hz), 7.32 (1H, dd, <i>J</i> = 2.7 Hz, <i>J</i> = 8.8 Hz), 3.81 (3H, s), 2.12 (3H, s); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 168.7, 164.6, 138.4, 136.8, 136.4, 132.0, 131.5, 130.7, 130.2, 129.1, 128.3, 127.1, 126.5, 123.7, 122.7, 121.5, 120.1, 115.7, 52.4, 23.9; MS (MALDI(+)) <i>m</i>/<i>z</i> 457 (M + Na).</div><div class="NLM_p">To 4.81 g (11.1 mmol) of the above material was added 160 mL of 5 N NaOH and 7 mL of dioxane. The mixture was allowed to stir at 55 °C for 18 h. Then the mixture was diluted with 30 mL of water and filtered through a 0.2 μm nylon filter. The resulting clear filtrate was carefully acidified with 26 mL of concentrated H<sub>2</sub>SO<sub>4</sub>. The finely divided solid precipitate was collected by vacuum filtration and dried in vacuo. This produced 4.01 g (95%) of 5-{[(7-amino(2-naphthyl))sulfonyl]amino}-2-chlorobenzoic acid as a tan solid: mp = 160−165 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.63 (1H, s), 8.00 (1H, s), 7.80 (1H, d, <i>J</i> = 8.4 Hz), 7.68 (1H, d, <i>J</i> = 8.8 Hz), 7.53 (1H, d, <i>J</i> = 2.6 Hz), 7.39 (1H, d, <i>J</i> = 8.7 Hz), 7.34 (1H, dd, <i>J</i> = 1.5 Hz, <i>J</i> = 8.7 Hz), 7.27 (1H, dd, <i>J</i> = 2.7 Hz, <i>J</i> = 8.7 Hz), 7.11 (1H, dd, <i>J</i> = 2.0 Hz, <i>J</i> = 8.7 Hz), 6.96 (1H, s); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 165.8, 147.4, 136.8, 136.1, 133.5, 131.6, 131.2, 128.9, 128.5, 127.5, 126.2, 124.8, 123.1, 121.4, 121.2, 116.6, 107.0; MS (ES(−)) <i>m</i>/<i>z</i> 375 (M − H).</div><div class="NLM_p last">To 3.90 g (10.4 mmol) of 5-{[(7-amino(2-naphthyl))sulfonyl]amino}-2-chlorobenzoic acid was added 55 mL of 1 M acetate buffer (pH 4.6), 2.1 mL of 5 N NaOH (10.5 mol), and 34 mL of THF. To this reaction solution, a solution of 0.508 g (1.71 mmol) of triphosgene in 2 mL of THF was added slowly over a 1 h period. The reaction was judged incomplete, so another 4.2 mL of 5 N NaOH and 25 mL of water were added followed by the dropwise addition of a THF solution of 0.508 g of triphosgene in 2 mL of THF. The reaction was still incomplete, so another 4.2 mL of 5 N NaOH, 25 mL of water, and 0.508 g of triphosgene in 2 mL of THF (dropwise) were added. The reaction was essentially complete. The volatiles (THF) were removed from the reaction by rotary evaporation, and then the mixture was acidified with concentrated HCl. The resulting solid was collected by vacuum filtration and was washed with water. After drying in vacuo, this provided 3.79 g (93%) of the title compound as an off-white solid: mp = 182−185 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.42 (2H, br s), 10.73 (2H, s), 9.23 (2H, s), 8.32 (2H, s), 8.25 (2H, d, <i>J</i> = 1.3 Hz), 8.02 (2H, d, <i>J</i> = 8.8 Hz), 7.97 (2H, d, <i>J</i> = 8.8 Hz), 7.76 (2H, dd, <i>J</i> = 1.9 Hz, <i>J</i> = 9.0 Hz), 7.62 (2H, dd, <i>J</i> = 1.6 Hz, <i>J</i> = 8.7 Hz), 7.54 (2H, d, <i>J</i> = 2.7 Hz), 7.41 (2H, d, <i>J</i> = 8.7 Hz), 7.31 (2H, dd, <i>J</i> = 2.6 Hz, <i>J</i> = 8.7 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 165.8, 152.4, 138.8, 136.7, 136.6, 132.3, 131.7, 131.4, 130.3, 129.2, 128.6, 126.8, 126.5, 123.2, 122.6, 121.5, 119.8, 114.5; MS (MALDI(−)) <i>m</i>/<i>z</i> 780 (M − H). Anal. (C<sub>35</sub>H<sub>24</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>9</sub>S<sub>2</sub>) C, H, N.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 5-{[(7-{[(7-{[(3-Carboxy-4-hydroxyphenyl)amino]sulfonyl}-5-hydroxy(2-naphthyl))amino]carbonylamino}-4-hydroxy(2-naphthyl))sulfonyl]amino}-2-hydroxybenzoic Acid (<b>24</b>)</h3><div class="NLM_p last">The title compound was prepared by method A from compound <b>45</b> and 5-aminosalicylic acid in 5% yield as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.75 (2H, s), 10.07 (2H, s), 9.14 (2H, s), 8.08 (2H, d, <i>J</i> = 8.9 Hz), 8.08 (2H, d, <i>J</i> = 2.1 Hz), 7.66 (2H, dd, <i>J</i> = 2.0 Hz, <i>J</i> = 9.2 Hz), 7.61 (2H, s), 7.52 (2H, d, <i>J</i> = 2.7 Hz), 7.24 (2H, dd, <i>J</i> = 2.8 Hz, <i>J</i> = 8.8 Hz), 6.92 (2H, d, <i>J</i> = 1.5 Hz), 6.84 (2H, d, <i>J</i> = 8.8 Hz); MS (ES(−)) <i>m</i>/<i>z</i> 773 (M − H). Anal. (C<sub>35</sub>H<sub>26</sub>N<sub>4</sub>O<sub>13</sub>S<sub>2</sub>) C, H, N.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 2-Hydroxy-5-{[(7-{[(7-sulfo(2-naphthyl))amino]carbonylamino}(2-naphthyl))sulfonyl]amino}benzoic Acid (<b>25</b>)</h3><div class="NLM_p last">This compound was prepared by a variation of the general method A. To 120 mg (0.78 mmol) of 5-aminosalicylic acid suspended in 4 mL of pyridine was added 100 mg (0.20 mmol) of compound <b>44</b> as a solid. The mixture was allowed to stir at ambient temperature for 16 h. Then 100 mL of diethyl ether was added and the resulting solid collected by centrifugation. The title compound was obtained by RP-HPLC purification using a gradient system of CH<sub>3</sub>CN/H<sub>2</sub>O and 0.5% TFA. This provided 24 mg (20%) of the desired product <b>25</b> as a brown solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.73 (1H, s), 9.24 (1H, s), 9.18 (1H, s), 8.15 (1H, s), 8.14 (1H, s), 8.03 (1H, s), 8.01 (1H, s), 7.96 (1H, d, <i>J</i> = 8.0 Hz), 7.94 (1H, d, <i>J</i> = 8.3 Hz), 7.85 (1H, d, <i>J</i> = 8.8 Hz), 7.78 (2H, d, <i>J</i> = 8.3 Hz), 7.67 (1H, dd, <i>J</i> = 1.8 Hz, <i>J</i> = 8.7 Hz), 7.57 (1H, dd, <i>J</i> = 1.4 Hz, <i>J</i> = 8.4 Hz), 7.53 (1H, dd, <i>J</i> = 1.8 Hz, <i>J</i> = 8.7 Hz), 7.46 (1H, d, <i>J</i> = 2.8 Hz), 6.94 (1H, d, <i>J</i> = 8.8 Hz), 6.53 (1H, d, <i>J</i> = 8.8 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 171.4, 159.6, 152.6, 145.8, 138.9, 137.7, 137.3, 132.7, 132.3, 131.3, 129.9, 128.8, 128.5, 128.3, 127.9, 127.6, 126.8, 126.43, 126.36, 124.7, 123.1, 122.1, 121.9, 120.1, 120.0, 116.2, 114.2, 114.1; MS (MALDI(−)) <i>m</i>/<i>z</i> 606 (M − H).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-Chloro-5-{[(7-{[(7-{[(4-chloro-3-sulfophenyl)amino]sulfonyl}(2-naphthyl))amino]carbonylamino}(2-naphthyl))sulfonyl]amino}benzenesulfonic Acid, Disodium Salt (<b>29</b>)</h3><div class="NLM_p last">The title compound was prepared as described for compound <b>23</b> (method B) from compound <b>46</b> and 4-methylphenyl 5-amino-2-chlorobenzenesulfonate (<b>56</b>) in 61% overall yield for three steps as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.51 (2H, s), 9.27 (2H, s), 8.29 (2H, s), 8.21 (2H, s), 8.00 (2H, d, <i>J</i> = 8.8 Hz), 7.95 (2H, d, <i>J</i> = 8.8 Hz), 7.80 (2H, dd, <i>J</i> = 1.8 Hz, <i>J</i> = 8.8 Hz), 7.71 (2H, d, <i>J</i> = 2.7 Hz), 7.60 (2H, dd, <i>J</i> = 1.6 Hz, <i>J</i> = 8.7 Hz), 7.22 (2H, d, <i>J</i> = 8.5 Hz), 7.12 (2H, dd, <i>J</i> = 2.7 Hz, <i>J</i> = 8.6 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 152.2, 145.9, 138.4, 137.4, 135.8, 132.1, 130.2, 130.0, 128.4, 128.0, 126.1, 125.2, 122.1, 121.1, 120.6, 119.7, 114.5; MS (ES(−)) <i>m</i>/<i>z</i> 851 (M − H). Anal. (C<sub>33</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>4</sub>Na<sub>2</sub>O<sub>11</sub>S<sub>4</sub>) C, H, N.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-Chloro-5-{[(7-{[(7-{[(4-chloro-3-sulfophenyl)amino]sulfonyl}-5-hydroxy(2-naphthyl))amino]carbonylamino}-4-hydroxy(2-naphthyl))sulfonyl]amino}benzenesulfonic Acid, Disodium Salt (<b>30</b>)</h3><div class="NLM_p last">The title compound was prepared as described for compound <b>23</b> (method B) from compound <b>47</b> and 4-methylphenyl 5-amino-2-chlorobenzenesulfonate (<b>56</b>) in 29% overall as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.83 (2H, s), 10.48 (2H, s), 9.23 (2H, s), 8.11 (2H, d, <i>J</i> = 2.5 Hz), 8.09 (2H, d, <i>J</i> = 8.7 Hz), 7.75 (2H, d, <i>J</i> = 1.4 Hz), 7.73 (2H, d, <i>J</i> = 2.7 Hz), 7.71 (2H, dd, <i>J</i> = 2.5 Hz, <i>J</i> = 8.7 Hz), 7.22 (2H, d, <i>J</i> = 8.5 Hz), 7.05 (2H, dd, <i>J</i> = 2.7 Hz, <i>J</i> = 8.5 Hz), 6.96 (2H, d, <i>J</i> = 1.4 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 154.1, 152.4, 145.6, 139.0, 137.5, 135.9, 133.7, 130.8, 125.5, 123.0, 122.0, 120.79, 120.76, 120.5, 117.4, 114.3, 102.1; MS (ES(−)) <i>m</i>/<i>z</i> 882 (M − H). Anal. (C<sub>33</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>4</sub>Na<sub>2</sub>O<sub>13</sub>S<sub>4</sub>·0.5NaCl) C, H, N, Cl.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 3-({7-[(<i>N</i>-{7-[<i>N</i>-(3-Carboxyphenyl)carbamoyl]-2-naphthyl}carbamoyl)amino]-2-naphthyl}carbonylamino)benzoic Acid (<b>33</b>)</h3><div class="NLM_p last">To 20 mg (0.022 mmol) of compound <b>61</b> was added 1.5 mL of 1.37 M sodium methoxide in methanol, 1 mL of water, and 0.5 mL of THF. The resulting solution was allowed to stir at ambient temperature for 2 days. The reaction was acidified with 1 N HCl (aqueous), and the organic volatiles were removed in vacuo. The solid precipitate was collected by vacuum filtration to afford 13 mg (90%) of the title compound as a tan solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.00 (2H, br s), 10.57 (2H, s), 9.19 (2H, s), 8.54 (2H, s), 8.48 (2H, s), 8.34 (2H, s), 8.12 (2H, d, <i>J</i> = 7.9 Hz), 7.96−8.00 (4H, m), 7.90 (2H, dd, <i>J</i> = 1.5 Hz, <i>J</i> = 8.4 Hz), 7.68−7.71 (4H, m), 7.51 (2H, app t, <i>J</i> = 7.9 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 127.3, 126.0, 113.0, 99.7, 98.3, 93.1, 92.6, 91.6, 90.7, 89.0, 88.5, 87.9, 87.3, 84.7, 82.8, 81.8, 81.5, 74.9; MS (MALDI(−)) <i>m</i>/<i>z</i> 638 (M).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 5-({[7-(<i>N</i>-{2-[<i>N</i>-(7-{[(3-Carboxy-4-chlorophenyl)amino]sulfonyl}(2-naphthyl))acetylamino]ethyl}acetylamino)(2-naphthyl)]sulfonyl}amino)-2-chlorobenzoic Acid (<b>36</b>)</h3><div class="NLM_p last">To 750 mg (4.37 mmol) of 5-amino-2-chlorobenzoic acid was added 30 mL of THF and 605 μL of pyridine. This solution was cooled in an ice bath, and then 452 mg (0.76 mmol) of the disulfonyl chloride (<b>63</b>) was added. The mixture was left to stir and warm to room temperature for 16 h. Then the volatiles were removed by rotary evaporation. The resulting residue was extracted with ethyl acetate and 0.5 N HCl. The ethyl acetate layer was dried (MgSO<sub>4</sub>) and filtered, and the volatiles were removed by rotary evaporation. The title compound was purified by silica gel column chromatography, eluting with 20:2:1 ethyl acetate/isopropanol/water and then 10:2:1 ethyl actate/isopropanol/water. This provided 156 mg (24%) of the desired product as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.26 (2H, s), 8.01 (2H, d, <i>J</i> = 7.4 Hz), 7.88 (2H, d, <i>J</i> = 8.4 Hz), 7.78 (2H, s), 7.76 (2H, d, <i>J</i> = 7.4 Hz), 7.38 (2H, d, <i>J</i> = 8.4 Hz), 7.26 (2H, s), 7.11 (2H, d, <i>J</i> = 8.5 Hz), 7.02 (2H, d, <i>J</i> = 8.1 Hz), 3.87 (4H, s), 1.70 (6H, s); MS (MALDI(+)) <i>m</i>/<i>z</i> 886 (M + Na).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 5-({[7-({2-[(7-{[(3-Carboxy-4-chlorophenyl)amino]sulfonyl}(2-naphthyl))amino]ethyl}amino)(2-naphthyl)]sulfonyl}amino)-2-chlorobenzoic Acid (<b>37</b>)</h3><div class="NLM_p last">To 156 mg (0.18 mmol) of compound <b>36</b> was added 10 mL of 5 N NaOH, and the resulting solution was heated at 70 °C for 16 h. The mixture was cooled and then acidified with 6 N HCl to pH 1. The resulting solid was collected by vacuum filtration to give, after drying, 137 mg (98%) of the title compound as a tan solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.43 (2H, br s), 10.62 (2H, s), 8.08 (2H, s), 7.80 (2H, d, <i>J</i> = 8.4 Hz), 7.68 (2H, d, <i>J</i> = 8.8 Hz), 7.53 (2H, d, <i>J</i> = 2.6 Hz), 7.39 (2H, d, <i>J</i> = 8.7 Hz), 7.35 (2H, dd, <i>J</i> = 1.8 Hz, <i>J</i> = 8.5 Hz), 7.27 (2H, dd, <i>J</i> = 2.6 Hz, <i>J</i> = 8.8 Hz), 7.16 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 8.8 Hz), 6.95 (2H, s), 6.35 (2H, br s), methylene protons are under HOD peak; MS (ES(−)) <i>m</i>/<i>z</i> 778 (M − H).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 5-({[7-({[(7-{[(3-Carboxy-4-chlorophenyl)amino]sulfonyl}(2-naphthyl))amino]thioxomethyl}amino)(2-naphthyl)]sulfonyl}amino)-2-chlorobenzoic Acid (<b>38</b>)</h3><div class="NLM_p last">To 53 mg (64.3 μmol) of compound <b>66</b> was added 5 mL of 1 N NaOH. The resulting solution was allowed to stir for 1 h at ambient temperature, and then it was acidified with 6 N HCl to pH 1. The resulting solid was collected by vacuum filtration. Drying provided 44 mg (86%) of the title compound as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.42 (2H, br s), 10.73 (2H, s), 10.31 (2H, s), 8.38 (2H, s), 8.19 (2H, d, <i>J</i> = 1.4 Hz), 8.07 (2H, d, <i>J</i> = 8.8 Hz), 7.98 (2H, d, <i>J</i> = 9.2 Hz), 7.85 (2H, dd, <i>J</i> = 1.8 Hz, <i>J</i> = 8.9 Hz), 7.69 (2H, dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.7 Hz), 7.54 (2H, d, <i>J</i> = 2.7 Hz), 7.39 (2H, d, <i>J</i> = 8.8 Hz), 7.29 (2H, dd, <i>J</i> = 2.7 Hz, <i>J</i> = 8.8 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 180.0, 165.6, 138.6, 136.5, 131.8, 131.7, 131.6, 131.2, 131.1, 128.9, 127.7, 127.0, 126.7, 126.4, 123.2, 121.6, 120.9, 120.8; MS (ES(−)) <i>m</i>/<i>z</i> 795 (M). Anal. (C<sub>35</sub>H<sub>24</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>8</sub>S<sub>3</sub>) C, H, N.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 5-{[(7-{2-Amino-1-aza-2-[(7-{[(3-carboxy-4-chlorophenyl)amino]sulfonyl}(2-naphthyl))amino]vinyl}(2-naphthyl))sulfonyl]amino}-2-chlorobenzoic Acid (<b>39</b>)</h3><div class="NLM_p last">To 50 mg (62.0 μmol) of compound <b>67</b> was added 10 mL of 1 N NaOH. The resulting solution was allowed to stir at ambient temperature for 1 h. The mixture was acidified to pH 1 using 11 mL of 1 N HCl. A white precipitate formed, which was collected by vacuum filtration and was washed with water. The solid was dried in vacuo to provide 45 mg (93%) of the title compound as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.65 (2H, br s), 8.40 (2H, s), 8.08 (2H, d, <i>J</i> = 9.3 Hz), 8.06 (2H, s), 8.02 (2H, d, <i>J</i> = 8.9 Hz), 7.71 (2H, dd, <i>J</i> = 1.5 Hz, <i>J</i> = 8.7 Hz), 7.62 (2H, dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.7 Hz), 7.43 (2H, d, <i>J</i> = 2.6 Hz), 7.34 (2H, d, <i>J</i> = 8.7 Hz), 7.24 (2H, dd, <i>J</i> = 2.6 Hz, <i>J</i> = 8.7 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 166.7, 152.3, 138.3, 136.7, 136.4, 133.8, 132.2, 131.4, 130.8, 129.0, 128.8, 126.9, 126.0, 125.7, 122.5, 121.3, 120.7, 120.5; MS (MALDI(+)) <i>m</i>/<i>z</i> 779 (M).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 5-{[(7-{[<i>N</i>-(7-{[(3-Carboxy-4-chlorophenyl)amino]sulfonyl}(2-naphthyl))-<i>N</i>-methylcarbamoyl]methylamino}(2-naphthyl))sulfonyl]amino}-2-chlorobenzoic Acid (<b>42</b>)</h3><div class="NLM_p">To 300 mg (0.58 mmol) of 7-{[(7-sulfo-2-naphthyl)amino]carbonylamino}naphthalene-2-sulfonic acid, disodium salt (first intermediate in synthesis of <b>44</b>) suspended in 40 mL of DMF was added 60 mg (60% dispersion in mineral oil, 1.50 mmol) of NaH. The mixture was allowed to stir for 1 h, and then 90 μL (1.45 mmol) of iodomethane was added. The mixture was allowed to stir for 19 h, and then another 25 mg (0.625 mmol) of NaH dispersion was added followed by 30 μL (0.483 mmol) of iodomethane after 1 h. The mixture was allowed to stir an additional 24 h before precipitation with diethyl ether. The resulting solid was collected by vacuum filtration, and the solid was dissolved in water. The product was precipitated by the addition of brine and was collected by vacuum filtration. Drying provided 7-{<i>N</i>-methyl[methyl(7-sulfo(2-naphthyl))amino]carbonylamino}naphthalene-2-sulfonic acid, disodium salt, as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.01 (2H, s), 7.65 (2H, d, <i>J</i> = 8.8 Hz), 7.63 (2H, s), 7.55 (4H, d, <i>J</i> = 6.8 Hz), 7.17 (2H, dd, <i>J</i> = 1.9 Hz, <i>J</i> = 8.8 Hz), 3.22 (6H, s); MS (MALDI(−)) <i>m</i>/<i>z</i> 521 (M − Na).</div><div class="NLM_p">To all of the product from step 1 was added 25 mL of phosphorus oxychloride. This stirred suspension was cooled in an ice bath for 1 h and then allowed to warm to room temperature. The suspension was allowed to stir at ambient temperature for 26 h. Then the cloudy suspension was poured onto 1 L of ice and this suspension placed in a second ice bath. After the ice had melted, the precipitate was collected by vacuum filtration and was washed with water. The white solid was dried to provide 247 mg of <i>N</i>-[7-(chlorosulfonyl)(2-naphthyl)]{[7-(chlorosulfonyl)(2-naphthyl)]methylamino}-<i>N</i>-methylcarboxamide.</div><div class="NLM_p">To 300 mg (1.62 mmol) of methyl 5-amino-2-chlorobenzoate dissolved in 15 mL of freshly distilled THF was added 100 μL (1.24 mmol) of pyridine. To this solution was added 243 mg (0.452 mmol) of the disulfonylchloride prepared above. The mixture was heated to reflux for 40 h. Then the mixture was partitioned between ethyl acetate and 1 N HCl (aq). The organic layer was further washed with 6 N HCl (2×), 1 N NaHCO<sub>3</sub> (2×), water, and brine. The ethyl acetate layer was dried with MgSO<sub>4</sub> and filtered, and the volatiles were removed by rotary evaporation. This provided 275 mg (73%) of methyl 2-chloro-5-({[7-({<i>N</i>-[7-({[4-chloro-3-(methoxycarbonyl)phenyl]amino}sulfonyl)(2-naphthyl)]-<i>N</i>-methylcarbamoyl}methylamino)(2-naphthyl)]sulfonyl}amino)benzoate as an off-white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.75 (2H, br s), 8.28 (2H, s), 7.75 (2H, d, <i>J</i> = 8.5 Hz), 7.74 (2H, s), 7.56 (2H, dd, <i>J</i> = 1.6 Hz, <i>J</i> = 8.7 Hz), 7.55 (2H, d, <i>J</i> = 2.6 Hz), 7.45 (2H, d, <i>J</i> = 8.7 Hz), 7.40 (2H, d, <i>J</i> = 9.1 Hz), 7.29 (2H, dd, <i>J</i> = 2.7 Hz, <i>J</i> = 8.7 Hz), 7.22 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 8.9 Hz), 3.81 (6H, s), 3.24 (6H, s); MS (ES(−)) <i>m</i>/<i>z</i> 835 (M − H).</div><div class="NLM_p last">To 140 mg (0.168 mmol) of the product from step 3 was added 25 mL of 1 N NaOH (aq). After 1 h, the reaction solution was acidified with 6 N HCl (aq) to produce a white precipitate. The solid was collected by vacuum filtration, washed with water, and dried to give 119 mg (88%) of the title compound as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.53 (2H, br s), 10.71 (2H, s), 8.27 (2H, s), 7.74 (2H, d, <i>J</i> = 8.7 Hz), 7.72 (2H, s), 7.55 (2H, dd, <i>J</i> = 1.6 Hz, <i>J</i> = 8.8 Hz), 7.54 (2H, d, <i>J</i> = 2.8 Hz), 7.41 (2H, d, <i>J</i> = 8.8 Hz), 7.35 (2H, d, <i>J</i> = 8.7 Hz), 7.26 (2H, dd, <i>J</i> = 2.8 Hz, <i>J</i> = 8.7 Hz), 7.18 (2H, dd, <i>J</i> = 2.0 Hz, 8.9 Hz), 3.24 (6H, s); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 165.7, 159.1, 143.6, 136.5, 136.2, 131.8, 131.7, 131.6, 131.1, 130.9, 128.5, 127.7, 127.0, 126.4, 126.2, 123.1, 121.5, 120.7, 37.7; MS (ES(−)) <i>m</i>/<i>z</i> 807 (M − H).</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 5-[({7-[3-(7-{[(3-Carboxy-4-chlorophenyl)amino]sulfonyl}(2-naphthyl))-2-oxoimidazolidinyl](2-naphthyl)}sulfonyl)amino]-2-chlorobenzoic Acid (<b>43</b>)</h3><div class="NLM_p last">To 126 mg (0.16 mmol) of compound <b>37</b> was added 10 mL of saturated Na<sub>2</sub>CO<sub>3</sub>, 10 mL of water, and 10 mL of THF. This formed a clear brown solution. To this solution was added, dropwise over 30 min, a solution of 52 mg (0.18 mmol) of triphosgene in 800 μL of THF. An aliquot was examined by HPLC, and the reaction was determined to be incomplete. Then another solution of triphosgene (53 mg in 800 μL of THF) was added dropwise and the reaction monitored by HPLC. This was repeated six times until all starting amine had been consumed. The reaction solution was acidified with 6 N HCl and then reduced in volume by rotary evaporation. The resulting brown solid was collected by vacuum filtration. The title compound, 73 mg (56%), was obtained by preparative RP-HPLC (CH<sub>3</sub>CN/water with 0.5% TFA) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.45 (2H, br s), 10.75 (2H, s), 8.43 (2H, dd, <i>J</i> = 2.0 Hz, <i>J</i> = 8.8 Hz), 8.40 (2H, s), 8.06 (2H, d, <i>J</i> = 9.3 Hz), 8.05 (2H, s), 8.03 (2H, d, <i>J</i> = 9.3 Hz), 7.66 (2H, dd, <i>J</i> = 1.8 Hz, <i>J</i> = 8.6 Hz), 7.54 (2H, d, <i>J</i> = 2.6 Hz), 7.41 (2H, d, <i>J</i> = 8.7 Hz), 7.30 (2H, dd, <i>J</i> = 2.5 Hz, <i>J</i> = 8.6 Hz), 4.17 (4H, s); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 165.6, 154.1, 139.2, 136.6, 136.5, 131.9, 131.7, 131.2, 130.3, 128.9, 128.1, 127.0, 126.5, 123.3, 121.7, 121.3, 121.2, 120.1, 114.4; MS (ES(−)) <i>m</i>/<i>z</i> 805 (M − H). Anal. (C<sub>37</sub>H<sub>26</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>9</sub>S<sub>2</sub>) C, H, N.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-[7-(Chlorosulfonyl)(2-naphthyl)]{[7-(chlorosulfonyl)(2-naphthyl)]amino}carboxamide (<b>44</b>)</h3><div class="NLM_p last">To 5.25 g (0.024 mol) of 7-amino-2-naphthalenesulfonic acid suspended in 80 mL of water was added a solution of 6.5 mL of 10 N aqueous NaOH (0.065 mol) diluted to 30 mL with water and a solution of 3.20 g (0.011 mol) of triphosgene in 30 mL of THF portionwise, alternating such that the pH of the reaction was maintained above 8. After the reaction was complete by TLC (6:2:1 ethyl acetate/isopropanol/water) the pH was lowered to 1 with aqueous HCl and the volatiles were removed by rotary evaporation. The solid product was collected by vacuum filtration and was washed with water. This afforded 3.41 g (63%) of 7-{[(7-sulfo-2-naphthyl)amino]carbonylamino}naphthalene-2-sulfonic acid, disodium salt, as an off-white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.04 (2H, s), 8.01 (2H, s), 8.00 (2H, d, <i>J</i> = 2.0 Hz), 7.85 (2H, d, <i>J</i> = 8.8 Hz), 7.77 (2H, d, <i>J</i> = 8.6 Hz), 7.71 (2H, dd, <i>J</i> = 2.0 Hz, <i>J</i> = 8.9 Hz), 7.57 (2H, dd, <i>J</i> = 1.5 Hz, <i>J</i> = 8.5 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 152.6, 145.7, 137.8, 132.7, 128.8, 127.9, 126.9, 123.2, 121.9, 120.1, 114.0; MS (MALDI(−)) <i>m</i>/<i>z</i> 492 (M − Na). To 2.35 g (4.55 mmol) of 7-{[(7-sulfo-2-naphthyl)amino]carbonyl amino}naphthalene-2-sulfonic acid, disodium salt, prepared above was added 116 mL of sulfolane, 25 mL of acetonitrile, 31 mL of phosphorus oxychloride, and 1 mL of dimethylacetamide. The mixture was allowed to stir for 72 h at ambient temperature. This produced a nearly clear solution. The mixture was poured onto 1.5 L of ice, and the flask was placed in an ice bath. After all the ice within the flask had melted, the solid was collected by vacuum filtration and was washed with water. The solid was dried under high vacuum for 24 h. This produced 2.29 g (99%) of the title compound as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.10 (2H, s), 8.00 (4H, s), 7.84 (2H, d, <i>J</i> = 9.1 Hz), 7.77 (2H, d, <i>J</i> = 8.5 Hz), 7.70 (2H, dd, <i>J</i> = 2.0 Hz, <i>J</i> = 8.8 Hz), 7.56 (2H, dd, <i>J</i> = 1.5 Hz, <i>J</i> = 8.5 Hz). This compound was used without further characterization.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-[7-(Chlorosulfonyl)-5-hydroxy(2-naphthyl)]{[7-(chlorosulfonyl)-5-hydroxy(2-naphthyl)]amino}carboxamide (<b>45</b>)</h3><div class="NLM_p">To 10.77 g (0.045 mol) of 7-amino-4-hydroxy-2-naphthalenesulfonic acid dissolved in 45 mL of 1 N aqueous NaOH and 50 mL of water was added 3.70 g (0.045 mol) of sodium acetate. The pH of the solution was above 9. The mixture was cooled to less than 5 °C in an ice−water bath. Then 2.23 g (7.50 mmol) of triphosgene dissolved in 15 mL of THF was added in three portions. The pH of the mixture fell to 4−5 and was readjusted to 7−8 by the addition of 1 N aqueous NaOH. TLC (6:2:1 ethyl acetate/isopropanol/water) indicated the reaction was incomplete. Another 2.20 g (7.50 mmol) of triphosgene in 10 mL of THF was added portionwise with the pH kept above 7 by the addition of 1 N aqueous NaOH. When the reaction was judged complete by TLC, the pH was lowered to 1 with aqueous HCl and the volatiles were removed by rotary evaporation. The solid product was collected by vacuum filtration. This afforded 10.85 g (88%) of 4-hydroxy-7-{[(5-hydroxy-7-sulfo(2-naphthyl))amino]carbonylamino}naphthalene-2-sulfonic acid, disodium salt, as a tan solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.06 (2H, s), 9.22 (2H, s), 8.01 (2H, d, <i>J</i> = 9.25 Hz), 7.96 (2H, d, <i>J</i> = 2.15 Hz), 7.58 (2H, dd, <i>J</i> = 2.15 Hz, <i>J</i> = 9.25 Hz), 7.50 (2H, s), 7.03 (2H, s); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 152.9, 152.6, 146.2, 138.1, 134.2, 122.5, 120.3, 118.4, 114.3, 113.5, 104.4; MS (ES(−)) <i>m</i>/<i>z</i> 525 (M − Na).</div><div class="NLM_p last">To 5.00 g (9.11 mmol) of 4-hydroxy-7-{[(5-hydroxy-7-sulfo(2-naphthyl))amino]carbonylamino}naphthalene-2-sulfonic acid, disodium salt, suspended in 70 mL of phosphorus oxychloride was added dropwise 4 mL of dimethylacetamide. The mixture was allowed to stir at ambient temperature for 24 h. Then the mixture was poured onto 1 L of ice, and this flask was placed in an ice bath. After the ice within the flask had melted, the solid was collected by vacuum filtration and was washed with water. The product was dried under high vacuum for 24 h to provide 4.1 g (83%) of the title compound as a tan solid. This compound was not stable to long-term storage and was therefore prepared and used within a few weeks. The compound was used without characterization.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-[7-(Chlorosulfonyl)-2-naphthyl]acetamide (<b>46</b>)</h3><div class="NLM_p">To a mixture of 300 mL each of acetic anhydride and pyridine cooled in an ice bath was added 59.7 g (0.27 mol) of solid 7-amino-2-naphthalenesulfonic acid portionwise, keeping the reaction temperature below 20 °C. After the final addition, the reaction solution was allowed to warm to ambient temperature and stirred for 16 h. The suspension was poured into a mixture of 2 L of diethyl ether and 1 L of THF. The resulting solid was collected by vacuum filtration. The pyridinum salt was dissolved in 300 mL of methanol. Next, a sodium methoxide solution in methanol was prepared by the addition of 7.9 g (0.34 mol) Na(s) to 300 mL of methanol. After all of the Na(s) had reacted, this clear solution was added to the above methanol solution of crude product. A solid began to form and was allowed to sit for 12 h. The product was collected by vacuum filtration and dried in vacuo to afford 64.2 g. The filtrate was reduced in volume to about 400 mL and allowed to sit for an additional 12 h for precipitate formation. Collection of this second crop of product provided 4.8 g. This provided a total yield of 69.0 g (88%) of 7-(acetylamino)naphthalene-2-sulfonic acid, sodium salt, as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.16 (1H, s), 8.16 (1H,s), 7.96 (1H, s), 7.83 (1H, d, <i>J</i> = 8.8 Hz), 7.77 (1H, d, <i>J</i> = 8.4 Hz), 7.68 (1H, dd, <i>J</i> = 2.0 Hz, <i>J</i> = 8.8 Hz), 7.58 (1H, dd, <i>J</i> = 1.5 Hz, <i>J</i> = 8.5 Hz), 2.10 (3H, s); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 168.6, 146.0, 137.4, 132.6, 129.4, 127.9, 126.9, 123.5, 122.5, 120.5, 115.7, 24.0; MS (MALDI(−)) <i>m</i>/<i>z</i> 263 (M − H).</div><div class="NLM_p last">To 10.3 g (35.8 mmol) of the above material was added 125 mL of phosphorus oxychloride. The resulting suspension was allowed to cool in an ice bath until an internal temperature of 5 °C was reached. Then 5 mL of dimethylacetamide was added dropwise. The mixture was allowed to stir and warm to ambient temperature for 23 h. Then the suspension was poured onto 4 L of ice. The container of ice was placed in a second container of ice and allowed to melt. When most of the ice had melted, the white solid precipitate was collected by vacuum filtration and washed with additional water. The solid was dried in vacuo to afford 6.67 g (66%) of <i>N</i>-[7-(chlorosulfonyl)-2-naphthyl]acetamide (<b>46</b>) as an off-white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.19 (1H, s), 8.18(1H, s), 7.96 (1H, s), 7.84 (1H, d, <i>J</i> = 8.8 Hz), 7.78 (1H, d, <i>J</i> = 8.7 Hz), 7.67 (1H, dd, <i>J</i> = 1.8 Hz, <i>J</i> = 8.8 Hz), 7.58 (1H, dd, <i>J</i> = 1.4 Hz, <i>J</i> = 8.5 Hz), 2.10 (3H, s).</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 7-Acetamido-4-hydroxynaphthalene-2-sulfonyl Chloride (<b>47</b>)</h3><div class="NLM_p">To 93.0 g (0.389 mol) of 7-amino-4-hydroxynaphthalene-2-sulfonic acid was added a solution of 200 mL of acetic anhydride and 200 mL of pyridine. The reaction temperature increased, and so the mixture was was placed in an ice bath for 10 min. The mixture was removed from the ice bath and allowed to stir at ambient temperature for 16 h. The solid was collected by vacuum filtration and was washed with THF. Drying in vacuo provided 155 g (99%) of 7-(acetylamino)-4-acetyloxynaphthalene-2-sulfonic acid, pyridinium salt, as a tan solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.25 (1H, s), 8.84 (2H, d, <i>J</i> = 4.9 Hz), 8.38 (1H, dt, <i>J</i> = 1.5 Hz, <i>J</i> = 7.8 Hz), 8.27 (1H, s), 7.89 (2H, dd, <i>J</i> = 4.9 Hz, <i>J</i> = 7.8 Hz), 7.85 (1 H, d, <i>J</i> = 9.1 Hz), 7.81 (1H, s), 7.71 (1H, dd, <i>J</i> = 1.9 Hz, <i>J</i> = 9.1 Hz), 7.34 (1H, d, <i>J</i> = 1.4 Hz), 2.44 (3H, s), 2.11 (3H, s); MS (ES(−)) <i>m</i>/<i>z</i> 280 (M − CH<sub>3</sub>CO).</div><div class="NLM_p last">This was converted to the title compound as described for the synthesis of <i>N</i>-[7-(chlorosulfonyl)-2-naphthyl]acetamide (<b>46</b>). The compound was used without characterization.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Methyl 3-({7-[(Fluoren-9-ylmethoxy)carbonylamino]-2-naphthyl}carbonylamino)benzoate (<b>59</b>)</h3><div class="NLM_p">To 0.504 g (2.70 mmol) of 7-aminonaphthalene-2-carboxylic acid (<b>58</b>) was added 10 mL of dioxane, 5 mL of 10% sodium carbonate, and 35 mL of water. To this clear solution was added 0.786 g (3.04 mmol) of 9-fluorenylmethyl chloroformate, portionwise, over 15 min. After 3 h, the mixture was acidified with 1 N HCl and the resulting white precipitate was collected by vacuum filtration. This solid was suspended in diethyl ether and stirred to give a fine precipitate that was collected by vacuum filtration. This provided 0.948 g (86%) of 7-[(fluoren-9-ylmethoxy)carbonylamino]naphthalene-2-carboxylic acid as an off-white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.93 (1H, br s), 8.25 (1H, s), 8.02 (1H, br s), 7.94 (2H, d, <i>J</i> = 7.3 Hz), 7.86 (1H, d, <i>J</i> = 8.5 Hz), 7.73−7.83 (4H, m), 7.59 (1H, br s), 7.44 (2H, app t, <i>J</i> = 7.1 Hz), 7.36 (2H, app t, <i>J</i> = 6.8 Hz), 4.55 (2H, d, <i>J</i> = 6.0 Hz), 4.35 (1H, t, <i>J</i> = 6.2 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 169.0, 146.3, 142.4, 139.2, 137.2, 137.2, 134.1, 134.0, 128.6, 127.8, 127.2, 126.9, 126.3, 121.5, 120.9, 119.6, 119.0, 109.1, 106.8; MS (MALDI(+)) <i>m</i>/<i>z</i> 431 (M + Na).</div><div class="NLM_p last">To 305 mg (0.75 mmol) of 7-[(fluoren-9-ylmethoxy)carbonylamino]naphthalene-2-carboxylic acid was added 10 mL of chloroform, 3.5 mL of thionyl chloride, and 180 μL of pyridine. The mixture was allowed to stir at ambient temperature for three hours, followed by removal of volatiles by rotary evaporation. The resulting residue was stripped 2 times from chloroform. Then 50 mL of chloroform, 124 mg (0.89 mmol) of methyl-3-aminobenzoate, and 100 μL of pyridine were added. The mixture was allowed to stir at ambient temperature for 16 h. The mixture was extracted twice with 1 N HCl (aqueous) and once with water. The dried organic layer (MgSO<sub>4</sub>) was filtered, and the volatiles were removed by rotary evaporation. The resulting residue was treated with methanol to form a solid precipitate that was collected by vacuum filtration. This afforded 380 mg (93%) of the title compound as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.59 (1H, s), 10.06 (1H, br s), 8.51 (1H, d, <i>J</i> = 1.7 Hz), 8.50 (1H, d, <i>J</i> = 9.0 Hz), 8.24 (1H, br s), 8.14 (1H, d, <i>J</i> = 9.1 Hz), 7.88−7.98 (5H, m), 7.80 (2H, d, <i>J</i> = 7.3 Hz), 7.72 (1H, d, <i>J</i> = 7.8 Hz), 7.63 (1H, br s), 7.54 (1H, app t, <i>J</i> = 7.9 Hz), 7.44 (2H, app t, <i>J</i> = 7.3 Hz), 7.37 (2H, app t, <i>J</i> = 7.3 Hz), 4.58 (2H, d, <i>J</i> = 6.4 Hz), 4.37 (1H, t, <i>J</i> = 6.3 Hz), 3.89 (3H, s); MS (MALDI(−)) <i>m</i>/<i>z</i> 542 (M − H).</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Methyl 3-[(7-{[(7-{<i>N</i>-[3-(Methoxycarbonyl)phenyl]carbamoyl}-2-naphthyl)amino]carbonylamino}-2-naphthyl)carbonylamino]benzoate (<b>61</b>)</h3><div class="NLM_p">To 380 mg (0.70 mmol) of compound <b>59</b> was added 30 mL of dichloromethane, 3 mL of THF, and 1 mL of piperidine. The resulting clear solution was allowed to stir for 3 h. Then the reaction was extracted with ethyl acetate and 1 N HCl (aqueous). The dried organic layer (MgSO<sub>4</sub>) was filtered, and the volatiles were removed in vacuo. The resulting residue was dissolved in dichloromethane, and 3 mL of 1 N HCl in diethyl ether and 50 mL of diethyl ether were added to form a precipitate that was collected by vacuum filtration. Drying provided 212 mg (85%) of methyl 3-[(7-amino-2-naphthyl)carbonylamino]benzoate hydrochloride. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.50 (1H, s), 8.51 (1H, s), 8.42 (2H, br s), 8.20 (1H, s), 8.12 (1H, d, <i>J</i> = 7.8 Hz), 7.76 (1H, d, <i>J</i> = 8.4 Hz), 7.70 (1H, d, <i>J</i> = 8.6 Hz), 7.68 (1H, d, <i>J</i> = 8.3 Hz), 7.62 (1H, dd, <i>J</i> = 1.5 Hz, <i>J</i> = 8.6 Hz), 7.52 (1H, app t, <i>J</i> = 7.9 Hz), 7.05 (1H, dd, <i>J</i> = 2.0 Hz, <i>J</i> = 8.7 Hz), 6.96 (1H, s), 3.88 (3H, s); MS (MALDI(+)) <i>m</i>/<i>z</i> 342 (M + Na).</div><div class="NLM_p last">To 305 mg (0.75 mmol) of methyl 3-[(7-amino-2-naphthyl)carbonylamino]benzoate hydrochloride was added 10 mL of chloroform, 3.5 mL of thionyl chloride, and 180 μL of pyridine. The mixture was allowed to stir at ambient temperature for 3 h, followed by removal of volatiles by rotary evaporation. The resulting residue was stripped 2 times from chloroform. Then 50 mL of chloroform, 124 mg (0.89 mmol) of methyl-3-aminobenzoate, and 100 μL of pyridine were added. The mixture was allowed to stir at ambient temperature for 16 h. The mixture was extracted twice with 1 N HCl (aqueous) and once with water. The dried organic layer (MgSO<sub>4</sub>) was filtered, and the volatiles were removed by rotary evaporation. The resulting residue was treated with methanol to form a solid precipitate that was collected by vacuum filtration. This afforded 380 mg (93%) of the title compound as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.59 (1H, s), 10.06 (1H, br s), 8.51 (1H, d, <i>J</i> = 1.7 Hz), 8.50 (1H, d, <i>J</i> = 9.0 Hz), 8.24 (1H, br s), 8.14 (1H, d, <i>J</i> = 9.1 Hz), 7.88−7.98 (5H, m), 7.80 (2H, d, <i>J</i> = 7.3 Hz), 7.72 (1H, d, <i>J</i> = 7.8 Hz), 7.63 (1H, br s), 7.54 (1H, app t, <i>J</i> = 7.9 Hz), 7.44 (2H, app t, <i>J</i> = 7.3 Hz), 7.37 (2H, app t, <i>J</i> = 7.3 Hz), 4.58 (2H, d, <i>J</i> = 6.4 Hz), 4.37 (1H, t, <i>J</i> = 6.3 Hz), 3.89 (3H, s); MS (MALDI(−)) <i>m</i>/<i>z</i> 542 (M − H).</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-[7-(Chlorosulfonyl)(2-naphthyl)]-<i>N</i>-(2-{<i>N</i>-[7-(chlorosulfonyl)(2-naphthyl)]acetylamino}ethyl)acetamide (<b>63</b>)</h3><div class="NLM_p">To 2.04 g (9.33 mmol) of 7-amino-2-naphthalenesulfonic acid was added 50 mL of dry DMF. The stirred suspension was heated at 110 °C, and then 1.4 g of potassium carbonate was added followed by 400 μL (4.6 mmol) of 1,2-dibromoethane. The mixture was kept at 110 °C for 18 h and at 80 °C for an additional 18 h. Then the mixture was allowed to cool to ambient temperature. The resulting insoluble precipitate was collected by vacuum filtration and washed with methanol. The crude product was purified by silica gel flash chromatography (6:2:1 ethyl acetate/isopropanol/water). This provided 596 mg (14%) of 7-({2-[(7-sulfo-2-naphthyl)amino]ethyl}amino)naphthalene-2-sulfonic acid as a tan solid. <sup>1</sup>H NMR (D<sub>2</sub>O) δ 7.99 (2H, s), 7.78 (2H, d, <i>J</i> = 8.7 Hz), 7.63 (2H, d, <i>J</i> = 8.8 Hz), 7.51 (2H, d, <i>J</i> = 8.4 Hz), 7.01 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 8.4 Hz), 7.00 (2H, s), 3.44 (4H, s); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 146.7, 145.6, 134.0, 127.7, 126.4, 125.9, 121.9, 119.0, 118.2, 103.3, 42.0; MS (MALDI(−)) <i>m</i>/<i>z</i> 494 (M − H+Na).</div><div class="NLM_p">To a solution of 25 mL each of acetic anhydride and pyridine was added 2.13 g (4.51 mmol) of 7-({2-[(7-sulfo-2-naphthyl)amino]ethyl}amino)naphthalene-2-sulfonic acid, and the mixture was allowed to stir at 70 °C for 16 h. The mixture was poured into 400 mL of THF and left to stir for 12 h. The resulting solid was collected by vacuum filtration. Then this solid was dissolved in 35 mL of methanol, and a solution of 0.273 g (11.9 mmol) of sodium in 10 mL of methanol was added. The solution was cooled in an ice bath and diluted with 100 mL of isopropyl alcohol. The resulting solid was collected by vacuum filtration. The solid was redissolved in a minimum of methanol, filtered through a 0.2 μm nylon filter, and then precipitated by the addition of isopropyl alcohol. Drying in vacuo provided 2.01 g (74%) of 7-(<i>N</i>-{2-[N-(7-sulfo-2-naphthyl)acetylamino]ethyl}acetylamino)naphthalene-2-sulfonic acid, disodium salt, the title compound as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.12 (2H, s), 7.93 (2H, d, <i>J</i> = 7.3 Hz), 7.90 (2H, d, <i>J</i> = 7.9 Hz), 7.89 (2H, s), 7.74 (2H, d, <i>J</i> = 7.4 Hz), 7.32 (2H, d, <i>J</i> = 8.3 Hz), 3.88 (4H, s), 1.73 (6H, s); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 169.2, 146.4, 140.4, 132.3, 131.4, 128.8, 126.9, 126.7, 126.1, 124.5, 123.9, 46.3, 22.3; MS (ES(−)) <i>m</i>/<i>z</i> 555 (M − H).</div><div class="NLM_p last">To 511 mg (0.85 mmol) of compound <b>44</b> was added 50 mL of phosphorus oxychloride in an ice bath. The mixture was allowed to stir and warm slowly to room temperature. The mixture was allowed to stir for a total of 4 days. Then the mixture was poured onto 600 mL of ice and this suspension placed in a second ice bath. After the ice had melted, the yellow solid was collected by vacuum filtration. This provided 455 mg (90%) of the title compound (<b>63</b>) as a white solid. It was used immediately without characterization.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Methyl 5-{[(7-Amino(2-naphthyl))sulfonyl]amino}-2-chlorobenzoate (<b>64</b>)</h3><div class="NLM_p">To 4.98 g (22.4 mmol) of methyl 5-amino-2-chlorobenzoate hydrochloride was added 50 mL of THF followed by 11 mL (0.136 mol) of pyridine. The stirred suspension was cooled in an ice bath, and then 5.30 g (18.7 mmol) of <i>N</i>-[7-(chlorosulfonyl)-2-naphthyl]acetamide (<b>46</b>) prepared above was added as a suspension in 50 mL of THF. The mixture was allowed to warm to ambient temperature and to stir for 16 h. All volatiles were removed by rotary evaporation, and the resulting goo was extracted with ethyl acetate and 1 N HCl. The organic layer was dried (MgSO<sub>4</sub>) and filtered, and volatiles were removed to provide 6.63 g (82%) of methyl 5-{[(7-amino(2-naphthyl))sulfonyl]amino}-2-chlorobenzoate as a faint yellow solid: mp = 165−172 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.77 (1H, s), 10.31 (1H, s), 8.42 (1H, s), 8.31 (1H, s), 8.01 (1H, d, <i>J</i> = 8.5 Hz), 7.95 (1H, d, <i>J</i> = 8.9 Hz), 7.74 (1H, dd, <i>J</i> = 1.8 Hz, <i>J</i> = 8.9 Hz), 7.63 (1H, dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.6 Hz), 7.56 (1H, d, <i>J</i> = 2.6 Hz), 7.43 (1H, d, <i>J</i> = 8.7 Hz), 7.32 (1H, dd, <i>J</i> = 2.7 Hz, <i>J</i> = 8.8 Hz), 3.81 (3H, s), 2.12 (3H, s); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 168.7, 164.6, 138.4, 136.8, 136.4, 132.0, 131.5, 130.7, 130.2, 129.1, 128.3, 127.1, 126.5, 123.7, 122.7, 121.5, 120.1, 115.7, 52.4, 23.9; MS (MALDI(+)) <i>m</i>/<i>z</i> 457 (M + Na).</div><div class="NLM_p">To 4.81 g (11.1 mmol) of methyl 5-{[(7-amino(2-naphthyl))sulfonyl]amino}-2-chlorobenzoate was added 160 mL of 5 N NaOH and 7 mL of dioxane. The mixture was allowed to stir at 55 °C for 18 h. Then the mixture was diluted with 30 mL of water and filtered through a 0.2 μm nylon filter. The resulting clear filtrate was carefully acidified with 26 mL of concentrated H<sub>2</sub>SO<sub>4</sub>. The finely divided solid precipitate was collected by vacuum filtration and dried in vacuo. This produced 4.01 g (95%) of 5-{[(7-amino(2-naphthyl))sulfonyl]amino}-2-chlorobenzoic acid as a tan solid: mp = 160−165 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.63 (1H, s), 8.00 (1H, s), 7.80 (1H, d, <i>J</i> = 8.4 Hz), 7.68 (1H, d, <i>J</i> = 8.8 Hz), 7.53 (1H, d, <i>J</i> = 2.6 Hz), 7.39 (1H, d, <i>J</i> = 8.7 Hz), 7.34 (1H, dd, <i>J</i> = 1.5 Hz, <i>J</i> = 8.7 Hz), 7.27 (1H, dd, <i>J</i> = 2.7 Hz, <i>J</i> = 8.7 Hz), 7.11 (1H, dd, <i>J</i> = 2.0 Hz, <i>J</i> = 8.7 Hz), 6.96 (1H, s); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 165.8, 147.4, 136.8, 136.1, 133.5, 131.6, 131.2, 128.9, 128.5, 127.5, 126.2, 124.8, 123.1, 121.4, 121.2, 116.6, 107.0; MS (ES(−)) <i>m</i>/<i>z</i> 375 (M − H).</div><div class="NLM_p last">To 10.1 g (0.027 mol) of 5-{[(7-amino(2-naphthyl))sulfonyl]amino}-2-chlorobenzoic acid dissolved in 250 mL of methanol was added 50 mL of 4 N HCl in dioxane. This solution was allowed to stir at ambient temperature for 18 h. The reaction was incomplete, so the solution was heated at reflux for an additional 5 h. Then the volatiles were removed by rotary evaporation and the resulting solid was extracted with ethyl acetate and 0.4 N sodium bicarbonate, water, and brine. The organic layer was dried (MgSO<sub>4</sub>) and filtered, and the volatiles were removed by rotary evaporation to yield 8.71 g (83%) of the title compound as a tan solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.66 (1H, s), 7.98 (1H, d, <i>J</i> = 1.4 Hz), 7.78 (1H, d, <i>J</i> = 8.7 Hz), 7.66 (1H, d, <i>J</i> = 8.8 Hz), 7.56 (1H, d, <i>J</i> = 2.7 Hz), 7.43 (1H, d, <i>J</i> = 8.7 Hz), 7.31 (1H, dd, <i>J</i> = 1.8 Hz, <i>J</i> = 8.5 Hz), 7.30 (1H, dd, <i>J</i> = 2.8 Hz, <i>J</i> = 8.7 Hz), 7.08 (1H, dd, <i>J</i> = 2.2 Hz, <i>J</i> = 8.8 Hz), 6.91 (1H, d, <i>J</i> = 2.0 Hz), 5.71 (2H, s), 3.82 (3H, s); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 164.6, 148.0, 136.9, 135.9, 133.5, 131.3, 130.2, 128.8, 128.3, 127.2, 126.2, 124.7, 123.5, 121.4, 121.0, 116.3, 106.2, 52.2; MS (ES(−)) <i>m</i>/<i>z</i> 389 (M − H).</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Methyl 2-Chloro-5-{[(7-isothiocyanato(2-naphthyl))sulfonyl]amino}benzoate (<b>65</b>)</h3><div class="NLM_p last">To 4.5 g (11.5 mmol) of compound <b>64</b> and 9.01 g (50.6 mmol) of 1,1′-thiocarbonyldiimidazole was added 50 mL of THF. The solution was allowed to stir at ambient temperature for 1.5 h. Then the mixture was poured into 300 mL of ethyl acetate and extracted with 1 N HCl, water, and brine. The organic layer was dried (MgSO<sub>4</sub>) and filtered, and the volatiles were removed by rotary evaporation to yield 4.77 g (96%) of the title compound as a tan solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.86 (1H, br s), 8.48 (1H, s), 8.27 (1H, d, <i>J</i> = 1.9 Hz), 8.16 (1H, d, <i>J</i> = 8.8 Hz), 8.10 (1H, d, <i>J</i> = 8.8 Hz), 7.80 (1H, dd, <i>J</i> = 1.8 Hz, <i>J</i> = 8.7 Hz), 7.72 (1H, dd, <i>J</i> = 2.0 Hz, <i>J</i> = 8.8 Hz), 7.54 (1H, d, <i>J</i> = 2.6 Hz), 7.44 (1H, d, <i>J</i> = 8.7 Hz), 7.30 (1H, dd, <i>J</i> = 2.7 Hz, <i>J</i> = 8.8 Hz), 3.81 (3H, s); MS (MALDI(−)) <i>m</i>/<i>z</i> 431 (M − H).</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Methyl 5-({[7-({[(7-{[(3-Methoxycarbonyl-4-chlorophenyl)amino]sulfonyl}(2-naphthyl))amino]thioxomethyl}amino)(2-naphthyl)]sulfonyl} amino)-2-chlorobenzoate (<b>66</b>)</h3><div class="NLM_p last">To 4.0 g (9.26 mmol) of compound <b>65</b> dissolved in 200 mL of dichloromethane was added 3.0 g (7.67 mmol) of compound <b>64</b>. The mixture was allowed to stir at ambient temperature for 16 h. A white solid had formed, which was collected by vacuum filtration. This provided 5.2 g (82%) of the title compound as a white solid: mp = 157 − 163 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.80 (2H, s), 10.32 (2H, s), 8.40 (2H, s), 8.20 (2H, s), 8.07 (2H, d, <i>J</i> = 8.8 Hz), 7.98 (2H, d, <i>J</i> = 8.9 Hz), 7.85 (2H, dd, <i>J</i> = 1.9 Hz, <i>J</i> = 8.8 Hz), 7.70 (2H, dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.7 Hz), 7.57 (2H, d, <i>J</i> = 2.6 Hz), 7.43 (2H, d, <i>J</i> = 8.7 Hz), 7.32 (2H, dd, <i>J</i> = 2.7 Hz, <i>J</i> = 8.7 Hz), 3.80 (6H, s); MS (ES(−)) <i>m</i>/<i>z</i> 823 (M − H).</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Methyl 5-({[7-(2-Amino-1-aza-2-{[7-({[4-chloro-3-(methoxycarbonyl)phenyl]amino}sulfonyl)(2-naphthyl)]amino}vinyl)(2-naphthyl)]sulfonyl}amino)-2-chlorobenzoate (<b>67</b>)</h3><div class="NLM_p">To 1.0 g (1.21 mmol) of compound <b>66</b> dissolved in 50 mL of acetonitrile was added 1.1 mL of methyl iodide (17.7 mmol). The mixture was allowed to stir under an argon atmosphere for 72 h. The volatiles were removed by rotary evaporation, and the resulting yellow solid was extracted using ethyl acetate and 1 M sodium carbonate. The organic layer was washed with 50/50 brine/water followed by brine. The organic layer was separated and dried (MgSO<sub>4</sub>), and volatiles were removed by rotary evaporation to yield 0.95 g (94%) of methyl 5-{[(7-{[(1<i>Z</i>)-2-aza-2-(7-{[(3-methoxycarbonyl-4-chlorophenyl)amino]sulfonyl}(2-naphthyl))-1-methylthiovinyl]amino}(2-naphthyl))sulfonyl]amino}-2-chlorobenzoate as a yellow solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.17 (1H, s), 8.40 (1H, s), 8.28 (1H, s), 8.21 (1H, s), 7.95 (1H, d, <i>J</i> = 9.2 Hz), 7.90 (1H, s), 7.90 (1H, d, <i>J</i> = 9.0 Hz), 7.88 (2H, s), 7.61 (2H, d, <i>J</i> = 8.6 Hz), 7.50 (1H, s), 7.45 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 10.1 Hz), 7.33 (1H, dd, <i>J</i> = 1.8 Hz, <i>J</i> = 8.5 Hz), 7.30 (1H, app t, <i>J</i> = 8.5 Hz), 7.25 (1H, d, <i>J</i> = 8.8 Hz), 7.20 (1H, dd, <i>J</i> = 2.4 Hz, <i>J</i> = 8.9 Hz), 7.15 (1H, dd, <i>J</i> = 2.4 Hz, <i>J</i> = 8.9 Hz), 3.80 (3H, s), 3.74 (3H, s), 2.42 (3H, s); MS (ES(−)) <i>m</i>/<i>z</i> 836 (M − H).</div><div class="NLM_p last">To 220 mg (0.26 mmol) of the material obtained above was added 10 mL of a 0.5 M NH<sub>3</sub> solution in dioxane. The resulting solution was placed in a sealed tube and heated at 70 °C for 18 h, followed by 24 h at 80 °C. Then additional NH<sub>3</sub> gas was bubbled into the mixture for 4 min. The mixture was sealed, and heating at 80 °C continued for an additional 51 h. Then the reaction temperature was lowered to 65 °C, and the reaction continued for 11 days. At this point, the reaction had reached 70% completion based upon HPLC analysis. The reaction was stopped by removal of the volatiles using rotary evaporation. The product was purified by silica gel column chromatography, eluting with 3% methanol in dichloromethane followed by 5% methanol in dichloromethane. Finally, the product was eluted with 90:2:1 ethyl acetate/isopropanol/water. This provided 117 mg (56%) of the title compound as an off-white solid. This compound exists as a mixture of tautomers: <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.65 (2H, br s), 8.27 (2H, s), 7.98 (3H, d, <i>J</i> = 8.8 Hz), 7.90 (3H, d, <i>J</i> = 8.9 Hz), 7.57 (6H, m), 7.42 (2H, d, <i>J</i> = 8.7 Hz), 7.31 (2H, dd, <i>J</i> = 2.6 Hz, <i>J</i> = 8.8 Hz), 5.30 (3H, br s), 3.80 (6H, s); MS (MALDI(+)) <i>m</i>/<i>z</i> 806 (M).</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Autophosphorylation of Human Insulin Receptor Cytoplasmic Kinase Domain (IR CKD)</h3><div class="NLM_p last">An amount of 200 ng of IR CKD, “β-insulin receptor kinase” which is the entire cytoplasmic domain of the insulin receptor without any extracellular or transmembrane domain residues (Stratagene, Inc., San Diego, CA), was dissolved in 30 μL of 50 mM Tris, pH 7.4, 2 mM MnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>, 50 μM ATP, and [γ-<sup>32</sup>P]ATP (10 μCi) and combined with different concentrations of either <b>1</b> or <b>3</b>, and the mixture was incubated for 10 min at 25 °C. For gel analysis, the samples were boiled in SDS−PAGE sample buffer for 5 min, electrophoresed on 10% SDS−PAGE gels, and visualized by autoradiography. Radioactivity was quantified by scintillation counting of the excised, labeled bands. For analysis by blotting, the samples were precipitated with trichloroacetic acid, spotted on a 96-well plate (Multiscreen, Millipore, Bedford, MA), washed three times with cold 75 mM phosphoric acid, air-dried, and quantified by scintillation counting.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Glucose Transport in Adipocytes and GLUT4 Translocation</h3><div class="NLM_p last">3T3-L1 fibroblasts (ATCC no. 173-CL) were cultured in 96-well plates and induced to differentiate into adipocytes by incubation in medium containing 1 μM dexamthasone, 0.5 mM isobutylmethylxanthine, and 1.7 μM insulin for 72 h.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The cells were shifted to media containing 1.7 μM insulin but without dexamthasone or isobutylmethylxanthine for 48 h. Finally, the cells were returned to normal supplemented medium for 4 days. The cells were serum-starved in medium containing 0.1% bovine serum albumin for 16 h, stimulated with various concentrations of compound with and without 5.6 nM insulin (a submaximal concentration; 100 nM insulin gives maximal response) for 30 min at 37 °C, and then incubated with 0.5 μCi/mL of 2-deoxy-<span class="smallcaps smallerCapital">d</span>-[<sup>14</sup>C]glucose for 30 min at 37 °C. The cells were rinsed with cold phosphate buffered saline and 20 μM glucose and lysed. The radioactivity was quantified by scintillation counting. The preparation of plasma membrane sheets and GLUT4 translocation was performed as described by Clancy and Czech.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> In Vivo Experiments</h3><div class="NLM_p last">All animal protocols were approved by the Telik Institutional Animal Care and Use Committee. Outbred male CD IGS rats (250−300 g; Charles River, Wilmington, MA) were administered 60 mg/kg streptozotocin (STZ) by intraperitoneal (ip) injection. Blood samples were taken for glucose measurements 3 days post-STZ injection, and animals were enrolled in glucose tolerance test studies if their fed glucose values were ≥250 mg/dL. To assess effects of test compounds on oral glucose tolerance, animals were used 4 days post-STZ injection and fasted overnight (typically 12−16 h). On the day of the experiment, animals were weighed and blood samples for glucose analyses taken by tail incision before dosing (0 min time point). Animals were divided (using a spreadsheet-based randomization software application) into two groups (<i>n</i> = 12 per group) based on the time-zero glucose reading. Animals were treated with <b>30</b> or phosphate buffered saline administered either ip or orally (po). Ten minutes after dosing, animals were given a bolus of standard glucose solution (50% dextrose, 4 mL/kg) by gavage. Blood glucose was measured at the indicated times after glucose loading using a glucometer (Glucometer Elite, Bayer). Data are expressed as mean ± SEM values. Differences between mean values were assessed by the Student’s <i>t</i> test. Statistical significance was accepted at <i>P</i> < 0.05. All analyses (and graphics) were performed using GraphPad Prism (MS Windows, version 4.0), GraphPad Software, San Diego, CA (<a href="http://www.graphpad.com" class="extLink">www.graphpad.com</a>).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41"><a href="/doi/suppl/10.1021/jm800600v">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30173" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30173" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Table of purity of all target compounds along with HPLC tracings and conditions. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800600v/suppl_file/jm800600v_si_001.pdf">jm800600v_si_001.pdf (0.99 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm800600v" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36660" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36660" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph L. Evans</span> - <span class="hlFld-Affiliation affiliation">Telik, Inc., 3165 Porter Drive, Palo Alto, California 94304, University of California at San Francisco, Mount Zion Medical Center, San Francisco, California 94115, ReceptorBio, Inc., 1155 Chess Drive, Suite 116, Foster City, California 95051, and Sanwa Kaguku Kenkyusho Co. Ltd., Nagoya 461-8631, Japan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ed87889b8c839e9d8589ad888c9f998581848386c3838899"><span class="__cf_email__" data-cfemail="3c56594a5d524f4c54587c595d4e48545055525712525948">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert T. Lum</span> - <span class="hlFld-Affiliation affiliation">Telik, Inc., 3165 Porter Drive, Palo Alto, California 94304, University of California at San Francisco, Mount Zion Medical Center, San Francisco, California 94115, ReceptorBio, Inc., 1155 Chess Drive, Suite 116, Foster City, California 95051, and Sanwa Kaguku Kenkyusho Co. Ltd., Nagoya 461-8631, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mingshan Cheng</span> - <span class="hlFld-Affiliation affiliation">Telik, Inc., 3165 Porter Drive, Palo Alto, California 94304, University of California at San Francisco, Mount Zion Medical Center, San Francisco, California 94115, ReceptorBio, Inc., 1155 Chess Drive, Suite 116, Foster City, California 95051, and Sanwa Kaguku Kenkyusho Co. Ltd., Nagoya 461-8631, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina P. Cristobal</span> - <span class="hlFld-Affiliation affiliation">Telik, Inc., 3165 Porter Drive, Palo Alto, California 94304, University of California at San Francisco, Mount Zion Medical Center, San Francisco, California 94115, ReceptorBio, Inc., 1155 Chess Drive, Suite 116, Foster City, California 95051, and Sanwa Kaguku Kenkyusho Co. Ltd., Nagoya 461-8631, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ira D. Goldfine</span> - <span class="hlFld-Affiliation affiliation">Telik, Inc., 3165 Porter Drive, Palo Alto, California 94304, University of California at San Francisco, Mount Zion Medical Center, San Francisco, California 94115, ReceptorBio, Inc., 1155 Chess Drive, Suite 116, Foster City, California 95051, and Sanwa Kaguku Kenkyusho Co. Ltd., Nagoya 461-8631, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James G. Keck</span> - <span class="hlFld-Affiliation affiliation">Telik, Inc., 3165 Porter Drive, Palo Alto, California 94304, University of California at San Francisco, Mount Zion Medical Center, San Francisco, California 94115, ReceptorBio, Inc., 1155 Chess Drive, Suite 116, Foster City, California 95051, and Sanwa Kaguku Kenkyusho Co. Ltd., Nagoya 461-8631, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert W. Macsata</span> - <span class="hlFld-Affiliation affiliation">Telik, Inc., 3165 Porter Drive, Palo Alto, California 94304, University of California at San Francisco, Mount Zion Medical Center, San Francisco, California 94115, ReceptorBio, Inc., 1155 Chess Drive, Suite 116, Foster City, California 95051, and Sanwa Kaguku Kenkyusho Co. Ltd., Nagoya 461-8631, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vara Prasad Manchem</span> - <span class="hlFld-Affiliation affiliation">Telik, Inc., 3165 Porter Drive, Palo Alto, California 94304, University of California at San Francisco, Mount Zion Medical Center, San Francisco, California 94115, ReceptorBio, Inc., 1155 Chess Drive, Suite 116, Foster City, California 95051, and Sanwa Kaguku Kenkyusho Co. Ltd., Nagoya 461-8631, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yukiharu Matsumoto</span> - <span class="hlFld-Affiliation affiliation">Telik, Inc., 3165 Porter Drive, Palo Alto, California 94304, University of California at San Francisco, Mount Zion Medical Center, San Francisco, California 94115, ReceptorBio, Inc., 1155 Chess Drive, Suite 116, Foster City, California 95051, and Sanwa Kaguku Kenkyusho Co. Ltd., Nagoya 461-8631, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sophia J. Park</span> - <span class="hlFld-Affiliation affiliation">Telik, Inc., 3165 Porter Drive, Palo Alto, California 94304, University of California at San Francisco, Mount Zion Medical Center, San Francisco, California 94115, ReceptorBio, Inc., 1155 Chess Drive, Suite 116, Foster City, California 95051, and Sanwa Kaguku Kenkyusho Co. Ltd., Nagoya 461-8631, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandhya S. Rao</span> - <span class="hlFld-Affiliation affiliation">Telik, Inc., 3165 Porter Drive, Palo Alto, California 94304, University of California at San Francisco, Mount Zion Medical Center, San Francisco, California 94115, ReceptorBio, Inc., 1155 Chess Drive, Suite 116, Foster City, California 95051, and Sanwa Kaguku Kenkyusho Co. Ltd., Nagoya 461-8631, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louise Robinson</span> - <span class="hlFld-Affiliation affiliation">Telik, Inc., 3165 Porter Drive, Palo Alto, California 94304, University of California at San Francisco, Mount Zion Medical Center, San Francisco, California 94115, ReceptorBio, Inc., 1155 Chess Drive, Suite 116, Foster City, California 95051, and Sanwa Kaguku Kenkyusho Co. Ltd., Nagoya 461-8631, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Songyuan Shi</span> - <span class="hlFld-Affiliation affiliation">Telik, Inc., 3165 Porter Drive, Palo Alto, California 94304, University of California at San Francisco, Mount Zion Medical Center, San Francisco, California 94115, ReceptorBio, Inc., 1155 Chess Drive, Suite 116, Foster City, California 95051, and Sanwa Kaguku Kenkyusho Co. Ltd., Nagoya 461-8631, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wayne R. Spevak</span> - <span class="hlFld-Affiliation affiliation">Telik, Inc., 3165 Porter Drive, Palo Alto, California 94304, University of California at San Francisco, Mount Zion Medical Center, San Francisco, California 94115, ReceptorBio, Inc., 1155 Chess Drive, Suite 116, Foster City, California 95051, and Sanwa Kaguku Kenkyusho Co. Ltd., Nagoya 461-8631, Japan</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32334" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32334" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 45 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Zimmet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberti, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span> </span><span class="NLM_article-title">Global and societal implications of the diabetes epidemic</span> <span class="citation_source-journal">Nature</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">414</span> <span class="NLM_fpage">782</span> <span class="NLM_lpage">787</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1038%2F414782a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=11742409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD38Xhtlymtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=782-787&author=P.+Zimmetauthor=K.+G.+Albertiauthor=J.+Shaw&title=Global+and+societal+implications+of+the+diabetes+epidemic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Global and societal implications of the diabetes epidemic</span></div><div class="casAuthors">Zimmet, Paul; Alberti, K. G. M. M.; Shaw, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">414</span>
        (<span class="NLM_cas:issue">6865</span>),
    <span class="NLM_cas:pages">782-787</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Changes in human behavior and lifestyle over the last century have resulted in a dramatic increase in the incidence of diabetes worldwide.  The epidemic is chiefly of type 2 diabetes and also the assocd. conditions known as 'diabesity' and 'metabolic syndrome'.  In conjunction with genetic susceptibility, particularly in certain ethnic groups, type 2 diabetes is brought on by environmental and behavioral factors such as a sedentary lifestyle, overly rich nutrition and obesity.  The prevention of diabetes and control of its micro- and macrovascular complications will require an integrated, international approach if we are to see significant redn. in the huge premature morbidity and mortality it causes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3G3dd0CuoQbVg90H21EOLACvtfcHk0lgTYwrGQ5s3pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xhtlymtg%253D%253D&md5=3b7fd57f6bd54a45a5c20c70fab864bd</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F414782a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F414782a%26sid%3Dliteratum%253Aachs%26aulast%3DZimmet%26aufirst%3DP.%26aulast%3DAlberti%26aufirst%3DK.%2BG.%26aulast%3DShaw%26aufirst%3DJ.%26atitle%3DGlobal%2520and%2520societal%2520implications%2520of%2520the%2520diabetes%2520epidemic%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D782%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Wild, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roglic, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicree, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, H.</span><span> </span><span class="NLM_article-title">Global prevalence of diabetes: estimates for the year 2000 and projections for 2030</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">27</span> <span class="NLM_fpage">1047</span> <span class="NLM_lpage">1053</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.2337%2Fdiacare.27.5.1047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=15111519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A280%3ADC%252BD2c3itVymsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=1047-1053&author=S.+Wildauthor=G.+Roglicauthor=A.+Greenauthor=R.+Sicreeauthor=H.+King&title=Global+prevalence+of+diabetes%3A+estimates+for+the+year+2000+and+projections+for+2030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Global prevalence of diabetes: estimates for the year 2000 and projections for 2030</span></div><div class="casAuthors">Wild Sarah; Roglic Gojka; Green Anders; Sicree Richard; King Hilary</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes care</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1047-53</span>
        ISSN:<span class="NLM_cas:issn">0149-5992</span>.
    </div><div class="casAbstract">OBJECTIVE:  The goal of this study was to estimate the prevalence of diabetes and the number of people of all ages with diabetes for years 2000 and 2030.  RESEARCH DESIGN AND METHODS:  Data on diabetes prevalence by age and sex from a limited number of countries were extrapolated to all 191 World Health Organization member states and applied to United Nations' population estimates for 2000 and 2030.  Urban and rural populations were considered separately for developing countries.  RESULTS:  The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030.  The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030.  The prevalence of diabetes is higher in men than women, but there are more women with diabetes than men.  The urban population in developing countries is projected to double between 2000 and 2030.  The most important demographic change to diabetes prevalence across the world appears to be the increase in the proportion of people >65 years of age.  CONCLUSIONS:  These findings indicate that the "diabetes epidemic" will continue even if levels of obesity remain constant.  Given the increasing prevalence of obesity, it is likely that these figures provide an underestimate of future diabetes prevalence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRS1_5FBm4QLEbxh97K6Vt6fW6udTcc2eb6qC4q7Lemzrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3itVymsw%253D%253D&md5=93096de002d513e4fdd49028be51d85d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2337%2Fdiacare.27.5.1047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiacare.27.5.1047%26sid%3Dliteratum%253Aachs%26aulast%3DWild%26aufirst%3DS.%26aulast%3DRoglic%26aufirst%3DG.%26aulast%3DGreen%26aufirst%3DA.%26aulast%3DSicree%26aufirst%3DR.%26aulast%3DKing%26aufirst%3DH.%26atitle%3DGlobal%2520prevalence%2520of%2520diabetes%253A%2520estimates%2520for%2520the%2520year%25202000%2520and%2520projections%2520for%25202030%26jtitle%3DDiabetes%2520Care%26date%3D2004%26volume%3D27%26spage%3D1047%26epage%3D1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">DeFronzo, R. A.</span><span> </span><span class="NLM_article-title">Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes</span> <span class="citation_source-journal">Diabetes Rev.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">177</span> <span class="NLM_lpage">269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1997&pages=177-269&author=R.+A.+DeFronzo&title=Pathogenesis+of+type+2+diabetes%3A+metabolic+and+molecular+implications+for+identifying+diabetes+genes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeFronzo%26aufirst%3DR.%2BA.%26atitle%3DPathogenesis%2520of%2520type%25202%2520diabetes%253A%2520metabolic%2520and%2520molecular%2520implications%2520for%2520identifying%2520diabetes%2520genes%26jtitle%3DDiabetes%2520Rev.%26date%3D1997%26volume%3D5%26spage%3D177%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Facchini, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbasi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reaven, G. M.</span><span> </span><span class="NLM_article-title">Insulin resistance as a predictor of age-related diseases</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">86</span> <span class="NLM_fpage">3574</span> <span class="NLM_lpage">3578</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1210%2Fjc.86.8.3574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=11502781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFektrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2001&pages=3574-3578&author=F.+S.+Facchiniauthor=N.+Huaauthor=F.+Abbasiauthor=G.+M.+Reaven&title=Insulin+resistance+as+a+predictor+of+age-related+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin resistance as a predictor of age-related diseases</span></div><div class="casAuthors">Facchini, Francesco S.; Hua, Nancy; Abbasi, Fahim; Reaven, Gerald M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3574-3578</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The current study was initiated to evaluate the ability of insulin resistance to predict a variety of age-related diseases.  Baseline measurements of insulin resistance and related variables were made between 1988-1995 in 208 apparently healthy, nonobese (body mass index < 30 kg/m2) individuals, who were then evaluated 4-11 yr later (mean ± SEM = 6.3 ± 0.2 yr) for the appearance of the following age-related diseases: hypertension, coronary heart disease, stroke, cancer, and type 2 diabetes.  The effect of insulin resistance on the development of clin. events was evaluated by dividing the study group into tertiles of insulin resistance at baseline and comparing the events in these 3 groups.  Clin. endpoints (n = 40) were identified in 37 individuals (18%) of those evaluated, including 12 with hypertension, 3 with hypertension + type 2 diabetes, 9 with cancer, 7 with coronary heart disease, 4 with stroke, and 2 with type 2 diabetes.  Twenty-eight out of the total 40 clin. events were seen in 25 individuals (36%) in the most insulin-resistant tertile, with the other 12 occurring in the group with an intermediate degree of insulin resistance.  Furthermore, insulin resistance was an independent predictor of all clin. events, using both multiple logistic regression and Cox's proportional hazards anal.  The fact that an age-related clin. event developed in approx. 1 out of 3 healthy individuals in the upper tertile of insulin resistance at baseline, followed for an av. of 6 yr, whereas no clin. events were obsd. in the most insulin-sensitive tertile, should serve as a strong stimulus to further efforts to define the role of insulin resistance in the genesis of age-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHCdrUQGFn67Vg90H21EOLACvtfcHk0lgfuVhThoIwgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFektrc%253D&md5=7ebe20852848a49ad461baa16a96d484</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1210%2Fjc.86.8.3574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.86.8.3574%26sid%3Dliteratum%253Aachs%26aulast%3DFacchini%26aufirst%3DF.%2BS.%26aulast%3DHua%26aufirst%3DN.%26aulast%3DAbbasi%26aufirst%3DF.%26aulast%3DReaven%26aufirst%3DG.%2BM.%26atitle%3DInsulin%2520resistance%2520as%2520a%2520predictor%2520of%2520age-related%2520diseases%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2001%26volume%3D86%26spage%3D3574%26epage%3D3578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Reaven, G. M.</span><span> </span><span class="NLM_article-title">Role of insulin resistance in human disease</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_year" style="font-weight: bold;">1988</span> <span class="NLM_volume">37</span> <span class="NLM_fpage">1595</span> <span class="NLM_lpage">1607</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1988&pages=1595-1607&author=G.+M.+Reaven&title=Role+of+insulin+resistance+in+human+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReaven%26aufirst%3DG.%2BM.%26atitle%3DRole%2520of%2520insulin%2520resistance%2520in%2520human%2520disease%26jtitle%3DDiabetes%26date%3D1988%26volume%3D37%26spage%3D1595%26epage%3D1607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Turner, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cull, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frighi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, R. R.</span><span> </span><span class="NLM_article-title">Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49)</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">281</span> <span class="NLM_fpage">2005</span> <span class="NLM_lpage">2012</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1999&pages=2005-2012&author=R.+C.+Turnerauthor=C.+A.+Cullauthor=V.+Frighiauthor=R.+R.+Holman&title=Glycemic+control+with+diet%2C+sulfonylurea%2C+metformin%2C+or+insulin+in+patients+with+type+2+diabetes+mellitus.+Progressive+requirement+for+multiple+therapies+%28UKPDS+49%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DR.%2BC.%26aulast%3DCull%26aufirst%3DC.%2BA.%26aulast%3DFrighi%26aufirst%3DV.%26aulast%3DHolman%26aufirst%3DR.%2BR.%26atitle%3DGlycemic%2520control%2520with%2520diet%252C%2520sulfonylurea%252C%2520metformin%252C%2520or%2520insulin%2520in%2520patients%2520with%2520type%25202%2520diabetes%2520mellitus.%2520Progressive%2520requirement%2520for%2520multiple%2520therapies%2520%2528UKPDS%252049%2529%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D1999%26volume%3D281%26spage%3D2005%26epage%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Evans, J. L.; Rushakoff, R. J.</span><span> </span><span class="NLM_article-title">Oral Pharmacological Agents for Type 2 Diabetes: Sulfonylureas, Meglitinides, Metformin, Thiazolidinediones, α-Glucosidase Inhibitors, and Emerging Approaches</span>. In  <span class="citation_source-book">Endotext.com: Diabetes and Carbohydrate Metabolism</span>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_contrib-group">Degroot, L.; Goldfine, I. D.; Rushakoff, R. J.</span>, Eds.; <span class="NLM_publisher-name">Medtext, Inc.</span>: <span class="NLM_publisher-loc">Burr Ridge, IL</span>, <span class="NLM_year">2007</span>; <a href="http://www.medtext.com" class="extLink">http://www.medtext.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+L.+Evans&author=R.+J.+Rushakoffauthor=L.+Degroot&author=I.+D.+Goldfine&author=R.+J.+Rushakoff&title=Endotext.com%3A+Diabetes+and+Carbohydrate+Metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DJ.%2BL.%26atitle%3DOral%2520Pharmacological%2520Agents%2520for%2520Type%25202%2520Diabetes%253A%2520Sulfonylureas%252C%2520Meglitinides%252C%2520Metformin%252C%2520Thiazolidinediones%252C%2520%25CE%25B1-Glucosidase%2520Inhibitors%252C%2520and%2520Emerging%2520Approaches%26btitle%3DEndotext.com%253A%2520Diabetes%2520and%2520Carbohydrate%2520Metabolism%26aulast%3DDegroot%26aufirst%3DL.%26pub%3DMedtext%252C%2520Inc%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Pfeifer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halter, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, D.,  Jr.</span><span> </span><span class="NLM_article-title">Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin-dependent diabetes mellitus</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_year" style="font-weight: bold;">1981</span> <span class="NLM_volume">53</span> <span class="NLM_fpage">1256</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=7028776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A280%3ADyaL38%252Fltleqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1981&pages=1256-1262&author=M.+Pfeiferauthor=J.+B.+Halterauthor=J.+C.+Beardauthor=D.+Porte&title=Differential+effects+of+tolbutamide+on+first+and+second+phase+insulin+secretion+in+noninsulin-dependent+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin-dependent diabetes mellitus</span></div><div class="casAuthors">Pfeifer M A; Halter J B; Beard J C; Porte D Jr</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical endocrinology and metabolism</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1256-62</span>
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">Immunoreactive insulin responses to a 20-g iv glucose challenge during a 7.5 mg/m2/min tolbutamide infusion were studied in 21 untreated noninsulin-dependent male diabetics.  All data were analyzed by paired t tests.  During the tolbutamide infusion, compared to the saline control period in the same subjects, glucose levels were lowered [217 +/- 17 vs. 196 +/- 16 mg/dl (mean +/- SEM); P less than 0.005], and there was an increase in both first phase (2 +/- 1 vs. 16 +/- 4 micro U/ml; P less than 0.005) and second phase insulin responses (296 +/- 71 vs. 499 +/- 101 micro U. min/ml; P less than 0.05; n = 21).  However, when the prestimulus glucose level was lowered by an insulin infusion (214 +/- 20 vs. 145 +/- 17 mg/dl; P less than 0.001), no effect on first phase insulin secretion was observed, and the second phase response decreased (290 +/- 78 vs. 124 +/ 55 micro U. min/ml; P less than 0.005; n = 11; saline control vs. insulin infusion).  In 8 subjects, the plasma glucose level during the tolbutamide infusion was kept constant by a concurrent variable glucose infusion.  First phase insulin secretion was still increased, though no more than in studies were plasma glucose was not kept constant.  However, there was further augmentation of the second phase response (tolbutamide alone, 443 +/- 142 micro U. min/ml; tolbutamide plus glucose, 802 +/- 232 micro U. min/ml; P less than 0.05).  These findings indicate that tolbutamide augments first phase insulin secretion in untreated diabetics independently of the prestimulus glucose level.  However, changes in the glucose level significantly modulate the sulfonylurea influence on the second phase insulin response to glucose.  This effect of glucose level is an important consideration when evaluating the insulinotropic effects of a sulfonylurea.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTVGPVto5hO2TW1zwg2yUK5fW6udTcc2ebWzzkq5xWGg7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL38%252Fltleqsw%253D%253D&md5=16aa155c81500a897853c866a9c7b3fc</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPfeifer%26aufirst%3DM.%26aulast%3DHalter%26aufirst%3DJ.%2BB.%26aulast%3DBeard%26aufirst%3DJ.%2BC.%26aulast%3DPorte%26aufirst%3DD.%26atitle%3DDifferential%2520effects%2520of%2520tolbutamide%2520on%2520first%2520and%2520second%2520phase%2520insulin%2520secretion%2520in%2520noninsulin-dependent%2520diabetes%2520mellitus%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1981%26volume%3D53%26spage%3D1256%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Lebovitz, H. E.</span><span> </span><span class="NLM_article-title">Insulin Secretagogues: Sulfonylureas and Meglitinides</span>. In  <span class="citation_source-book">Diabetes Mellitus: A Fundamental and Clinical Text</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group">LeRoith, D.; Taylor, S. I.; Olefsky, J. M.</span>, Eds.; <span class="NLM_publisher-name">Lippincott Williams & Wilkins</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, <span class="NLM_year">2000</span>; pp  <span class="NLM_fpage">769</span>− <span class="NLM_lpage">778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=769-778&author=H.+E.+Lebovitz&title=Diabetes+Mellitus%3A+A+Fundamental+and+Clinical+Text"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLebovitz%26aufirst%3DH.%2BE.%26atitle%3DInsulin%2520Secretagogues%253A%2520Sulfonylureas%2520and%2520Meglitinides%26btitle%3DDiabetes%2520Mellitus%253A%2520A%2520Fundamental%2520and%2520Clinical%2520Text%26aulast%3DLeRoith%26aufirst%3DD.%26pub%3DLippincott%2520Williams%2520%2526%2520Wilkins%26date%3D2000%26spage%3D769%26epage%3D778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Stumvoll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurjhan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perriello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dailey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerich, J. E.</span><span> </span><span class="NLM_article-title">Metabolic effects of metformin in non-insulin-dependent diabetes mellitus</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">333</span> <span class="NLM_fpage">550</span> <span class="NLM_lpage">554</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1056%2FNEJM199508313330903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=7623903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADyaK2MXpsVanurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=1995&pages=550-554&author=M.+Stumvollauthor=N.+Nurjhanauthor=G.+Perrielloauthor=G.+Daileyauthor=J.+E.+Gerich&title=Metabolic+effects+of+metformin+in+non-insulin-dependent+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic effects of metformin in non-insulin-dependent diabetes mellitus</span></div><div class="casAuthors">Stumvoll, Michael; Nurjhan, Nurjahan; Perriello, Gabriele; Dailey, George; Gerich, John E.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">550-4</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">The metabolic effects and mechanism of action of metformin are still poorly understood, despite the fact that it has been used to treat patients with non-insulin-dependent diabetes mellitus (NIDDM) for more than 30 yr.  In 10 obese patients with NIDDM, we used a combination of isotope diln., indirect calorimetry, bio-impedance, and tissue-balance techniques to assess the effects of metformin on systemic lactate, glucose, and free-fatty-acid turnover; lactate oxidn. and the conversion of lactate to glucose; skeletal-muscle glucose and lactate metab.; body compn.; and energy expenditure before and after four months of treatment.  Metformin treatment decreased the mean (±SD) glycosylated Hb value from 13.2±2.2 percent to 10.5±1.6 percent (P<0.001) and reduced fasting plasma glucose concns. from 220±41 to 155±28 mg per dL (12.2±0.7 to 8.6±0.5 mmol per L) (P<0.001).  Although resting energy expenditure did not change, the patients lost 2.7±1.3 kg of wt. (P<0.001), 88 percent of which was adipose tissue.  The mean (±SE) rate of plasma glucose turnover (hepatic glucose output and systemic glucose disposal) decreased from 2.8±0.2 to 2.0±0.2 mg per kg of body wt. per min (15.3±0.9 to 10.8±0.9 μmol per kg per min) (P<0.001), as a result of a decrease in hepatic glucose output; systemic glucose clearance did not change.  The rate of conversion of lactate to glucose (gluconeogenesis) decreased by 37 percent (P<0.001), whereas lactate oxidn. increased by 25 percent (P<0.001).  There were no changes in the plasma lactate concn., plasma lactate turnover, muscle lactate release, plasma free-fatty-acid turnover, or uptake of glucose by muscle.  Metformin acts primarily by decreasing hepatic glucose output, largely by inhibiting gluconeogenesis.  It also seems to induce wt. loss, preferentially involving adipose tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosVINNDspoQ7Vg90H21EOLACvtfcHk0lgWBnHb9YIEmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpsVanurc%253D&md5=8bff183df92e10e9d0c3cef5bb726601</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1056%2FNEJM199508313330903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199508313330903%26sid%3Dliteratum%253Aachs%26aulast%3DStumvoll%26aufirst%3DM.%26aulast%3DNurjhan%26aufirst%3DN.%26aulast%3DPerriello%26aufirst%3DG.%26aulast%3DDailey%26aufirst%3DG.%26aulast%3DGerich%26aufirst%3DJ.%2BE.%26atitle%3DMetabolic%2520effects%2520of%2520metformin%2520in%2520non-insulin-dependent%2520diabetes%2520mellitus%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1995%26volume%3D333%26spage%3D550%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenyk-Melody, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirshman, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodyear, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">Role of AMP-activated protein kinase in mechanism of metformin action</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">108</span> <span class="NLM_fpage">1167</span> <span class="NLM_lpage">1174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1172%2FJCI13505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=11602624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXns1ChsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2001&pages=1167-1174&author=G.+Zhouauthor=R.+Myersauthor=Y.+Liauthor=Y.+Chenauthor=X.+Shenauthor=J.+Fenyk-Melodyauthor=M.+Wuauthor=J.+Ventreauthor=T.+Doebberauthor=N.+Fujiiauthor=N.+Musiauthor=M.+F.+Hirshmanauthor=L.+J.+Goodyearauthor=D.+E.+Moller&title=Role+of+AMP-activated+protein+kinase+in+mechanism+of+metformin+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Role of AMP-activated protein kinase in mechanism of metformin action</span></div><div class="casAuthors">Zhou, Gaochao; Myers, Robert; Li, Ying; Chen, Yuli; Shen, Xiaolan; Fenyk-Melody, Judy; Wu, Margaret; Ventre, John; Doebber, Thomas; Fujii, Nobuharu; Musi, Nicolas; Hirshman, Michael F.; Goodyear, Laurie J.; Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1167-1174</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Metformin is a widely used drug for treatment of type 2 diabetes with no defined cellular mechanism of action.  Its glucose-lowering effect results from decreased hepatic glucose prodn. and increased glucose utilization.  Metformin's beneficial effects on circulating lipids have been linked to reduced fatty liver.  AMP-activated protein kinase (AMPK) is a major cellular regulator of lipid and glucose metab.  Here we report that metformin activates AMPK in hepatocytes; as a result, acetyl-CoA carboxylase (ACC) activity is reduced, fatty acid oxidn. is induced, and expression of lipogenic enzymes is suppressed.  Activation of AMPK by metformin or an adenosine analog suppresses expression of SREBP-1, a key lipogenic transcription factor.  In metformin-treated rats, hepatic expression of SREBP-1 (and other lipogenic) mRNAs and protein is reduced; activity of the AMPK target, ACC, is also reduced.  Using a novel AMPK inhibitor, we find that AMPK activation is required for metformin's inhibitory effect on glucose prodn. by hepatocytes.  In isolated rat skeletal muscles, metformin stimulates glucose uptake coincident with AMPK activation.  Activation of AMPK provides a unified explanation for the pleiotropic beneficial effects of this drug; these results also suggest that alternative means of modulating AMPK should be useful for the treatment of metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT3nG6tsYQkLVg90H21EOLACvtfcHk0lgWBnHb9YIEmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXns1ChsL4%253D&md5=a086134de3fd5ed011ed15761b46cf84</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1172%2FJCI13505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI13505%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DMyers%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DFenyk-Melody%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DVentre%26aufirst%3DJ.%26aulast%3DDoebber%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DMusi%26aufirst%3DN.%26aulast%3DHirshman%26aufirst%3DM.%2BF.%26aulast%3DGoodyear%26aufirst%3DL.%2BJ.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DRole%2520of%2520AMP-activated%2520protein%2520kinase%2520in%2520mechanism%2520of%2520metformin%2520action%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2001%26volume%3D108%26spage%3D1167%26epage%3D1174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bischoff, H.</span><span> </span><span class="NLM_article-title">Pharmacology of alpha-glucosidase inhibition</span> <span class="citation_source-journal">Eur. J. Clin. Invest.</span><span class="NLM_year" style="font-weight: bold;">1994</span> <span class="NLM_volume">24</span><span class="NLM_issue">Suppl. 3</span> <span class="NLM_fpage">3</span> <span class="NLM_lpage">10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1994&pages=3-10&issue=Suppl.+3&author=H.+Bischoff&title=Pharmacology+of+alpha-glucosidase+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBischoff%26aufirst%3DH.%26atitle%3DPharmacology%2520of%2520alpha-glucosidase%2520inhibition%26jtitle%3DEur.%2520J.%2520Clin.%2520Invest.%26date%3D1994%26volume%3D24%26issue%3DSuppl.%25203%26spage%3D3%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Berger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">The mechanisms of action of PPARs</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">53</span> <span class="NLM_fpage">409</span> <span class="NLM_lpage">435</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1146%2Fannurev.med.53.082901.104018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=11818483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD38Xitl2mt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2002&pages=409-435&author=J.+Bergerauthor=D.+E.+Moller&title=The+mechanisms+of+action+of+PPARs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The Mechanisms of Action of PPARs</span></div><div class="casAuthors">Berger, Joel; Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">409-435</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The peroxisome proliferator-activated receptors (PPARs) are a group of three nuclear receptor isoforms, PPARγ, PPARα, and PPARδ, encoded by different genes.  PPARs are ligand-regulated transcription factors that control gene expression by binding to specific response elements (PPREs) within promoters.  PPARs bind as heterodimers with a retinoid X receptor and, upon binding agonist, interact with co-factors such that the rate of transcription initiation is increased.  The PPARs play a crit. physiol. role as lipid sensors and regulators of lipid metab.  Fatty acids and eicosanoids have been identified as natural ligands for the PPARs.  More potent synthetic PPAR ligands, including the fibrates and thiazolidinediones, have proven effective in the treatment of dyslipidemia and diabetes.  Use of such ligands has allowed researchers to unveil many potential roles for the PPARs in pathol. states including atherosclerosis, inflammation, cancer, infertility, and demyelination.  Here, we present the current state of knowledge regarding the mol. mechanisms of PPAR action and the involvement of the PPARs in the etiol. and treatment of several chronic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6rxPu_VgKKLVg90H21EOLACvtfcHk0lgWBnHb9YIEmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xitl2mt7s%253D&md5=cc724640866d5fa365b4e637d85f6732</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1146%2Fannurev.med.53.082901.104018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.med.53.082901.104018%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DThe%2520mechanisms%2520of%2520action%2520of%2520PPARs%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2002%26volume%3D53%26spage%3D409%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">New drug targets for type 2 diabetes and the metabolic syndrome</span> <span class="citation_source-journal">Nature</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">414</span> <span class="NLM_fpage">821</span> <span class="NLM_lpage">827</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1038%2F414821a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=11742415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD38Xhtlyltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=821-827&author=D.+E.+Moller&title=New+drug+targets+for+type+2+diabetes+and+the+metabolic+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">New drug targets for type 2 diabetes and the metabolic syndrome</span></div><div class="casAuthors">Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">414</span>
        (<span class="NLM_cas:issue">6865</span>),
    <span class="NLM_cas:pages">821-827</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  An insidious increase in features of the 'metabolic syndrome' - obesity, insulin resistance and dyslipidemia - has conspired to produce a worldwide epidemic of type 2 insulin-resistant diabetes mellitus.  Most current therapies for this disease were developed in the absence of defined mol. targets or an understanding of disease pathogenesis.  Emerging knowledge of key pathogenic mechanisms, such as the impairment of glucose-stimulated insulin secretion and the role of 'lipotoxicity' as a probable cause of hepatic and muscle resistance to insulin's effects on glucose metab., has led to a host of new mol. drug targets.  Several have been validated through genetic engineering in mice or the preliminary use of lead compds. and therapeutic agents in animals and humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLanr95TYBxrVg90H21EOLACvtfcHk0li3dgUWKY-9Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xhtlyltw%253D%253D&md5=3561a033fea0c3aabe71a8cde8e69e77</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2F414821a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F414821a%26sid%3Dliteratum%253Aachs%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DNew%2520drug%2520targets%2520for%2520type%25202%2520diabetes%2520and%2520the%2520metabolic%2520syndrome%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D821%26epage%3D827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Sharma, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staels, B.</span><span> </span><span class="NLM_article-title">Review: peroxisome proliferator-activated receptor gamma and adipose tissue—understanding obesity-related changes in regulation of lipid and glucose metabolism</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">92</span> <span class="NLM_fpage">386</span> <span class="NLM_lpage">395</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1210%2Fjc.2006-1268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=17148564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVaksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2007&pages=386-395&author=A.+M.+Sharmaauthor=B.+Staels&title=Review%3A+peroxisome+proliferator-activated+receptor+gamma+and+adipose+tissue%E2%80%94understanding+obesity-related+changes+in+regulation+of+lipid+and+glucose+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor γ and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism</span></div><div class="casAuthors">Sharma, Arya M.; Staels, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">386-395</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Context: Adipose tissue is a metabolically dynamic organ, serving as a buffer to control fatty acid flux and a regulator of endocrine function.  In obese subjects, and those with type 2 diabetes or the metabolic syndrome, adipose tissue function is altered (i.e. adipocytes display morphol. differences alongside aberrant endocrine and metabolic function and low-grade inflammation).  Evidence Acquisition: Articles on the role of peroxisome proliferator-activated receptor γ (PPARγ) in adipose tissue of healthy individuals and those with obesity, metabolic syndrome, or type 2 diabetes were sourced using MEDLINE (1990-2006).  Evidence Synthesis: Articles were assessed to provide a comprehensive overview of how PPARγ-activating ligands improve adipose tissue function, and how this links to improvements in insulin resistance and the progression to type 2 diabetes and atherosclerosis.  Conclusions: PPARγ is highly expressed in adipose tissue, where its activation with thiazolidinediones alters fat topog. and adipocyte phenotype and up-regulates genes involved in fatty acid metab. and triglyceride storage.  Furthermore, PPARγ activation is assocd. with potentially beneficial effects on the expression and secretion of a range of factors, including adiponectin, resistin, IL-6, TNFα, plasminogen activator inhibitor-1, monocyte chemoattractant protein-1, and angiotensinogen, as well as a redn. in plasma nonesterified fatty acid supply.  The effects of PPARγ also extend to macrophages, where they suppress prodn. of inflammatory mediators.  As such, PPARγ activation appears to have a beneficial effect on the relationship between the macrophage and adipocyte that is distorted in obesity.  Thus, PPARγ-activating ligands improve adipose tissue function and may have a role in preventing progression of insulin resistance to diabetes and endothelial dysfunction to atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnhOXoZbEGDLVg90H21EOLACvtfcHk0li3dgUWKY-9Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVaksr0%253D&md5=b4c73940d128e43a662b71eccfeabdc0</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1210%2Fjc.2006-1268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2006-1268%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%2BM.%26aulast%3DStaels%26aufirst%3DB.%26atitle%3DReview%253A%2520peroxisome%2520proliferator-activated%2520receptor%2520gamma%2520and%2520adipose%2520tissue%25E2%2580%2594understanding%2520obesity-related%2520changes%2520in%2520regulation%2520of%2520lipid%2520and%2520glucose%2520metabolism%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2007%26volume%3D92%26spage%3D386%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Deacon, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahren, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, J. J.</span><span> </span><span class="NLM_article-title">Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of type 2 diabetes</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">1091</span> <span class="NLM_lpage">1102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1517%2F13543784.13.9.1091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=15330741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFSmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=1091-1102&author=C.+F.+Deaconauthor=B.+Ahrenauthor=J.+J.+Holst&title=Inhibitors+of+dipeptidyl+peptidase+IV%3A+a+novel+approach+for+the+prevention+and+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?</span></div><div class="casAuthors">Deacon, Carolyn F.; Ahren, Bo; Holst, Jens J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1091-1102</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Inhibitors of the enzyme dipeptidyl peptidase IV (DPP IV) are of increasing interest to both diabetologists and the pharmaceutical industry alike, as they may become established as the next member of the oral antidiabetic class of therapeutic agents, designed to lower blood glucose and, possibly, prevent the progressive impairment of glucose metab. in patients with impaired glucose tolerance and Type 2 diabetes.  DPP IV has become a focus of attention for drug design, as it has a pivotal role in the rapid degrdn. of at least two of the hormones released during food ingestion, a property that has warranted the design of inhibitor-based drugs.  At the mol. level, DPP IV cleaves two amino acids from the N-terminus of the intact, biol. active forms of both so-called incretin hormones, glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide (formerly known as gastric inhibitory polypeptide), resulting in truncated metabolites, which are largely inactive.  Inhibition of the enzyme, therefore, is thought to increase levels of the active forms of both incretin hormones, culminating in an increase in insulin release after a meal, in a fully glucose-dependent manner.  DPP IV inhibitors combine several features of interest to the drug design process.  They can be readily optimized for their target and be designed as low mol. wt., orally active entities compatible with once-daily administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLIYyj_kReyrVg90H21EOLACvtfcHk0li3dgUWKY-9Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFSmsr0%253D&md5=cae60dec469fc5009b3fbb174d182059</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1517%2F13543784.13.9.1091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.13.9.1091%26sid%3Dliteratum%253Aachs%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26aulast%3DAhren%26aufirst%3DB.%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26atitle%3DInhibitors%2520of%2520dipeptidyl%2520peptidase%2520IV%253A%2520a%2520novel%2520approach%2520for%2520the%2520prevention%2520and%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D13%26spage%3D1091%26epage%3D1102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Richter, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandeira-Echtler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergerhoff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebrahim, S. H.</span><span> </span><span class="NLM_article-title">Rosiglitazone for type 2 diabetes mellitus</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_fpage">CD006063</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=CD006063&author=B.+Richterauthor=E.+Bandeira-Echtlerauthor=K.+Bergerhoffauthor=C.+Clarauthor=S.+H.+Ebrahim&title=Rosiglitazone+for+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DB.%26aulast%3DBandeira-Echtler%26aufirst%3DE.%26aulast%3DBergerhoff%26aufirst%3DK.%26aulast%3DClar%26aufirst%3DC.%26aulast%3DEbrahim%26aufirst%3DS.%2BH.%26atitle%3DRosiglitazone%2520for%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2007%26spage%3DCD006063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Devchand, P. R.</span><span> </span><span class="NLM_article-title">Glitazones and the cardiovascular system</span> <span class="citation_source-journal">Curr. Opin. Endocrinol. Diabetes Obes.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">15</span> <span class="NLM_fpage">188</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=18316956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjvF2htbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=188-192&author=P.+R.+Devchand&title=Glitazones+and+the+cardiovascular+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Glitazones and the cardiovascular system</span></div><div class="casAuthors">Devchand, Pallavi R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Endocrinology, Diabetes and Obesity</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">188-192</span>CODEN:
                <span class="NLM_cas:coden">COEDFK</span>;
        ISSN:<span class="NLM_cas:issn">1752-296X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: To chart recent progress on mol. mechanisms of rosiglitazone and pioglitazone in the cardiovascular system.  Recent findings: Several classes of oral antidiabetic drugs are available to treat type 2 diabetes, but glitazones offer the unique promise of insulin-sensitizing ability coupled with potential to reverse cardiovascular abnormalities assocd. with insulin resistance.  Currently the two drugs used are rosiglitazone and pioglitazone, marketed as Avandia and Actos.  Recent results of different metaanalyses were inconclusive as to whether rosiglitazone caused real adverse effects of myocardial ischemia.  Thus, the US Food and Drugs Administration placed a black box warning on Avandia to signal potential of myocardial infarction and heart-related deaths, as a precautionary measure until analyses of all available data provide clarity.  Also unresolved is the extent to which the two compds. share modes of action.  Summary: Type II diabetes affects more than 160 million people, approx. 5% of the world's population (http://www.who.org).  Recently, questions have been raised about the cardiovascular safety of glitazone antidiabetic drugs.  Clearly, there is an urgency to define mol. mechanisms of rosiglitazone and pioglitazone and understand how these drugs may impact patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOyN6sL43B8bVg90H21EOLACvtfcHk0li3dgUWKY-9Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjvF2htbs%253D&md5=ead168f3f95906b9ddb863823ed881d6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDevchand%26aufirst%3DP.%2BR.%26atitle%3DGlitazones%2520and%2520the%2520cardiovascular%2520system%26jtitle%3DCurr.%2520Opin.%2520Endocrinol.%2520Diabetes%2520Obes.%26date%3D2008%26volume%3D15%26spage%3D188%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Bolen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinopoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selvin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancati, F. L.</span><span> </span><span class="NLM_article-title">Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus</span> <span class="citation_source-journal">Ann. Intern. Med.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">147</span> <span class="NLM_fpage">386</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.7326%2F0003-4819-147-6-200709180-00178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=17638715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A280%3ADC%252BD2srlsFSnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2007&pages=386-399&author=S.+Bolenauthor=L.+Feldmanauthor=J.+Vassyauthor=L.+Wilsonauthor=H.+C.+Yehauthor=S.+Marinopoulosauthor=C.+Wileyauthor=E.+Selvinauthor=R.+Wilsonauthor=E.+B.+Bassauthor=F.+L.+Brancati&title=Systematic+review%3A+comparative+effectiveness+and+safety+of+oral+medications+for+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus</span></div><div class="casAuthors">Bolen Shari; Feldman Leonard; Vassy Jason; Wilson Lisa; Yeh Hsin-Chieh; Marinopoulos Spyridon; Wiley Crystal; Selvin Elizabeth; Wilson Renee; Bass Eric B; Brancati Frederick L</div><div class="citationInfo"><span class="NLM_cas:title">Annals of internal medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">386-99</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  As newer oral diabetes agents continue to emerge on the market, comparative evidence is urgently required to guide appropriate therapy.  PURPOSE:  To summarize the English-language literature on the benefits and harms of oral agents (second-generation sulfonylureas, biguanides, thiazolidinediones, meglitinides, and alpha-glucosidase inhibitors) in the treatment of adults with type 2 diabetes mellitus.  DATA SOURCES:  The MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials databases were searched from inception through January 2006 for original articles and through November 2005 for systematic reviews.  Unpublished U.S.  Food and Drug Administration and industry data were also searched.  STUDY SELECTION:  216 controlled trials and cohort studies and 2 systematic reviews that addressed benefits and harms of oral diabetes drug classes available in the United States.  DATA EXTRACTION:  Using standardized protocols, 2 reviewers serially abstracted data for each article.  DATA SYNTHESIS:  Evidence from clinical trials was inconclusive on major clinical end points, such as cardiovascular mortality.  Therefore, the review was limited mainly to studies of intermediate end points.  Most oral agents (thiazolidinediones, metformin, and repaglinide) improved glycemic control to the same degree as sulfonylureas (absolute decrease in hemoglobin A1c level of about 1 percentage point).  Nateglinide and alpha-glucosidase inhibitors may have slightly weaker effects, on the basis of indirect comparisons of placebo-controlled trials.  Thiazolidinediones were the only class that had a beneficial effect on high-density lipoprotein cholesterol levels (mean relative increase, 0.08 to 0.13 mmol/L [3 to 5 mg/dL]) but a harmful effect on low-density lipoprotein (LDL) cholesterol levels (mean relative increase, 0.26 mmol/L [10 mg/dL]) compared with other oral agents.  Metformin decreased LDL cholesterol levels by about 0.26 mmol/L (10 mg/dL), whereas other oral agents had no obvious effects on LDL cholesterol levels.  Most agents other than metformin increased body weight by 1 to 5 kg.  Sulfonylureas and repaglinide were associated with greater risk for hypoglycemia, thiazolidinediones with greater risk for heart failure, and metformin with greater risk for gastrointestinal problems compared with other oral agents.  Lactic acidosis was no more common in metformin recipients without comorbid conditions than in recipients of other oral diabetes agents.  LIMITATIONS:  Data on major clinical end points were limited.  Studies inconsistently reported adverse events other than hypoglycemia, and definitions of adverse events varied across studies.  Some harms not assessed in trials or observational studies may have been overlooked.  CONCLUSIONS:  Compared with newer, more expensive agents (thiazolidinediones, alpha-glucosidase inhibitors, and meglitinides), older agents (second-generation sulfonylureas and metformin) have similar or superior effects on glycemic control, lipids, and other intermediate end points.  Large, long-term comparative studies are needed to determine the comparative effects of oral diabetes agents on hard clinical end points.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTL7C4f3LYdsgWRJ3OJdH_qfW6udTcc2ea1BmOFJPmpPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srlsFSnsw%253D%253D&md5=ead007e4646359920b3b4fffd14e8a04</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-147-6-200709180-00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-147-6-200709180-00178%26sid%3Dliteratum%253Aachs%26aulast%3DBolen%26aufirst%3DS.%26aulast%3DFeldman%26aufirst%3DL.%26aulast%3DVassy%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DL.%26aulast%3DYeh%26aufirst%3DH.%2BC.%26aulast%3DMarinopoulos%26aufirst%3DS.%26aulast%3DWiley%26aufirst%3DC.%26aulast%3DSelvin%26aufirst%3DE.%26aulast%3DWilson%26aufirst%3DR.%26aulast%3DBass%26aufirst%3DE.%2BB.%26aulast%3DBrancati%26aufirst%3DF.%2BL.%26atitle%3DSystematic%2520review%253A%2520comparative%2520effectiveness%2520and%2520safety%2520of%2520oral%2520medications%2520for%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2007%26volume%3D147%26spage%3D386%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Ginsberg, H. N.</span><span> </span><span class="NLM_article-title">Insulin resistance and cardiovascular disease</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">106</span> <span class="NLM_fpage">453</span> <span class="NLM_lpage">458</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2000&pages=453-458&author=H.+N.+Ginsberg&title=Insulin+resistance+and+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGinsberg%26aufirst%3DH.%2BN.%26atitle%3DInsulin%2520resistance%2520and%2520cardiovascular%2520disease%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D106%26spage%3D453%26epage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Kahn, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flier, J. S.</span><span> </span><span class="NLM_article-title">Obesity and insulin resistance</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">106</span> <span class="NLM_fpage">473</span> <span class="NLM_lpage">481</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1172%2FJCI10842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=10953022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFCltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2000&pages=473-481&author=B.+B.+Kahnauthor=J.+S.+Flier&title=Obesity+and+insulin+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Obesity and insulin resistance</span></div><div class="casAuthors">Kahn, Barbara B.; Flier, Jeffrey S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">473-481</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review, with 56 refs.  The relationship of obesity to insulin resistance and type 2 diabetes is a long-recognized phenomenon with fundamentally important scientific and clin. implications.  The paradox that either absence or excess of adipose tissue causes insulin resistance highlights the complexity of this relationship and underscores the fact that adipose tissue undoubtedly subserves multiple functions.  Advances over the last decade have expanded our understanding of the role of adipocytes in biol., and this has begun to provide mechanistic insights into the causal relationship between obesity and diabetes.  It is now clear that adipocytes function as endocrine glands with wide-reaching effects on other organs including the brain.  The release of a wide variety of mols. including hormones such as leptin, cytokines such as TNF-α, and substrates such as FFAs allows the adipose organ to play a major regulatory role in energy balance and glucose homeostasis.  Current challenges on the horizon include (a) discovering addnl. adipocyte-secreted products which are central to these processes; (b) deepening our understanding of the cellular and mol. mechanisms underlying insulin sensitivity and secretion, including previously unidentified pathways such as those mediated by nuclear receptors such as PPARγ, and (c) exploring the possibility of divergence among different insulin-mediated processes, such that those driving adipogenesis and fat storage may actually be augmented, at least in some tissues, in insulin-resistant states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh3ENRAIvrwrVg90H21EOLACvtfcHk0lh5h-D6kgnZUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFCltbw%253D&md5=9b92af02bed400f248b0e84f8861115d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1172%2FJCI10842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI10842%26sid%3Dliteratum%253Aachs%26aulast%3DKahn%26aufirst%3DB.%2BB.%26aulast%3DFlier%26aufirst%3DJ.%2BS.%26atitle%3DObesity%2520and%2520insulin%2520resistance%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D106%26spage%3D473%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Ward, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streltsov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKern, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovrecz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, T.</span><span> </span><span class="NLM_article-title">Structural insights into ligand-induced activation of the insulin receptor</span> <span class="citation_source-journal">Acta Physiol. (Oxford)</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">192</span> <span class="NLM_fpage">3</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=18171424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVaju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2008&pages=3-9&author=C.+Wardauthor=M.+Lawrenceauthor=V.+Streltsovauthor=T.+Garrettauthor=N.+McKernauthor=M.+Z.+Louauthor=G.+Lovreczauthor=T.+Adams&title=Structural+insights+into+ligand-induced+activation+of+the+insulin+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into ligand-induced activation of the insulin receptor</span></div><div class="casAuthors">Ward, C.; Lawrence, M.; Streltsov, V.; Garrett, T.; McKern, N.; Lou, M.-Z.; Lovrecz, G.; Adams, T.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Physiologica</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-9</span>CODEN:
                <span class="NLM_cas:coden">APCHC4</span>;
        ISSN:<span class="NLM_cas:issn">1748-1708</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The current model for insulin binding to the insulin receptor proposes that there are two binding sites, referred to as sites 1 and 2, on each monomer in the receptor homodimer and two binding surfaces on insulin, one involving residues predominantly from the dimerization face of insulin (the classical binding surface) and the other residues from the hexamerization face.  High-affinity binding involves one insulin mol. using its two surfaces to make bridging contacts with site 1 from one receptor monomer and site 2 from the other.  While the receptor dimer has two identical site 1-site 2 pairs, insulin mols. cannot bridge both pairs simultaneously.  Our structures of the insulin receptor (IR) ectodomain dimer and the L1-CR-L2 fragments of IR and insulin-like growth factor receptor (IGF-1R) explain many of the features of ligand-receptor binding and allow the two binding sites on the receptor to be described.  The IR dimer has an unexpected folded-over conformation which places the C-terminal surface of the first fibronectin-III domain in close juxtaposition to the known L1 domain ligand-binding surface suggesting that the C-terminal surface of FnIII-1 is the second binding site involved in high-affinity binding.  This is very different from previous models based on three-dimensional reconstruction from scanning transmission electron micrographs.  Our single-mol. images indicate that IGF-1R has a morphol. similar to that of IR.  In addn., the structures of the first three domains (L1-CR-L2) of the IR and IGF-1R show that there are major differences in the two regions governing ligand specificity.  The implications of these findings for ligand-induced receptor activation will be discussed.  This review summarizes the key findings regarding the discovery and characterization of the insulin receptor, the identification and arrangement of its structural domains in the sequence and the key features assocd. with ligand binding.  The remainder of the review deals with a description of the receptor structure and how it explains much of the large body of biochem. data in the literature on insulin binding and receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOQDmwZ20mD7Vg90H21EOLACvtfcHk0lh5h-D6kgnZUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVaju7g%253D&md5=933ad1b4a204bb861d7604171509ee57</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DC.%26aulast%3DLawrence%26aufirst%3DM.%26aulast%3DStreltsov%26aufirst%3DV.%26aulast%3DGarrett%26aufirst%3DT.%26aulast%3DMcKern%26aufirst%3DN.%26aulast%3DLou%26aufirst%3DM.%2BZ.%26aulast%3DLovrecz%26aufirst%3DG.%26aulast%3DAdams%26aufirst%3DT.%26atitle%3DStructural%2520insights%2520into%2520ligand-induced%2520activation%2520of%2520the%2520insulin%2520receptor%26jtitle%3DActa%2520Physiol.%2520%2528Oxford%2529%26date%3D2008%26volume%3D192%26spage%3D3%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">White, M. F.</span><span> </span><span class="NLM_article-title">Regulating insulin signaling and beta-cell function through IRS proteins</span> <span class="citation_source-journal">Can. J. Physiol. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">84</span> <span class="NLM_fpage">725</span> <span class="NLM_lpage">737</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1139%2FY06-008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=16998536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFGqtLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2006&pages=725-737&author=M.+F.+White&title=Regulating+insulin+signaling+and+beta-cell+function+through+IRS+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Regulating insulin signaling and β-cell function through IRS proteins</span></div><div class="casAuthors">White, Morris F.</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">725-737</span>CODEN:
                <span class="NLM_cas:coden">CJPPA3</span>;
        ISSN:<span class="NLM_cas:issn">0008-4212</span>.
    
            (<span class="NLM_cas:orgname">National Research Council of Canada</span>)
        </div><div class="casAbstract">A review.  Diabetes mellitus is a complex disorder that arise from various causes, including dysregulated glucose sensing and impaired insulin secretion (maturity onset diabetes of youth, MODY), autoimmune-mediated β-cell destruction (type 1), or insufficient compensation for peripheral insulin resistance (type 2).  Type 2 diabetes is the most prevalent form that usually occurs at middle age; it afflicts more than 30 million people over the age of 65, but is appearing with greater frequency in children and adolescents.  Dysregulated insulin signaling exacerbated by chronic hyperglycemia promotes a cohort of systemic disorders-including dyslipidemia, hypertension, cardiovascular disease, and female infertility.  Understanding the mol. basis of insulin resistance can prevent these disorders and their inevitable progression to type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMi20nEly_vbVg90H21EOLACvtfcHk0ljckf14_JQX7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFGqtLnM&md5=0ca6c0b5faaf5659b58434114484a35c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1139%2FY06-008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252FY06-008%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DM.%2BF.%26atitle%3DRegulating%2520insulin%2520signaling%2520and%2520beta-cell%2520function%2520through%2520IRS%2520proteins%26jtitle%3DCan.%2520J.%2520Physiol.%2520Pharmacol.%26date%3D2006%26volume%3D84%26spage%3D725%26epage%3D737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Watson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessin, J. E.</span><span> </span><span class="NLM_article-title">GLUT4 translocation: the last 200 nanometers</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">19</span> <span class="NLM_fpage">2209</span> <span class="NLM_lpage">2217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1016%2Fj.cellsig.2007.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=17629673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWmtb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=2209-2217&author=R.+T.+Watsonauthor=J.+E.+Pessin&title=GLUT4+translocation%3A+the+last+200+nanometers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">GLUT4 translocation: The last 200 nanometers</span></div><div class="casAuthors">Watson, Robert T.; Pessin, Jeffrey E.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2209-2217</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Insulin regulates circulating glucose levels by suppressing hepatic glucose prodn. and increasing glucose transport into muscle and adipose tissues.  Defects in these processes are assocd. with elevated vascular glucose levels and can lead to increased risk for the development of Type 2 diabetes mellitus and its assocd. disease complications.  At the cellular level, insulin stimulates glucose uptake by inducing the translocation of the glucose transporter 4 (GLUT4) from intracellular storage sites to the plasma membrane, where the transporter facilitates the diffusion of glucose into striated muscle and adipocytes.  Although the immediate downstream mols. that function proximal to the activated insulin receptor have been relatively well-characterized, it remains unknown how the distal insulin-signaling cascade interfaces with and recruits GLUT4 to the cell surface.  New biochem. assays and imaging techniques, however, have focused attention on the plasma membrane as a potential target of insulin action leading to GLUT4 translocation.  Indeed, it now appears that insulin specifically regulates the docking and/or fusion of GLUT4-vesicles with the plasma membrane.  Future work will focus on identifying the key insulin targets that regulate the GLUT4 docking/fusion processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLBw7jPSKFiLVg90H21EOLACvtfcHk0ljckf14_JQX7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWmtb3I&md5=7c9dffcca713d1706d807c864fdbbfed</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2007.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2007.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DR.%2BT.%26aulast%3DPessin%26aufirst%3DJ.%2BE.%26atitle%3DGLUT4%2520translocation%253A%2520the%2520last%2520200%2520nanometers%26jtitle%3DCell.%2520Signalling%26date%3D2007%26volume%3D19%26spage%3D2209%26epage%3D2217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czech, M. P.</span><span> </span><span class="NLM_article-title">The GLUT4 glucose transporter</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">237</span> <span class="NLM_lpage">252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1016%2Fj.cmet.2007.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=17403369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslGmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=237-252&author=S.+Huangauthor=M.+P.+Czech&title=The+GLUT4+glucose+transporter"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The GLUT4 glucose transporter</span></div><div class="casAuthors">Huang, Shaohui; Czech, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">237-252</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review on the mol. and cellular regulatory mechanisms for GLUT4, its gene regulation, its trafficking pathways and their integration with insulin signaling, and its profound effects on whole-body metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfuQi6GUhMBbVg90H21EOLACvtfcHk0ljckf14_JQX7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslGmsLg%253D&md5=2b8c8633582d57262896144ca09a0a96</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2007.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2007.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DCzech%26aufirst%3DM.%2BP.%26atitle%3DThe%2520GLUT4%2520glucose%2520transporter%26jtitle%3DCell%2520Metab.%26date%3D2007%26volume%3D5%26spage%3D237%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalkowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Royo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diez, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelaez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruby, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calaycay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zierath, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">Discovery of a small molecule insulin mimetic with antidiabetic activity in mice</span> <span class="citation_source-journal">Science</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">284</span> <span class="NLM_fpage">974</span> <span class="NLM_lpage">977</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1126%2Fscience.284.5416.974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=10320380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVWgu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=1999&pages=974-977&author=B.+B.+Zhangauthor=G.+Salituroauthor=D.+Szalkowskiauthor=Z.+H.+Liauthor=Y.+Zhangauthor=I.+Royoauthor=D.+Vilellaauthor=M.+T.+Diezauthor=F.+Pelaezauthor=C.+Rubyauthor=R.+L.+Kendallauthor=X.+Z.+Maoauthor=P.+Griffinauthor=J.+Calaycayauthor=J.+R.+Zierathauthor=J.+V.+Heckauthor=R.+G.+Smithauthor=D.+E.+Moller&title=Discovery+of+a+small+molecule+insulin+mimetic+with+antidiabetic+activity+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a small molecule insulin mimetic with antidiabetic activity in mice</span></div><div class="casAuthors">Zhang, Bei; Salituro, Gino; Szalkowski, Deborah; Li, Zhihua; Zhang, Yan; Royo, Inmaculada; Vilella, Dolores; Diez, Maria Teresa; Pelaez, Fernando; Ruby, Caroline; Kendall, Richard L.; Mao, Xianzhi; Griffin, Patrick; Calaycay, Jimmy; Zierath, Juleen R.; Heck, Ames V.; Smith, Roy G.; Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">5416</span>),
    <span class="NLM_cas:pages">974-977</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 25 refs.  Insulin elicits a spectrum of biol. responses by binding to its cell surface receptor.  In a screen for small mols. that activate the human insulin receptor tyrosine kinase, a nonpeptidyl fungal metabolite (L-783,281) was identified that acted as an insulin mimetic in several biochem. and cellular assays.  The compd. was selective for insulin receptor vs. insulin-like growth factor I (IGFI) receptor and other receptor tyrosine kinases.  Oral administration of L-783,281 to two mouse models of diabetes resulted in significant lowering in blood glucose levels.  These results demonstrate the feasibility of discovering novel insulin receptor activators that may lead to new therapies for diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNw95zd_yRj7Vg90H21EOLACvtfcHk0ljckf14_JQX7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVWgu7w%253D&md5=a8daa4f742728472bc840537e6bf512d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscience.284.5416.974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.284.5416.974%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DSalituro%26aufirst%3DG.%26aulast%3DSzalkowski%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DZ.%2BH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DRoyo%26aufirst%3DI.%26aulast%3DVilella%26aufirst%3DD.%26aulast%3DDiez%26aufirst%3DM.%2BT.%26aulast%3DPelaez%26aufirst%3DF.%26aulast%3DRuby%26aufirst%3DC.%26aulast%3DKendall%26aufirst%3DR.%2BL.%26aulast%3DMao%26aufirst%3DX.%2BZ.%26aulast%3DGriffin%26aufirst%3DP.%26aulast%3DCalaycay%26aufirst%3DJ.%26aulast%3DZierath%26aufirst%3DJ.%2BR.%26aulast%3DHeck%26aufirst%3DJ.%2BV.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DDiscovery%2520of%2520a%2520small%2520molecule%2520insulin%2520mimetic%2520with%2520antidiabetic%2520activity%2520in%2520mice%26jtitle%3DScience%26date%3D1999%26volume%3D284%26spage%3D974%26epage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Liu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalkowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwei, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huskey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. B.</span><span> </span><span class="NLM_article-title">Discovery of a potent, highly selective, and orally efficacious small-molecule activator of the insulin receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">43</span> <span class="NLM_fpage">3487</span> <span class="NLM_lpage">3494</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000285q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3487-3494&author=K.+Liuauthor=L.+Xuauthor=D.+Szalkowskiauthor=Z.+Liauthor=V.+Dingauthor=G.+Kweiauthor=S.+Huskeyauthor=D.+E.+Mollerauthor=J.+V.+Heckauthor=B.+B.+Zhangauthor=A.+B.+Jones&title=Discovery+of+a+potent%2C+highly+selective%2C+and+orally+efficacious+small-molecule+activator+of+the+insulin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm000285q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000285q%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DSzalkowski%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DV.%26aulast%3DKwei%26aufirst%3DG.%26aulast%3DHuskey%26aufirst%3DS.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DHeck%26aufirst%3DJ.%2BV.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DJones%26aufirst%3DA.%2BB.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520highly%2520selective%252C%2520and%2520orally%2520efficacious%2520small-molecule%2520activator%2520of%2520the%2520insulin%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3487%26epage%3D3494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Wood, H. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalkowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. B.</span><span> </span><span class="NLM_article-title">The basal SAR of a novel insulin receptor activator</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">10</span> <span class="NLM_fpage">1189</span> <span class="NLM_lpage">1192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1189-1192&author=H.+B.+Woodauthor=R.+Blackauthor=G.+Salituroauthor=D.+Szalkowskiauthor=Z.+Liauthor=Y.+Zhangauthor=D.+E.+Mollerauthor=B.+B.+Zhangauthor=A.+B.+Jones&title=The+basal+SAR+of+a+novel+insulin+receptor+activator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DH.%2BB.%26aulast%3DBlack%26aufirst%3DR.%26aulast%3DSalituro%26aufirst%3DG.%26aulast%3DSzalkowski%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DJones%26aufirst%3DA.%2BB.%26atitle%3DThe%2520basal%2520SAR%2520of%2520a%2520novel%2520insulin%2520receptor%2520activator%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D1189%26epage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Qureshi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalkowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biazzo-Ashnault, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saperstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huskey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span> </span><span class="NLM_article-title">Activation of insulin signal transduction pathway and anti-diabetic activity of small molecule insulin receptor activators</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">275</span> <span class="NLM_fpage">36590</span> <span class="NLM_lpage">36595</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=36590-36595&author=S.+A.+Qureshiauthor=V.+Dingauthor=Z.+Liauthor=D.+Szalkowskiauthor=D.+E.+Biazzo-Ashnaultauthor=D.+Xieauthor=R.+Sapersteinauthor=E.+Bradyauthor=S.+Huskeyauthor=X.+Shenauthor=K.+Liuauthor=L.+Xuauthor=G.+M.+Salituroauthor=J.+V.+Heckauthor=D.+E.+Mollerauthor=A.+B.+Jonesauthor=B.+B.+Zhang&title=Activation+of+insulin+signal+transduction+pathway+and+anti-diabetic+activity+of+small+molecule+insulin+receptor+activators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQureshi%26aufirst%3DS.%2BA.%26aulast%3DDing%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DSzalkowski%26aufirst%3DD.%26aulast%3DBiazzo-Ashnault%26aufirst%3DD.%2BE.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DSaperstein%26aufirst%3DR.%26aulast%3DBrady%26aufirst%3DE.%26aulast%3DHuskey%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DSalituro%26aufirst%3DG.%2BM.%26aulast%3DHeck%26aufirst%3DJ.%2BV.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DJones%26aufirst%3DA.%2BB.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26atitle%3DActivation%2520of%2520insulin%2520signal%2520transduction%2520pathway%2520and%2520anti-diabetic%2520activity%2520of%2520small%2520molecule%2520insulin%2520receptor%2520activators%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D36590%26epage%3D36595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Strowski, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalkowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juttner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span> </span><span class="NLM_article-title">Small-molecule insulin mimetic reduces hyperglycemia and obesity in a nongenetic mouse model of type 2 diabetes</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">145</span> <span class="NLM_fpage">5259</span> <span class="NLM_lpage">5268</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2004&pages=5259-5268&author=M.+Z.+Strowskiauthor=Z.+Liauthor=D.+Szalkowskiauthor=X.+Shenauthor=X.+M.+Guanauthor=S.+Juttnerauthor=D.+E.+Mollerauthor=B.+B.+Zhang&title=Small-molecule+insulin+mimetic+reduces+hyperglycemia+and+obesity+in+a+nongenetic+mouse+model+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStrowski%26aufirst%3DM.%2BZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DSzalkowski%26aufirst%3DD.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DX.%2BM.%26aulast%3DJuttner%26aufirst%3DS.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26atitle%3DSmall-molecule%2520insulin%2520mimetic%2520reduces%2520hyperglycemia%2520and%2520obesity%2520in%2520a%2520nongenetic%2520mouse%2520model%2520of%2520type%25202%2520diabetes%26jtitle%3DEndocrinology%26date%3D2004%26volume%3D145%26spage%3D5259%26epage%3D5268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Beroza, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damodaran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, R. T.</span><span> </span><span class="NLM_article-title">Target-related affinity profiling: Telik’s lead discovery technology</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">371</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.2174%2F1568026053828394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=15892680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFGht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=371-381&author=P.+Berozaauthor=K.+Damodaranauthor=R.+T.+Lum&title=Target-related+affinity+profiling%3A+Telik%E2%80%99s+lead+discovery+technology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Target-Related Affinity Profiling: Telik's lead discovery technology</span></div><div class="casAuthors">Beroza, Paul; Damodaran, Komath; Lum, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">371-381</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Target-Related Affinity Profiling (TRAP*) is a computational drug discovery technol. that is based on 'affinity fingerprints', which are mol. descriptors derived from the protein binding preferences of small mols.  The underlying concepts of TRAP are reviewed.  Affinity fingerprints are compared to mol. descriptors derived from chem. structures and shown to be a useful alternative for lead discovery.  The TRAP screening process is described and two example applications are presented: I. the discovery of novel inhibitors of human intestinal carboxylesterase, and II. the discovery of novel inhibitors of cyclooxygenase-1 through the use of the affinity fingerprints of known cyclooxygenase-1 inhibitors.  A summary of the complementary advantages of TRAP screening technol. compared to traditional approaches to drug lead discovery concludes the review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwR_tQSfq387Vg90H21EOLACvtfcHk0ljf9E5c51bZvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFGht7g%253D&md5=923b9484010e8badee5034ebb1a7fc34</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F1568026053828394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053828394%26sid%3Dliteratum%253Aachs%26aulast%3DBeroza%26aufirst%3DP.%26aulast%3DDamodaran%26aufirst%3DK.%26aulast%3DLum%26aufirst%3DR.%2BT.%26atitle%3DTarget-related%2520affinity%2520profiling%253A%2520Telik%25E2%2580%2599s%2520lead%2520discovery%2520technology%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D371%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Manchem, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldfine, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohanski, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristobal, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schow, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spevak, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laborde, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toavs, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villar, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wick, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, M. R.</span><span> </span><span class="NLM_article-title">A novel small molecule that directly sensitizes the insulin receptor <i>in vitro</i> and <i>in vivo</i></span> <span class="citation_source-journal">Diabetes</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">50</span> <span class="NLM_fpage">824</span> <span class="NLM_lpage">830</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=824-830&author=V.+P.+Manchemauthor=I.+D.+Goldfineauthor=R.+A.+Kohanskiauthor=C.+P.+Cristobalauthor=R.+T.+Lumauthor=S.+R.+Schowauthor=S.+Shiauthor=W.+R.+Spevakauthor=E.+Labordeauthor=D.+K.+Toavsauthor=H.+O.+Villarauthor=M.+M.+Wickauthor=M.+R.+Kozlowski&title=A+novel+small+molecule+that+directly+sensitizes+the+insulin+receptor+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManchem%26aufirst%3DV.%2BP.%26aulast%3DGoldfine%26aufirst%3DI.%2BD.%26aulast%3DKohanski%26aufirst%3DR.%2BA.%26aulast%3DCristobal%26aufirst%3DC.%2BP.%26aulast%3DLum%26aufirst%3DR.%2BT.%26aulast%3DSchow%26aufirst%3DS.%2BR.%26aulast%3DShi%26aufirst%3DS.%26aulast%3DSpevak%26aufirst%3DW.%2BR.%26aulast%3DLaborde%26aufirst%3DE.%26aulast%3DToavs%26aufirst%3DD.%2BK.%26aulast%3DVillar%26aufirst%3DH.%2BO.%26aulast%3DWick%26aufirst%3DM.%2BM.%26aulast%3DKozlowski%26aufirst%3DM.%2BR.%26atitle%3DA%2520novel%2520small%2520molecule%2520that%2520directly%2520sensitizes%2520the%2520insulin%2520receptor%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DDiabetes%26date%3D2001%26volume%3D50%26spage%3D824%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youngren, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manchem, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddux, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldfine, I. D.</span><span> </span><span class="NLM_article-title">Small molecule insulin receptor activators potentiate insulin action in insulin resistant cells</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">50</span> <span class="NLM_fpage">2323</span> <span class="NLM_lpage">2328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=2323-2328&author=M.+Liauthor=J.+F.+Youngrenauthor=V.+P.+Manchemauthor=M.+R.+Kozlowskiauthor=B.+B.+Zhangauthor=B.+A.+Madduxauthor=I.+D.+Goldfine&title=Small+molecule+insulin+receptor+activators+potentiate+insulin+action+in+insulin+resistant+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DYoungren%26aufirst%3DJ.%2BF.%26aulast%3DManchem%26aufirst%3DV.%2BP.%26aulast%3DKozlowski%26aufirst%3DM.%2BR.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DMaddux%26aufirst%3DB.%2BA.%26aulast%3DGoldfine%26aufirst%3DI.%2BD.%26atitle%3DSmall%2520molecule%2520insulin%2520receptor%2520activators%2520potentiate%2520insulin%2520action%2520in%2520insulin%2520resistant%2520cells%26jtitle%3DDiabetes%26date%3D2001%26volume%3D50%26spage%3D2323%26epage%3D2328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Koguro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orita, R.</span><span> </span><span class="NLM_article-title">Novel synthesis of 5-substituted tetrazoles from nitriles</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_fpage">910</span> <span class="NLM_lpage">914</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1055%2Fs-1998-2081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADyaK1cXjslKlsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&pages=910-914&author=K.+Koguroauthor=T.+Ogaauthor=S.+Mitsuiauthor=R.+Orita&title=Novel+synthesis+of+5-substituted+tetrazoles+from+nitriles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Novel synthesis of 5-substituted tetrazoles from nitriles</span></div><div class="casAuthors">Koguro, Kiyoto; Oga, Toshikazu; Mitsui, Sunao; Orita, Ryozo</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">910-914</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A variety of 5-substituted tetrazoles were prepd. by cycloaddn. of NaN3 with appropriate nitriles in an arom. solvent in the presence of an amine salt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrirgXuLXTynrVg90H21EOLACvtfcHk0ljf9E5c51bZvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjslKlsro%253D&md5=954039bdf3efa904b08cfabbc98ccdf6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1055%2Fs-1998-2081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1998-2081%26sid%3Dliteratum%253Aachs%26aulast%3DKoguro%26aufirst%3DK.%26aulast%3DOga%26aufirst%3DT.%26aulast%3DMitsui%26aufirst%3DS.%26aulast%3DOrita%26aufirst%3DR.%26atitle%3DNovel%2520synthesis%2520of%25205-substituted%2520tetrazoles%2520from%2520nitriles%26jtitle%3DSynthesis%26date%3D1998%26spage%3D910%26epage%3D914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Gray, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B.</span><span> </span><span class="NLM_article-title">The preparation of 4- and 5-<i>n</i>-alkoxy-1-naphthoic and 6- and 7-<i>n</i>-alkoxy-2-naphthoic acids</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_year" style="font-weight: bold;">1954</span> <span class="NLM_volume">1954</span> <span class="NLM_fpage">678</span> <span class="NLM_lpage">682</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1954&publication_year=1954&pages=678-682&author=G.+W.+Grayauthor=B.+Jones&title=The+preparation+of+4-+and+5-n-alkoxy-1-naphthoic+and+6-+and+7-n-alkoxy-2-naphthoic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DG.%2BW.%26aulast%3DJones%26aufirst%3DB.%26atitle%3DThe%2520preparation%2520of%25204-%2520and%25205-n-alkoxy-1-naphthoic%2520and%25206-%2520and%25207-n-alkoxy-2-naphthoic%2520acids%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1954%26volume%3D1954%26spage%3D678%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Cheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schow, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manchem, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spevak, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristobal, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macsata, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldfine, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keck, J. G.</span><span> </span><span class="NLM_article-title">In vitro and in vivo prevention of HIV protease inhibitor-induced insulin resistance by a novel small molecule insulin receptor activator</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">92</span> <span class="NLM_fpage">1234</span> <span class="NLM_lpage">1245</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2004&pages=1234-1245&author=M.+Chengauthor=S.+Chenauthor=S.+R.+Schowauthor=V.+P.+Manchemauthor=W.+R.+Spevakauthor=C.+P.+Cristobalauthor=S.+Shiauthor=R.+W.+Macsataauthor=R.+T.+Lumauthor=I.+D.+Goldfineauthor=J.+G.+Keck&title=In+vitro+and+in+vivo+prevention+of+HIV+protease+inhibitor-induced+insulin+resistance+by+a+novel+small+molecule+insulin+receptor+activator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DSchow%26aufirst%3DS.%2BR.%26aulast%3DManchem%26aufirst%3DV.%2BP.%26aulast%3DSpevak%26aufirst%3DW.%2BR.%26aulast%3DCristobal%26aufirst%3DC.%2BP.%26aulast%3DShi%26aufirst%3DS.%26aulast%3DMacsata%26aufirst%3DR.%2BW.%26aulast%3DLum%26aufirst%3DR.%2BT.%26aulast%3DGoldfine%26aufirst%3DI.%2BD.%26aulast%3DKeck%26aufirst%3DJ.%2BG.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520prevention%2520of%2520HIV%2520protease%2520inhibitor-induced%2520insulin%2520resistance%2520by%2520a%2520novel%2520small%2520molecule%2520insulin%2520receptor%2520activator%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2004%26volume%3D92%26spage%3D1234%26epage%3D1245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Etter, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panunto, T. W.</span><span> </span><span class="NLM_article-title">1,3-Bis(<i>m</i>-nitrophenyl)urea: an exceptionally good complexing agent for proton acceptors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_year" style="font-weight: bold;">1988</span> <span class="NLM_volume">110</span> <span class="NLM_fpage">5896</span> <span class="NLM_lpage">5897</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00225a049" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1988&pages=5896-5897&author=M.+C.+Etterauthor=T.+W.+Panunto&title=1%2C3-Bis%28m-nitrophenyl%29urea%3A+an+exceptionally+good+complexing+agent+for+proton+acceptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fja00225a049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00225a049%26sid%3Dliteratum%253Aachs%26aulast%3DEtter%26aufirst%3DM.%2BC.%26aulast%3DPanunto%26aufirst%3DT.%2BW.%26atitle%3D1%252C3-Bis%2528m-nitrophenyl%2529urea%253A%2520an%2520exceptionally%2520good%2520complexing%2520agent%2520for%2520proton%2520acceptors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1988%26volume%3D110%26spage%3D5896%26epage%3D5897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Dannecker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rust, H.</span><span> </span><span class="NLM_article-title"><i>N</i>,<i>N</i>′-Diphenylurea, C<sub>13</sub>H<sub>12</sub>N<sub>2</sub>O</span> <span class="citation_source-journal">Cryst. Struct. Commun.</span><span class="NLM_year" style="font-weight: bold;">1979</span> <span class="NLM_volume">8</span> <span class="NLM_fpage">429</span> <span class="NLM_lpage">432</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADyaE1MXktlSqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1979&pages=429-432&author=W.+Danneckerauthor=J.+Kopfauthor=H.+Rust&title=N%2CN%E2%80%B2-Diphenylurea%2C+C13H12N2O"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">[Crystal structure of] N,N'-diphenylurea, C13H12N2O</span></div><div class="casAuthors">Dannecker, W.; Kopf, J.; Rust, H.</div><div class="citationInfo"><span class="NLM_cas:title">Crystal Structure Communications</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">429-32</span>CODEN:
                <span class="NLM_cas:coden">CSCMCS</span>;
        ISSN:<span class="NLM_cas:issn">0302-1742</span>.
    </div><div class="casAbstract">N,N'-Diphenylurea is orthorhombic, space group Pna21, with a 909.1(8), b 1053.5(9), and c 1176.8 pm; d.(exptl.) = 1.23 and d.(calcd.) = 1.25 for Z = 4.  The structure was solved by direct methods with MULTAN 74 and refined by full-matrix least-squares to R = 0.038.  Both the Ph rings and the urea moiety are planar.  However, the torsion angles between the Ph rings and the urea portion are 43.0 and 36.1°, resp.  H bonding is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIMj2WdKA3pLVg90H21EOLACvtfcHk0lgEGV9SyqbEqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXktlSqu74%253D&md5=5471af5681562cc6381b8590a7bca158</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDannecker%26aufirst%3DW.%26aulast%3DKopf%26aufirst%3DJ.%26aulast%3DRust%26aufirst%3DH.%26atitle%3DN%252CN%25E2%2580%25B2-Diphenylurea%252C%2520C13H12N2O%26jtitle%3DCryst.%2520Struct.%2520Commun.%26date%3D1979%26volume%3D8%26spage%3D429%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Ganis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avitabile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, M.</span><span> </span><span class="NLM_article-title">Crystal and molecular structure of <i>N</i>,<i>N</i>′-diethyl-<i>N</i>,<i>N</i>′-diphenylurea</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">1970</span> <span class="NLM_volume">67</span> <span class="NLM_fpage">426</span> <span class="NLM_lpage">433</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1970&pages=426-433&author=P.+Ganisauthor=G.+Avitabileauthor=E.+Benedettiauthor=C.+Pedoneauthor=M.+Goodman&title=Crystal+and+molecular+structure+of+N%2CN%E2%80%B2-diethyl-N%2CN%E2%80%B2-diphenylurea"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGanis%26aufirst%3DP.%26aulast%3DAvitabile%26aufirst%3DG.%26aulast%3DBenedetti%26aufirst%3DE.%26aulast%3DPedone%26aufirst%3DC.%26aulast%3DGoodman%26aufirst%3DM.%26atitle%3DCrystal%2520and%2520molecular%2520structure%2520of%2520N%252CN%25E2%2580%25B2-diethyl-N%252CN%25E2%2580%25B2-diphenylurea%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1970%26volume%3D67%26spage%3D426%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Lozanova, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galabov, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilieva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, G.</span><span> </span><span class="NLM_article-title">Infrared intensities and conformation of substituted thioureas</span> <span class="citation_source-journal">J. Mol. Struct.</span><span class="NLM_year" style="font-weight: bold;">1984</span> <span class="NLM_volume">115</span> <span class="NLM_fpage">427</span> <span class="NLM_lpage">430</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1984&pages=427-430&author=C.+Lozanovaauthor=B.+Galabovauthor=M.+Ilievaauthor=G.+Vassilev&title=Infrared+intensities+and+conformation+of+substituted+thioureas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLozanova%26aufirst%3DC.%26aulast%3DGalabov%26aufirst%3DB.%26aulast%3DIlieva%26aufirst%3DM.%26aulast%3DVassilev%26aufirst%3DG.%26atitle%3DInfrared%2520intensities%2520and%2520conformation%2520of%2520substituted%2520thioureas%26jtitle%3DJ.%2520Mol.%2520Struct.%26date%3D1984%26volume%3D115%26spage%3D427%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Tanatani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azumaya, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukutomi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shudo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagechika, H.</span><span> </span><span class="NLM_article-title"><i>N</i>-Methylated diphenylguanidines: conformations, propeller-type molecular chirality, and construction of water-soluble oligomers with multilayered aromatic structures</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">120</span> <span class="NLM_fpage">6433</span> <span class="NLM_lpage">6422</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9806534" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1998&pages=6433-6422&author=A.+Tanataniauthor=K.+Yamaaguchiauthor=I.+Azumayaauthor=R.+Fukutomiauthor=K.+Shudoauthor=H.+Kagechika&title=N-Methylated+diphenylguanidines%3A+conformations%2C+propeller-type+molecular+chirality%2C+and+construction+of+water-soluble+oligomers+with+multilayered+aromatic+structures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fja9806534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9806534%26sid%3Dliteratum%253Aachs%26aulast%3DTanatani%26aufirst%3DA.%26aulast%3DYamaaguchi%26aufirst%3DK.%26aulast%3DAzumaya%26aufirst%3DI.%26aulast%3DFukutomi%26aufirst%3DR.%26aulast%3DShudo%26aufirst%3DK.%26aulast%3DKagechika%26aufirst%3DH.%26atitle%3DN-Methylated%2520diphenylguanidines%253A%2520conformations%252C%2520propeller-type%2520molecular%2520chirality%252C%2520and%2520construction%2520of%2520water-soluble%2520oligomers%2520with%2520multilayered%2520aromatic%2520structures%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1998%26volume%3D120%26spage%3D6433%26epage%3D6422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Carr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samaras, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chisholm, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, D. A.</span><span> </span><span class="NLM_article-title">Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance</span> <span class="citation_source-journal">Lancet</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">351</span> <span class="NLM_fpage">1881</span> <span class="NLM_lpage">1883</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=1998&pages=1881-1883&author=A.+Carrauthor=K.+Samarasauthor=D.+J.+Chisholmauthor=D.+A.+Cooper&title=Pathogenesis+of+HIV-1-protease+inhibitor-associated+peripheral+lipodystrophy%2C+hyperlipidaemia%2C+and+insulin+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarr%26aufirst%3DA.%26aulast%3DSamaras%26aufirst%3DK.%26aulast%3DChisholm%26aufirst%3DD.%2BJ.%26aulast%3DCooper%26aufirst%3DD.%2BA.%26atitle%3DPathogenesis%2520of%2520HIV-1-protease%2520inhibitor-associated%2520peripheral%2520lipodystrophy%252C%2520hyperlipidaemia%252C%2520and%2520insulin%2520resistance%26jtitle%3DLancet%26date%3D1998%26volume%3D351%26spage%3D1881%26epage%3D1883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Carr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samaras, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chisholm, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, D. A.</span><span> </span><span class="NLM_article-title">A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors</span> <span class="citation_source-journal">AIDS</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">12</span><span class="NLM_elocation-id">F51−F58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&author=A.+Carrauthor=K.+Samarasauthor=S.+Burtonauthor=M.+Lawauthor=J.+Freundauthor=D.+J.+Chisholmauthor=D.+A.+Cooper&title=A+syndrome+of+peripheral+lipodystrophy%2C+hyperlipidaemia+and+insulin+resistance+in+patients+receiving+HIV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarr%26aufirst%3DA.%26aulast%3DSamaras%26aufirst%3DK.%26aulast%3DBurton%26aufirst%3DS.%26aulast%3DLaw%26aufirst%3DM.%26aulast%3DFreund%26aufirst%3DJ.%26aulast%3DChisholm%26aufirst%3DD.%2BJ.%26aulast%3DCooper%26aufirst%3DD.%2BA.%26atitle%3DA%2520syndrome%2520of%2520peripheral%2520lipodystrophy%252C%2520hyperlipidaemia%2520and%2520insulin%2520resistance%2520in%2520patients%2520receiving%2520HIV%2520protease%2520inhibitors%26jtitle%3DAIDS%26date%3D1998%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Frost, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, M. D.</span><span> </span><span class="NLM_article-title">Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">1985</span> <span class="NLM_volume">260</span> <span class="NLM_fpage">2646</span> <span class="NLM_lpage">2652</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1985&pages=2646-2652&author=S.+C.+Frostauthor=M.+D.+Lane&title=Evidence+for+the+involvement+of+vicinal+sulfhydryl+groups+in+insulin-activated+hexose+transport+by+3T3-L1+adipocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DS.%2BC.%26aulast%3DLane%26aufirst%3DM.%2BD.%26atitle%3DEvidence%2520for%2520the%2520involvement%2520of%2520vicinal%2520sulfhydryl%2520groups%2520in%2520insulin-activated%2520hexose%2520transport%2520by%25203T3-L1%2520adipocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1985%26volume%3D260%26spage%3D2646%26epage%3D2652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Clancy, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czech, M. P.</span><span> </span><span class="NLM_article-title">Hexose transport stimulation and membrane redistribution of glucose transporter isoforms in response to cholera toxin, dibutyryl cyclic AMP, and insulin in 3T3-L1 adipocytes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">1990</span> <span class="NLM_volume">265</span> <span class="NLM_fpage">12434</span> <span class="NLM_lpage">12443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=12434-12443&author=B.+M.+Clancyauthor=M.+P.+Czech&title=Hexose+transport+stimulation+and+membrane+redistribution+of+glucose+transporter+isoforms+in+response+to+cholera+toxin%2C+dibutyryl+cyclic+AMP%2C+and+insulin+in+3T3-L1+adipocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClancy%26aufirst%3DB.%2BM.%26aulast%3DCzech%26aufirst%3DM.%2BP.%26atitle%3DHexose%2520transport%2520stimulation%2520and%2520membrane%2520redistribution%2520of%2520glucose%2520transporter%2520isoforms%2520in%2520response%2520to%2520cholera%2520toxin%252C%2520dibutyryl%2520cyclic%2520AMP%252C%2520and%2520insulin%2520in%25203T3-L1%2520adipocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26spage%3D12434%26epage%3D12443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Hong Ren, Kevin M. Maloney, Kallol Basu, Michael J. Di Maso, Guy R. Humphrey, Feng Peng, Richard Desmond, Douglas A. L. Otte, Embarek Alwedi, Wenjun Liu, Si-Wei Zhang, Siqing Song, Rebecca A. Arvary, Michael A. Zompa, Dan Lehnherr, Gary E. Martin, Hsieh Yao D. Chang, Anne E. Mohan, Francisco J. Guzman, Lisa Jellett, Alfred Y. Lee, Glenn Spencer, Elizabeth S. Fisher, John R. Naber, Hong Gao, Sachin Lohani, Rebecca T. Ruck, <span class="NLM_string-name hlFld-ContribAuthor">Louis-Charles Campeau</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Green and Sustainable Manufacturing Process for Gefapixant Citrate (MK-7264) Part 1: Introduction and Process Overview. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2020,</strong> <em>24 </em>
                                    (11)
                                     , 2445-2452. <a href="https://doi.org/10.1021/acs.oprd.0c00248" title="DOI URL">https://doi.org/10.1021/acs.oprd.0c00248</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.0c00248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.0c00248%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDevelopment%252Bof%252Ba%252BGreen%252Band%252BSustainable%252BManufacturing%252BProcess%252Bfor%252BGefapixant%252BCitrate%252B%252528MK-7264%252529%252BPart%252B1%25253A%252BIntroduction%252Band%252BProcess%252BOverview%26aulast%3DRen%26aufirst%3DHong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22052020%26date%3D16102020%26volume%3D24%26issue%3D11%26spage%3D2445%26epage%3D2452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunrui  Cai</span>, <span class="hlFld-ContribAuthor ">Tong  Chen</span>, <span class="hlFld-ContribAuthor ">Huajian  Zhu</span>, <span class="hlFld-ContribAuthor ">Hongbin  Zou</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Antitumor Assessment of Phenylureas Bearing 5-Fluoroindolin-2-one Moiety. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry</span><span> <strong>2020,</strong> <em>16 </em>
                                    (7)
                                     , 958-968. <a href="https://doi.org/10.2174/1573406416666200206123319" title="DOI URL">https://doi.org/10.2174/1573406416666200206123319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1573406416666200206123319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1573406416666200206123319%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BAntitumor%252BAssessment%252Bof%252BPhenylureas%252BBearing%252B5-Fluoroindolin-2-one%252BMoiety%26aulast%3DCai%26aufirst%3DYunrui%26date%3D2020%26volume%3D16%26issue%3D7%26spage%3D958%26epage%3D968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandro  Gómez‐Palomino</span>, <span class="hlFld-ContribAuthor ">Josep  Cornella</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Late‐Stage Sulfonyl Chloride Formation from Sulfonamides Enabled by Pyry‐BF
              4. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (50)
                                     , 18403-18407. <a href="https://doi.org/10.1002/ange.201910895" title="DOI URL">https://doi.org/10.1002/ange.201910895</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201910895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201910895%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DSelective%252BLate%2525E2%252580%252590Stage%252BSulfonyl%252BChloride%252BFormation%252Bfrom%252BSulfonamides%252BEnabled%252Bby%252BPyry%2525E2%252580%252590BF%252B4%26aulast%3DG%25C3%25B3mez%25E2%2580%2590Palomino%26aufirst%3DAlejandro%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D50%26spage%3D18403%26epage%3D18407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandro  Gómez‐Palomino</span>, <span class="hlFld-ContribAuthor ">Josep  Cornella</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Late‐Stage Sulfonyl Chloride Formation from Sulfonamides Enabled by Pyry‐BF
              4. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (50)
                                     , 18235-18239. <a href="https://doi.org/10.1002/anie.201910895" title="DOI URL">https://doi.org/10.1002/anie.201910895</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201910895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201910895%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DSelective%252BLate%2525E2%252580%252590Stage%252BSulfonyl%252BChloride%252BFormation%252Bfrom%252BSulfonamides%252BEnabled%252Bby%252BPyry%2525E2%252580%252590BF%252B4%26aulast%3DG%25C3%25B3mez%25E2%2580%2590Palomino%26aufirst%3DAlejandro%26date%3D2019%26volume%3D58%26issue%3D50%26spage%3D18235%26epage%3D18239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sebastian  Glomb</span>, <span class="hlFld-ContribAuthor ">Gamall  Makhloufi</span>, <span class="hlFld-ContribAuthor ">Irina  Gruber</span>, <span class="hlFld-ContribAuthor ">Christoph  Janiak</span>. </span><span class="cited-content_cbyCitation_article-title">Urea-based flexible dicarboxylate linkers for three-dimensional metal-organic frameworks. </span><span class="cited-content_cbyCitation_journal-name">Inorganica Chimica Acta</span><span> <strong>2018,</strong> <em>475 </em>, 35-46. <a href="https://doi.org/10.1016/j.ica.2017.09.029" title="DOI URL">https://doi.org/10.1016/j.ica.2017.09.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ica.2017.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ica.2017.09.029%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganica%2520Chimica%2520Acta%26atitle%3DUrea-based%252Bflexible%252Bdicarboxylate%252Blinkers%252Bfor%252Bthree-dimensional%252Bmetal-organic%252Bframeworks%26aulast%3DGlomb%26aufirst%3DSebastian%26date%3D2018%26volume%3D475%26spage%3D35%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Roslin</span>, <span class="hlFld-ContribAuthor ">Peter  Brandt</span>, <span class="hlFld-ContribAuthor ">Patrik  Nordeman</span>, <span class="hlFld-ContribAuthor ">Mats  Larhed</span>, <span class="hlFld-ContribAuthor ">Luke  Odell</span>, <span class="hlFld-ContribAuthor ">Jonas  Eriksson</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 11C-Labelled Ureas by Palladium(II)-Mediated Oxidative Carbonylation. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (10)
                                     , 1688. <a href="https://doi.org/10.3390/molecules22101688" title="DOI URL">https://doi.org/10.3390/molecules22101688</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22101688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22101688%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Bof%252B11C-Labelled%252BUreas%252Bby%252BPalladium%252528II%252529-Mediated%252BOxidative%252BCarbonylation%26aulast%3DRoslin%26aufirst%3DSara%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D10%26spage%3D1688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fatiha  Benmansour</span>, <span class="hlFld-ContribAuthor ">Iuni  Trist</span>, <span class="hlFld-ContribAuthor ">Bruno  Coutard</span>, <span class="hlFld-ContribAuthor ">Etienne  Decroly</span>, <span class="hlFld-ContribAuthor ">Gilles  Querat</span>, <span class="hlFld-ContribAuthor ">Andrea  Brancale</span>, <span class="hlFld-ContribAuthor ">Karine  Barral</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>125 </em>, 865-880. <a href="https://doi.org/10.1016/j.ejmech.2016.10.007" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.10.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.10.007%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bdengue%252Bvirus%252BNS5%252Bmethyltransferase%252Bnon-nucleoside%252Binhibitors%252Bby%252Bfragment-based%252Bdrug%252Bdesign%26aulast%3DBenmansour%26aufirst%3DFatiha%26date%3D2017%26volume%3D125%26spage%3D865%26epage%3D880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margaret  Wu</span>, <span class="hlFld-ContribAuthor ">Ge  Dai</span>, <span class="hlFld-ContribAuthor ">Jun  Yao</span>, <span class="hlFld-ContribAuthor ">Scott  Hoyt</span>, <span class="hlFld-ContribAuthor ">Liangsu  Wang</span>, <span class="hlFld-ContribAuthor ">James  Mu</span>, . </span><span class="cited-content_cbyCitation_article-title">Potentiation of Insulin-Mediated Glucose Lowering without Elevated Hypoglycemia Risk by a Small Molecule Insulin Receptor Modulator. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (3)
                                     , e0122012. <a href="https://doi.org/10.1371/journal.pone.0122012" title="DOI URL">https://doi.org/10.1371/journal.pone.0122012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0122012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0122012%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DPotentiation%252Bof%252BInsulin-Mediated%252BGlucose%252BLowering%252Bwithout%252BElevated%252BHypoglycemia%252BRisk%252Bby%252Ba%252BSmall%252BMolecule%252BInsulin%252BReceptor%252BModulator%26aulast%3DWu%26aufirst%3DMargaret%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D3%26spage%3De0122012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koichi  Sato</span>, <span class="hlFld-ContribAuthor ">Minyue  Zhu</span>, <span class="hlFld-ContribAuthor ">Naoko  Takenaga</span>. </span><span class="cited-content_cbyCitation_article-title">A facile preparation of modified hydrophilic azulene derivatives. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2013,</strong> <em>54 </em>
                                    (24)
                                     , 3204-3206. <a href="https://doi.org/10.1016/j.tetlet.2013.04.039" title="DOI URL">https://doi.org/10.1016/j.tetlet.2013.04.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2013.04.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2013.04.039%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bfacile%252Bpreparation%252Bof%252Bmodified%252Bhydrophilic%252Bazulene%252Bderivatives%26aulast%3DSato%26aufirst%3DKoichi%26date%3D2013%26volume%3D54%26issue%3D24%26spage%3D3204%26epage%3D3206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noelia  Fontán</span>, <span class="hlFld-ContribAuthor ">Patricia  García-Domínguez</span>, <span class="hlFld-ContribAuthor ">Rosana  Álvarez</span>, <span class="hlFld-ContribAuthor ">Ángel R.  de Lera</span>. </span><span class="cited-content_cbyCitation_article-title">Novel symmetrical ureas as modulators of protein arginine methyl transferases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (7)
                                     , 2056-2067. <a href="https://doi.org/10.1016/j.bmc.2013.01.017" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.01.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.01.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bsymmetrical%252Bureas%252Bas%252Bmodulators%252Bof%252Bprotein%252Barginine%252Bmethyl%252Btransferases%26aulast%3DFont%25C3%25A1n%26aufirst%3DNoelia%26date%3D2013%26volume%3D21%26issue%3D7%26spage%3D2056%26epage%3D2067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yannick  Borguet</span>, <span class="hlFld-ContribAuthor ">Guillermo  Zaragoza</span>, <span class="hlFld-ContribAuthor ">Albert  Demonceau</span>, <span class="hlFld-ContribAuthor ">Lionel  Delaude</span>. </span><span class="cited-content_cbyCitation_article-title">An Unexpected Synthesis of Dihydrophenazines en Route to Benzimidazolium Salts. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2012,</strong> <em>354 </em>
                                    (7)
                                     , 1356-1362. <a href="https://doi.org/10.1002/adsc.201100890" title="DOI URL">https://doi.org/10.1002/adsc.201100890</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201100890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201100890%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DAn%252BUnexpected%252BSynthesis%252Bof%252BDihydrophenazines%252Ben%252BRoute%252Bto%252BBenzimidazolium%252BSalts%26aulast%3DBorguet%26aufirst%3DYannick%26date%3D2012%26date%3D2012%26volume%3D354%26issue%3D7%26spage%3D1356%26epage%3D1362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Radhakrishnan  Selvi</span>, <span class="hlFld-ContribAuthor ">Renganathan  Bhuvanasundar</span>, <span class="hlFld-ContribAuthor ">Aluru Venkata  Saijyothi</span>, <span class="hlFld-ContribAuthor ">Konerirajapuram Natarajan  Sulochana</span>, <span class="hlFld-ContribAuthor ">Narayanasamy  Angayarkanni</span>. </span><span class="cited-content_cbyCitation_article-title">Amino Acids Potentiate Insulin Signaling in CHO-K1 at High Glucose Conditions. </span><span class="cited-content_cbyCitation_journal-name">Archives of Medical Research</span><span> <strong>2012,</strong> <em>43 </em>
                                    (3)
                                     , 173-182. <a href="https://doi.org/10.1016/j.arcmed.2012.04.008" title="DOI URL">https://doi.org/10.1016/j.arcmed.2012.04.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arcmed.2012.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arcmed.2012.04.008%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Medical%2520Research%26atitle%3DAmino%252BAcids%252BPotentiate%252BInsulin%252BSignaling%252Bin%252BCHO-K1%252Bat%252BHigh%252BGlucose%252BConditions%26aulast%3DSelvi%26aufirst%3DRadhakrishnan%26date%3D2012%26volume%3D43%26issue%3D3%26spage%3D173%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Summary of changes made to compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0017.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) triphosgene, THF/aqueous NaOH; (b) POCl<sub>3</sub>; (c) pyridine, THF.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0018.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Ac<sub>2</sub>O, pyridine; (b) POCl<sub>3</sub>; (c) pyridine, THF; (d) 5 N NaOH, 60°C; (e) triphosgene, THF, 1 M NaOAc buffer, pH 4.7.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0019.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>p</i>-cresol, pyridine, THF; (b) SnCl<sub>2</sub>, HCl; (c) POCl<sub>3</sub>, DMA; (d) NaN<sub>3</sub>, Et<sub>3</sub>NHCl, toluene, 100°C.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0001.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Fmoc-Cl, NaOH; (b) SOCl<sub>2</sub>, pyridine; (c) methyl 3-aminobenzoate or <b>54</b>; (d) piperidine, CH<sub>2</sub>Cl<sub>2</sub>; (e) triphosgene, THF/aqueous NaOH; (f) NaOMe, THF/H<sub>2</sub>O.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0002.jpeg" id="rightTab-gs5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 1,2-Dibromoethane, K<sub>2</sub>CO<sub>3</sub>, DMF; (b) Ac<sub>2</sub>O, pyridine; (c) POCl<sub>3</sub>; (d) 5-amino-2-chlorobenzoic acid, pyridine; (e) 5 N NaOH; (f) triphosgene THF/aqueous Na<sub>2</sub>CO<sub>3</sub>.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0003.jpeg" id="rightTab-gs6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) NaH, MeI, DMF, 70 °C; (b) POCl<sub>3</sub>; (c) methyl 2-amino-5-chlorobenzoate, pyridine; (d) NaOH.</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0004.jpeg" id="rightTab-gs7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 1,1′-Thiocarbonyldiimidazole; (b) <b>64</b>, CH<sub>2</sub>Cl<sub>2</sub>; (c) 1 N NaOH; (d) MeI; (e) R<sub>1</sub>NH<sub>2</sub>, sealed tube, 70−80 °C.</p></p></figure><figure data-id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effects of compounds <b>1</b> and <b>3</b> on the autophosphorylation of the insulin receptor cytoplasmic kinase domain (CKD). Results are mean ± SEM values of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of compound <b>30</b> on insulin receptor tyrosine phosphorylation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0014.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. GLUT4 content at the plasma membrane is increased by treatment with compound <b>30</b>: (∗) <i>p</i> < 0.05; (∗∗) <i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0015.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of a single intraperitoneal (ip) dose of compound <b>30</b> in an oral glucose tolerance test in STZ-diabetic rats. Glucose load was administered 15 min postdose (50 mg/kg): (∗) <i>p</i> = 0.014 (<i>t</i> test, unpaired).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/medium/jm-2008-00600v_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0016.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of a single oral (po) dose of compound <b>30</b> in an oral glucose tolerance test in STZ-diabetic rats. Glucose load was administered 15 min postdose (1000 mg/kg): (∗) <i>p</i> < 0.05 (<i>t</i> test, unpaired).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800600v/production/images/large/jm-2008-00600v_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800600v&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56158" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56158" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 45 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Zimmet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberti, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span> </span><span class="NLM_article-title">Global and societal implications of the diabetes epidemic</span> <span class="citation_source-journal">Nature</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">414</span> <span class="NLM_fpage">782</span> <span class="NLM_lpage">787</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1038%2F414782a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=11742409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD38Xhtlymtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=782-787&author=P.+Zimmetauthor=K.+G.+Albertiauthor=J.+Shaw&title=Global+and+societal+implications+of+the+diabetes+epidemic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Global and societal implications of the diabetes epidemic</span></div><div class="casAuthors">Zimmet, Paul; Alberti, K. G. M. M.; Shaw, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">414</span>
        (<span class="NLM_cas:issue">6865</span>),
    <span class="NLM_cas:pages">782-787</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Changes in human behavior and lifestyle over the last century have resulted in a dramatic increase in the incidence of diabetes worldwide.  The epidemic is chiefly of type 2 diabetes and also the assocd. conditions known as 'diabesity' and 'metabolic syndrome'.  In conjunction with genetic susceptibility, particularly in certain ethnic groups, type 2 diabetes is brought on by environmental and behavioral factors such as a sedentary lifestyle, overly rich nutrition and obesity.  The prevention of diabetes and control of its micro- and macrovascular complications will require an integrated, international approach if we are to see significant redn. in the huge premature morbidity and mortality it causes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3G3dd0CuoQbVg90H21EOLACvtfcHk0ljNv_4gzECaVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xhtlymtg%253D%253D&md5=3b7fd57f6bd54a45a5c20c70fab864bd</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F414782a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F414782a%26sid%3Dliteratum%253Aachs%26aulast%3DZimmet%26aufirst%3DP.%26aulast%3DAlberti%26aufirst%3DK.%2BG.%26aulast%3DShaw%26aufirst%3DJ.%26atitle%3DGlobal%2520and%2520societal%2520implications%2520of%2520the%2520diabetes%2520epidemic%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D782%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Wild, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roglic, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicree, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, H.</span><span> </span><span class="NLM_article-title">Global prevalence of diabetes: estimates for the year 2000 and projections for 2030</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">27</span> <span class="NLM_fpage">1047</span> <span class="NLM_lpage">1053</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.2337%2Fdiacare.27.5.1047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=15111519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A280%3ADC%252BD2c3itVymsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=1047-1053&author=S.+Wildauthor=G.+Roglicauthor=A.+Greenauthor=R.+Sicreeauthor=H.+King&title=Global+prevalence+of+diabetes%3A+estimates+for+the+year+2000+and+projections+for+2030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Global prevalence of diabetes: estimates for the year 2000 and projections for 2030</span></div><div class="casAuthors">Wild Sarah; Roglic Gojka; Green Anders; Sicree Richard; King Hilary</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes care</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1047-53</span>
        ISSN:<span class="NLM_cas:issn">0149-5992</span>.
    </div><div class="casAbstract">OBJECTIVE:  The goal of this study was to estimate the prevalence of diabetes and the number of people of all ages with diabetes for years 2000 and 2030.  RESEARCH DESIGN AND METHODS:  Data on diabetes prevalence by age and sex from a limited number of countries were extrapolated to all 191 World Health Organization member states and applied to United Nations' population estimates for 2000 and 2030.  Urban and rural populations were considered separately for developing countries.  RESULTS:  The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030.  The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030.  The prevalence of diabetes is higher in men than women, but there are more women with diabetes than men.  The urban population in developing countries is projected to double between 2000 and 2030.  The most important demographic change to diabetes prevalence across the world appears to be the increase in the proportion of people >65 years of age.  CONCLUSIONS:  These findings indicate that the "diabetes epidemic" will continue even if levels of obesity remain constant.  Given the increasing prevalence of obesity, it is likely that these figures provide an underestimate of future diabetes prevalence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRS1_5FBm4QLEbxh97K6Vt6fW6udTcc2eb-lEelIfNvZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3itVymsw%253D%253D&md5=93096de002d513e4fdd49028be51d85d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2337%2Fdiacare.27.5.1047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiacare.27.5.1047%26sid%3Dliteratum%253Aachs%26aulast%3DWild%26aufirst%3DS.%26aulast%3DRoglic%26aufirst%3DG.%26aulast%3DGreen%26aufirst%3DA.%26aulast%3DSicree%26aufirst%3DR.%26aulast%3DKing%26aufirst%3DH.%26atitle%3DGlobal%2520prevalence%2520of%2520diabetes%253A%2520estimates%2520for%2520the%2520year%25202000%2520and%2520projections%2520for%25202030%26jtitle%3DDiabetes%2520Care%26date%3D2004%26volume%3D27%26spage%3D1047%26epage%3D1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">DeFronzo, R. A.</span><span> </span><span class="NLM_article-title">Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes</span> <span class="citation_source-journal">Diabetes Rev.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">177</span> <span class="NLM_lpage">269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1997&pages=177-269&author=R.+A.+DeFronzo&title=Pathogenesis+of+type+2+diabetes%3A+metabolic+and+molecular+implications+for+identifying+diabetes+genes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeFronzo%26aufirst%3DR.%2BA.%26atitle%3DPathogenesis%2520of%2520type%25202%2520diabetes%253A%2520metabolic%2520and%2520molecular%2520implications%2520for%2520identifying%2520diabetes%2520genes%26jtitle%3DDiabetes%2520Rev.%26date%3D1997%26volume%3D5%26spage%3D177%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Facchini, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbasi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reaven, G. M.</span><span> </span><span class="NLM_article-title">Insulin resistance as a predictor of age-related diseases</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">86</span> <span class="NLM_fpage">3574</span> <span class="NLM_lpage">3578</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1210%2Fjc.86.8.3574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=11502781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFektrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2001&pages=3574-3578&author=F.+S.+Facchiniauthor=N.+Huaauthor=F.+Abbasiauthor=G.+M.+Reaven&title=Insulin+resistance+as+a+predictor+of+age-related+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin resistance as a predictor of age-related diseases</span></div><div class="casAuthors">Facchini, Francesco S.; Hua, Nancy; Abbasi, Fahim; Reaven, Gerald M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3574-3578</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The current study was initiated to evaluate the ability of insulin resistance to predict a variety of age-related diseases.  Baseline measurements of insulin resistance and related variables were made between 1988-1995 in 208 apparently healthy, nonobese (body mass index < 30 kg/m2) individuals, who were then evaluated 4-11 yr later (mean ± SEM = 6.3 ± 0.2 yr) for the appearance of the following age-related diseases: hypertension, coronary heart disease, stroke, cancer, and type 2 diabetes.  The effect of insulin resistance on the development of clin. events was evaluated by dividing the study group into tertiles of insulin resistance at baseline and comparing the events in these 3 groups.  Clin. endpoints (n = 40) were identified in 37 individuals (18%) of those evaluated, including 12 with hypertension, 3 with hypertension + type 2 diabetes, 9 with cancer, 7 with coronary heart disease, 4 with stroke, and 2 with type 2 diabetes.  Twenty-eight out of the total 40 clin. events were seen in 25 individuals (36%) in the most insulin-resistant tertile, with the other 12 occurring in the group with an intermediate degree of insulin resistance.  Furthermore, insulin resistance was an independent predictor of all clin. events, using both multiple logistic regression and Cox's proportional hazards anal.  The fact that an age-related clin. event developed in approx. 1 out of 3 healthy individuals in the upper tertile of insulin resistance at baseline, followed for an av. of 6 yr, whereas no clin. events were obsd. in the most insulin-sensitive tertile, should serve as a strong stimulus to further efforts to define the role of insulin resistance in the genesis of age-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHCdrUQGFn67Vg90H21EOLACvtfcHk0ljNv_4gzECaVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFektrc%253D&md5=7ebe20852848a49ad461baa16a96d484</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1210%2Fjc.86.8.3574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.86.8.3574%26sid%3Dliteratum%253Aachs%26aulast%3DFacchini%26aufirst%3DF.%2BS.%26aulast%3DHua%26aufirst%3DN.%26aulast%3DAbbasi%26aufirst%3DF.%26aulast%3DReaven%26aufirst%3DG.%2BM.%26atitle%3DInsulin%2520resistance%2520as%2520a%2520predictor%2520of%2520age-related%2520diseases%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2001%26volume%3D86%26spage%3D3574%26epage%3D3578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Reaven, G. M.</span><span> </span><span class="NLM_article-title">Role of insulin resistance in human disease</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_year" style="font-weight: bold;">1988</span> <span class="NLM_volume">37</span> <span class="NLM_fpage">1595</span> <span class="NLM_lpage">1607</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1988&pages=1595-1607&author=G.+M.+Reaven&title=Role+of+insulin+resistance+in+human+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReaven%26aufirst%3DG.%2BM.%26atitle%3DRole%2520of%2520insulin%2520resistance%2520in%2520human%2520disease%26jtitle%3DDiabetes%26date%3D1988%26volume%3D37%26spage%3D1595%26epage%3D1607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Turner, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cull, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frighi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, R. R.</span><span> </span><span class="NLM_article-title">Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49)</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">281</span> <span class="NLM_fpage">2005</span> <span class="NLM_lpage">2012</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1999&pages=2005-2012&author=R.+C.+Turnerauthor=C.+A.+Cullauthor=V.+Frighiauthor=R.+R.+Holman&title=Glycemic+control+with+diet%2C+sulfonylurea%2C+metformin%2C+or+insulin+in+patients+with+type+2+diabetes+mellitus.+Progressive+requirement+for+multiple+therapies+%28UKPDS+49%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DR.%2BC.%26aulast%3DCull%26aufirst%3DC.%2BA.%26aulast%3DFrighi%26aufirst%3DV.%26aulast%3DHolman%26aufirst%3DR.%2BR.%26atitle%3DGlycemic%2520control%2520with%2520diet%252C%2520sulfonylurea%252C%2520metformin%252C%2520or%2520insulin%2520in%2520patients%2520with%2520type%25202%2520diabetes%2520mellitus.%2520Progressive%2520requirement%2520for%2520multiple%2520therapies%2520%2528UKPDS%252049%2529%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D1999%26volume%3D281%26spage%3D2005%26epage%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Evans, J. L.; Rushakoff, R. J.</span><span> </span><span class="NLM_article-title">Oral Pharmacological Agents for Type 2 Diabetes: Sulfonylureas, Meglitinides, Metformin, Thiazolidinediones, α-Glucosidase Inhibitors, and Emerging Approaches</span>. In  <span class="citation_source-book">Endotext.com: Diabetes and Carbohydrate Metabolism</span>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_contrib-group">Degroot, L.; Goldfine, I. D.; Rushakoff, R. J.</span>, Eds.; <span class="NLM_publisher-name">Medtext, Inc.</span>: <span class="NLM_publisher-loc">Burr Ridge, IL</span>, <span class="NLM_year">2007</span>; <a href="http://www.medtext.com" class="extLink">http://www.medtext.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+L.+Evans&author=R.+J.+Rushakoffauthor=L.+Degroot&author=I.+D.+Goldfine&author=R.+J.+Rushakoff&title=Endotext.com%3A+Diabetes+and+Carbohydrate+Metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DJ.%2BL.%26atitle%3DOral%2520Pharmacological%2520Agents%2520for%2520Type%25202%2520Diabetes%253A%2520Sulfonylureas%252C%2520Meglitinides%252C%2520Metformin%252C%2520Thiazolidinediones%252C%2520%25CE%25B1-Glucosidase%2520Inhibitors%252C%2520and%2520Emerging%2520Approaches%26btitle%3DEndotext.com%253A%2520Diabetes%2520and%2520Carbohydrate%2520Metabolism%26aulast%3DDegroot%26aufirst%3DL.%26pub%3DMedtext%252C%2520Inc%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Pfeifer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halter, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, D.,  Jr.</span><span> </span><span class="NLM_article-title">Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin-dependent diabetes mellitus</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_year" style="font-weight: bold;">1981</span> <span class="NLM_volume">53</span> <span class="NLM_fpage">1256</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=7028776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A280%3ADyaL38%252Fltleqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1981&pages=1256-1262&author=M.+Pfeiferauthor=J.+B.+Halterauthor=J.+C.+Beardauthor=D.+Porte&title=Differential+effects+of+tolbutamide+on+first+and+second+phase+insulin+secretion+in+noninsulin-dependent+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin-dependent diabetes mellitus</span></div><div class="casAuthors">Pfeifer M A; Halter J B; Beard J C; Porte D Jr</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical endocrinology and metabolism</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1256-62</span>
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">Immunoreactive insulin responses to a 20-g iv glucose challenge during a 7.5 mg/m2/min tolbutamide infusion were studied in 21 untreated noninsulin-dependent male diabetics.  All data were analyzed by paired t tests.  During the tolbutamide infusion, compared to the saline control period in the same subjects, glucose levels were lowered [217 +/- 17 vs. 196 +/- 16 mg/dl (mean +/- SEM); P less than 0.005], and there was an increase in both first phase (2 +/- 1 vs. 16 +/- 4 micro U/ml; P less than 0.005) and second phase insulin responses (296 +/- 71 vs. 499 +/- 101 micro U. min/ml; P less than 0.05; n = 21).  However, when the prestimulus glucose level was lowered by an insulin infusion (214 +/- 20 vs. 145 +/- 17 mg/dl; P less than 0.001), no effect on first phase insulin secretion was observed, and the second phase response decreased (290 +/- 78 vs. 124 +/ 55 micro U. min/ml; P less than 0.005; n = 11; saline control vs. insulin infusion).  In 8 subjects, the plasma glucose level during the tolbutamide infusion was kept constant by a concurrent variable glucose infusion.  First phase insulin secretion was still increased, though no more than in studies were plasma glucose was not kept constant.  However, there was further augmentation of the second phase response (tolbutamide alone, 443 +/- 142 micro U. min/ml; tolbutamide plus glucose, 802 +/- 232 micro U. min/ml; P less than 0.05).  These findings indicate that tolbutamide augments first phase insulin secretion in untreated diabetics independently of the prestimulus glucose level.  However, changes in the glucose level significantly modulate the sulfonylurea influence on the second phase insulin response to glucose.  This effect of glucose level is an important consideration when evaluating the insulinotropic effects of a sulfonylurea.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTVGPVto5hO2TW1zwg2yUK5fW6udTcc2eYbezMaRbE6irntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL38%252Fltleqsw%253D%253D&md5=16aa155c81500a897853c866a9c7b3fc</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPfeifer%26aufirst%3DM.%26aulast%3DHalter%26aufirst%3DJ.%2BB.%26aulast%3DBeard%26aufirst%3DJ.%2BC.%26aulast%3DPorte%26aufirst%3DD.%26atitle%3DDifferential%2520effects%2520of%2520tolbutamide%2520on%2520first%2520and%2520second%2520phase%2520insulin%2520secretion%2520in%2520noninsulin-dependent%2520diabetes%2520mellitus%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1981%26volume%3D53%26spage%3D1256%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Lebovitz, H. E.</span><span> </span><span class="NLM_article-title">Insulin Secretagogues: Sulfonylureas and Meglitinides</span>. In  <span class="citation_source-book">Diabetes Mellitus: A Fundamental and Clinical Text</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group">LeRoith, D.; Taylor, S. I.; Olefsky, J. M.</span>, Eds.; <span class="NLM_publisher-name">Lippincott Williams & Wilkins</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, <span class="NLM_year">2000</span>; pp  <span class="NLM_fpage">769</span>− <span class="NLM_lpage">778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=769-778&author=H.+E.+Lebovitz&title=Diabetes+Mellitus%3A+A+Fundamental+and+Clinical+Text"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLebovitz%26aufirst%3DH.%2BE.%26atitle%3DInsulin%2520Secretagogues%253A%2520Sulfonylureas%2520and%2520Meglitinides%26btitle%3DDiabetes%2520Mellitus%253A%2520A%2520Fundamental%2520and%2520Clinical%2520Text%26aulast%3DLeRoith%26aufirst%3DD.%26pub%3DLippincott%2520Williams%2520%2526%2520Wilkins%26date%3D2000%26spage%3D769%26epage%3D778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Stumvoll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurjhan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perriello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dailey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerich, J. E.</span><span> </span><span class="NLM_article-title">Metabolic effects of metformin in non-insulin-dependent diabetes mellitus</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">333</span> <span class="NLM_fpage">550</span> <span class="NLM_lpage">554</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1056%2FNEJM199508313330903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=7623903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADyaK2MXpsVanurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=1995&pages=550-554&author=M.+Stumvollauthor=N.+Nurjhanauthor=G.+Perrielloauthor=G.+Daileyauthor=J.+E.+Gerich&title=Metabolic+effects+of+metformin+in+non-insulin-dependent+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic effects of metformin in non-insulin-dependent diabetes mellitus</span></div><div class="casAuthors">Stumvoll, Michael; Nurjhan, Nurjahan; Perriello, Gabriele; Dailey, George; Gerich, John E.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">550-4</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">The metabolic effects and mechanism of action of metformin are still poorly understood, despite the fact that it has been used to treat patients with non-insulin-dependent diabetes mellitus (NIDDM) for more than 30 yr.  In 10 obese patients with NIDDM, we used a combination of isotope diln., indirect calorimetry, bio-impedance, and tissue-balance techniques to assess the effects of metformin on systemic lactate, glucose, and free-fatty-acid turnover; lactate oxidn. and the conversion of lactate to glucose; skeletal-muscle glucose and lactate metab.; body compn.; and energy expenditure before and after four months of treatment.  Metformin treatment decreased the mean (±SD) glycosylated Hb value from 13.2±2.2 percent to 10.5±1.6 percent (P<0.001) and reduced fasting plasma glucose concns. from 220±41 to 155±28 mg per dL (12.2±0.7 to 8.6±0.5 mmol per L) (P<0.001).  Although resting energy expenditure did not change, the patients lost 2.7±1.3 kg of wt. (P<0.001), 88 percent of which was adipose tissue.  The mean (±SE) rate of plasma glucose turnover (hepatic glucose output and systemic glucose disposal) decreased from 2.8±0.2 to 2.0±0.2 mg per kg of body wt. per min (15.3±0.9 to 10.8±0.9 μmol per kg per min) (P<0.001), as a result of a decrease in hepatic glucose output; systemic glucose clearance did not change.  The rate of conversion of lactate to glucose (gluconeogenesis) decreased by 37 percent (P<0.001), whereas lactate oxidn. increased by 25 percent (P<0.001).  There were no changes in the plasma lactate concn., plasma lactate turnover, muscle lactate release, plasma free-fatty-acid turnover, or uptake of glucose by muscle.  Metformin acts primarily by decreasing hepatic glucose output, largely by inhibiting gluconeogenesis.  It also seems to induce wt. loss, preferentially involving adipose tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosVINNDspoQ7Vg90H21EOLACvtfcHk0lhNpXD3t30I4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpsVanurc%253D&md5=8bff183df92e10e9d0c3cef5bb726601</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1056%2FNEJM199508313330903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199508313330903%26sid%3Dliteratum%253Aachs%26aulast%3DStumvoll%26aufirst%3DM.%26aulast%3DNurjhan%26aufirst%3DN.%26aulast%3DPerriello%26aufirst%3DG.%26aulast%3DDailey%26aufirst%3DG.%26aulast%3DGerich%26aufirst%3DJ.%2BE.%26atitle%3DMetabolic%2520effects%2520of%2520metformin%2520in%2520non-insulin-dependent%2520diabetes%2520mellitus%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1995%26volume%3D333%26spage%3D550%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenyk-Melody, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirshman, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodyear, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">Role of AMP-activated protein kinase in mechanism of metformin action</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">108</span> <span class="NLM_fpage">1167</span> <span class="NLM_lpage">1174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1172%2FJCI13505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=11602624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXns1ChsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2001&pages=1167-1174&author=G.+Zhouauthor=R.+Myersauthor=Y.+Liauthor=Y.+Chenauthor=X.+Shenauthor=J.+Fenyk-Melodyauthor=M.+Wuauthor=J.+Ventreauthor=T.+Doebberauthor=N.+Fujiiauthor=N.+Musiauthor=M.+F.+Hirshmanauthor=L.+J.+Goodyearauthor=D.+E.+Moller&title=Role+of+AMP-activated+protein+kinase+in+mechanism+of+metformin+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Role of AMP-activated protein kinase in mechanism of metformin action</span></div><div class="casAuthors">Zhou, Gaochao; Myers, Robert; Li, Ying; Chen, Yuli; Shen, Xiaolan; Fenyk-Melody, Judy; Wu, Margaret; Ventre, John; Doebber, Thomas; Fujii, Nobuharu; Musi, Nicolas; Hirshman, Michael F.; Goodyear, Laurie J.; Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1167-1174</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Metformin is a widely used drug for treatment of type 2 diabetes with no defined cellular mechanism of action.  Its glucose-lowering effect results from decreased hepatic glucose prodn. and increased glucose utilization.  Metformin's beneficial effects on circulating lipids have been linked to reduced fatty liver.  AMP-activated protein kinase (AMPK) is a major cellular regulator of lipid and glucose metab.  Here we report that metformin activates AMPK in hepatocytes; as a result, acetyl-CoA carboxylase (ACC) activity is reduced, fatty acid oxidn. is induced, and expression of lipogenic enzymes is suppressed.  Activation of AMPK by metformin or an adenosine analog suppresses expression of SREBP-1, a key lipogenic transcription factor.  In metformin-treated rats, hepatic expression of SREBP-1 (and other lipogenic) mRNAs and protein is reduced; activity of the AMPK target, ACC, is also reduced.  Using a novel AMPK inhibitor, we find that AMPK activation is required for metformin's inhibitory effect on glucose prodn. by hepatocytes.  In isolated rat skeletal muscles, metformin stimulates glucose uptake coincident with AMPK activation.  Activation of AMPK provides a unified explanation for the pleiotropic beneficial effects of this drug; these results also suggest that alternative means of modulating AMPK should be useful for the treatment of metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT3nG6tsYQkLVg90H21EOLACvtfcHk0ljqMJm5FQr6dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXns1ChsL4%253D&md5=a086134de3fd5ed011ed15761b46cf84</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1172%2FJCI13505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI13505%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DMyers%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DFenyk-Melody%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DVentre%26aufirst%3DJ.%26aulast%3DDoebber%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DMusi%26aufirst%3DN.%26aulast%3DHirshman%26aufirst%3DM.%2BF.%26aulast%3DGoodyear%26aufirst%3DL.%2BJ.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DRole%2520of%2520AMP-activated%2520protein%2520kinase%2520in%2520mechanism%2520of%2520metformin%2520action%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2001%26volume%3D108%26spage%3D1167%26epage%3D1174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bischoff, H.</span><span> </span><span class="NLM_article-title">Pharmacology of alpha-glucosidase inhibition</span> <span class="citation_source-journal">Eur. J. Clin. Invest.</span><span class="NLM_year" style="font-weight: bold;">1994</span> <span class="NLM_volume">24</span><span class="NLM_issue">Suppl. 3</span> <span class="NLM_fpage">3</span> <span class="NLM_lpage">10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1994&pages=3-10&issue=Suppl.+3&author=H.+Bischoff&title=Pharmacology+of+alpha-glucosidase+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBischoff%26aufirst%3DH.%26atitle%3DPharmacology%2520of%2520alpha-glucosidase%2520inhibition%26jtitle%3DEur.%2520J.%2520Clin.%2520Invest.%26date%3D1994%26volume%3D24%26issue%3DSuppl.%25203%26spage%3D3%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Berger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">The mechanisms of action of PPARs</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">53</span> <span class="NLM_fpage">409</span> <span class="NLM_lpage">435</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1146%2Fannurev.med.53.082901.104018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=11818483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD38Xitl2mt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2002&pages=409-435&author=J.+Bergerauthor=D.+E.+Moller&title=The+mechanisms+of+action+of+PPARs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The Mechanisms of Action of PPARs</span></div><div class="casAuthors">Berger, Joel; Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">409-435</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The peroxisome proliferator-activated receptors (PPARs) are a group of three nuclear receptor isoforms, PPARγ, PPARα, and PPARδ, encoded by different genes.  PPARs are ligand-regulated transcription factors that control gene expression by binding to specific response elements (PPREs) within promoters.  PPARs bind as heterodimers with a retinoid X receptor and, upon binding agonist, interact with co-factors such that the rate of transcription initiation is increased.  The PPARs play a crit. physiol. role as lipid sensors and regulators of lipid metab.  Fatty acids and eicosanoids have been identified as natural ligands for the PPARs.  More potent synthetic PPAR ligands, including the fibrates and thiazolidinediones, have proven effective in the treatment of dyslipidemia and diabetes.  Use of such ligands has allowed researchers to unveil many potential roles for the PPARs in pathol. states including atherosclerosis, inflammation, cancer, infertility, and demyelination.  Here, we present the current state of knowledge regarding the mol. mechanisms of PPAR action and the involvement of the PPARs in the etiol. and treatment of several chronic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6rxPu_VgKKLVg90H21EOLACvtfcHk0ljqMJm5FQr6dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xitl2mt7s%253D&md5=cc724640866d5fa365b4e637d85f6732</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1146%2Fannurev.med.53.082901.104018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.med.53.082901.104018%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DThe%2520mechanisms%2520of%2520action%2520of%2520PPARs%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2002%26volume%3D53%26spage%3D409%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">New drug targets for type 2 diabetes and the metabolic syndrome</span> <span class="citation_source-journal">Nature</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">414</span> <span class="NLM_fpage">821</span> <span class="NLM_lpage">827</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1038%2F414821a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=11742415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD38Xhtlyltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=821-827&author=D.+E.+Moller&title=New+drug+targets+for+type+2+diabetes+and+the+metabolic+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">New drug targets for type 2 diabetes and the metabolic syndrome</span></div><div class="casAuthors">Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">414</span>
        (<span class="NLM_cas:issue">6865</span>),
    <span class="NLM_cas:pages">821-827</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  An insidious increase in features of the 'metabolic syndrome' - obesity, insulin resistance and dyslipidemia - has conspired to produce a worldwide epidemic of type 2 insulin-resistant diabetes mellitus.  Most current therapies for this disease were developed in the absence of defined mol. targets or an understanding of disease pathogenesis.  Emerging knowledge of key pathogenic mechanisms, such as the impairment of glucose-stimulated insulin secretion and the role of 'lipotoxicity' as a probable cause of hepatic and muscle resistance to insulin's effects on glucose metab., has led to a host of new mol. drug targets.  Several have been validated through genetic engineering in mice or the preliminary use of lead compds. and therapeutic agents in animals and humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLanr95TYBxrVg90H21EOLACvtfcHk0ljqMJm5FQr6dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xhtlyltw%253D%253D&md5=3561a033fea0c3aabe71a8cde8e69e77</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2F414821a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F414821a%26sid%3Dliteratum%253Aachs%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DNew%2520drug%2520targets%2520for%2520type%25202%2520diabetes%2520and%2520the%2520metabolic%2520syndrome%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D821%26epage%3D827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Sharma, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staels, B.</span><span> </span><span class="NLM_article-title">Review: peroxisome proliferator-activated receptor gamma and adipose tissue—understanding obesity-related changes in regulation of lipid and glucose metabolism</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">92</span> <span class="NLM_fpage">386</span> <span class="NLM_lpage">395</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1210%2Fjc.2006-1268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=17148564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVaksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2007&pages=386-395&author=A.+M.+Sharmaauthor=B.+Staels&title=Review%3A+peroxisome+proliferator-activated+receptor+gamma+and+adipose+tissue%E2%80%94understanding+obesity-related+changes+in+regulation+of+lipid+and+glucose+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor γ and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism</span></div><div class="casAuthors">Sharma, Arya M.; Staels, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">386-395</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Context: Adipose tissue is a metabolically dynamic organ, serving as a buffer to control fatty acid flux and a regulator of endocrine function.  In obese subjects, and those with type 2 diabetes or the metabolic syndrome, adipose tissue function is altered (i.e. adipocytes display morphol. differences alongside aberrant endocrine and metabolic function and low-grade inflammation).  Evidence Acquisition: Articles on the role of peroxisome proliferator-activated receptor γ (PPARγ) in adipose tissue of healthy individuals and those with obesity, metabolic syndrome, or type 2 diabetes were sourced using MEDLINE (1990-2006).  Evidence Synthesis: Articles were assessed to provide a comprehensive overview of how PPARγ-activating ligands improve adipose tissue function, and how this links to improvements in insulin resistance and the progression to type 2 diabetes and atherosclerosis.  Conclusions: PPARγ is highly expressed in adipose tissue, where its activation with thiazolidinediones alters fat topog. and adipocyte phenotype and up-regulates genes involved in fatty acid metab. and triglyceride storage.  Furthermore, PPARγ activation is assocd. with potentially beneficial effects on the expression and secretion of a range of factors, including adiponectin, resistin, IL-6, TNFα, plasminogen activator inhibitor-1, monocyte chemoattractant protein-1, and angiotensinogen, as well as a redn. in plasma nonesterified fatty acid supply.  The effects of PPARγ also extend to macrophages, where they suppress prodn. of inflammatory mediators.  As such, PPARγ activation appears to have a beneficial effect on the relationship between the macrophage and adipocyte that is distorted in obesity.  Thus, PPARγ-activating ligands improve adipose tissue function and may have a role in preventing progression of insulin resistance to diabetes and endothelial dysfunction to atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnhOXoZbEGDLVg90H21EOLACvtfcHk0lh6H7UL6RJ-5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVaksr0%253D&md5=b4c73940d128e43a662b71eccfeabdc0</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1210%2Fjc.2006-1268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2006-1268%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%2BM.%26aulast%3DStaels%26aufirst%3DB.%26atitle%3DReview%253A%2520peroxisome%2520proliferator-activated%2520receptor%2520gamma%2520and%2520adipose%2520tissue%25E2%2580%2594understanding%2520obesity-related%2520changes%2520in%2520regulation%2520of%2520lipid%2520and%2520glucose%2520metabolism%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2007%26volume%3D92%26spage%3D386%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Deacon, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahren, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, J. J.</span><span> </span><span class="NLM_article-title">Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of type 2 diabetes</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">1091</span> <span class="NLM_lpage">1102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1517%2F13543784.13.9.1091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=15330741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFSmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=1091-1102&author=C.+F.+Deaconauthor=B.+Ahrenauthor=J.+J.+Holst&title=Inhibitors+of+dipeptidyl+peptidase+IV%3A+a+novel+approach+for+the+prevention+and+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?</span></div><div class="casAuthors">Deacon, Carolyn F.; Ahren, Bo; Holst, Jens J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1091-1102</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Inhibitors of the enzyme dipeptidyl peptidase IV (DPP IV) are of increasing interest to both diabetologists and the pharmaceutical industry alike, as they may become established as the next member of the oral antidiabetic class of therapeutic agents, designed to lower blood glucose and, possibly, prevent the progressive impairment of glucose metab. in patients with impaired glucose tolerance and Type 2 diabetes.  DPP IV has become a focus of attention for drug design, as it has a pivotal role in the rapid degrdn. of at least two of the hormones released during food ingestion, a property that has warranted the design of inhibitor-based drugs.  At the mol. level, DPP IV cleaves two amino acids from the N-terminus of the intact, biol. active forms of both so-called incretin hormones, glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide (formerly known as gastric inhibitory polypeptide), resulting in truncated metabolites, which are largely inactive.  Inhibition of the enzyme, therefore, is thought to increase levels of the active forms of both incretin hormones, culminating in an increase in insulin release after a meal, in a fully glucose-dependent manner.  DPP IV inhibitors combine several features of interest to the drug design process.  They can be readily optimized for their target and be designed as low mol. wt., orally active entities compatible with once-daily administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLIYyj_kReyrVg90H21EOLACvtfcHk0lh6H7UL6RJ-5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFSmsr0%253D&md5=cae60dec469fc5009b3fbb174d182059</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1517%2F13543784.13.9.1091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.13.9.1091%26sid%3Dliteratum%253Aachs%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26aulast%3DAhren%26aufirst%3DB.%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26atitle%3DInhibitors%2520of%2520dipeptidyl%2520peptidase%2520IV%253A%2520a%2520novel%2520approach%2520for%2520the%2520prevention%2520and%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D13%26spage%3D1091%26epage%3D1102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Richter, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandeira-Echtler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergerhoff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebrahim, S. H.</span><span> </span><span class="NLM_article-title">Rosiglitazone for type 2 diabetes mellitus</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_fpage">CD006063</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=CD006063&author=B.+Richterauthor=E.+Bandeira-Echtlerauthor=K.+Bergerhoffauthor=C.+Clarauthor=S.+H.+Ebrahim&title=Rosiglitazone+for+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DB.%26aulast%3DBandeira-Echtler%26aufirst%3DE.%26aulast%3DBergerhoff%26aufirst%3DK.%26aulast%3DClar%26aufirst%3DC.%26aulast%3DEbrahim%26aufirst%3DS.%2BH.%26atitle%3DRosiglitazone%2520for%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2007%26spage%3DCD006063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Devchand, P. R.</span><span> </span><span class="NLM_article-title">Glitazones and the cardiovascular system</span> <span class="citation_source-journal">Curr. Opin. Endocrinol. Diabetes Obes.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">15</span> <span class="NLM_fpage">188</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=18316956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjvF2htbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=188-192&author=P.+R.+Devchand&title=Glitazones+and+the+cardiovascular+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Glitazones and the cardiovascular system</span></div><div class="casAuthors">Devchand, Pallavi R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Endocrinology, Diabetes and Obesity</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">188-192</span>CODEN:
                <span class="NLM_cas:coden">COEDFK</span>;
        ISSN:<span class="NLM_cas:issn">1752-296X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: To chart recent progress on mol. mechanisms of rosiglitazone and pioglitazone in the cardiovascular system.  Recent findings: Several classes of oral antidiabetic drugs are available to treat type 2 diabetes, but glitazones offer the unique promise of insulin-sensitizing ability coupled with potential to reverse cardiovascular abnormalities assocd. with insulin resistance.  Currently the two drugs used are rosiglitazone and pioglitazone, marketed as Avandia and Actos.  Recent results of different metaanalyses were inconclusive as to whether rosiglitazone caused real adverse effects of myocardial ischemia.  Thus, the US Food and Drugs Administration placed a black box warning on Avandia to signal potential of myocardial infarction and heart-related deaths, as a precautionary measure until analyses of all available data provide clarity.  Also unresolved is the extent to which the two compds. share modes of action.  Summary: Type II diabetes affects more than 160 million people, approx. 5% of the world's population (http://www.who.org).  Recently, questions have been raised about the cardiovascular safety of glitazone antidiabetic drugs.  Clearly, there is an urgency to define mol. mechanisms of rosiglitazone and pioglitazone and understand how these drugs may impact patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOyN6sL43B8bVg90H21EOLACvtfcHk0lh6H7UL6RJ-5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjvF2htbs%253D&md5=ead168f3f95906b9ddb863823ed881d6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDevchand%26aufirst%3DP.%2BR.%26atitle%3DGlitazones%2520and%2520the%2520cardiovascular%2520system%26jtitle%3DCurr.%2520Opin.%2520Endocrinol.%2520Diabetes%2520Obes.%26date%3D2008%26volume%3D15%26spage%3D188%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Bolen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinopoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selvin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancati, F. L.</span><span> </span><span class="NLM_article-title">Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus</span> <span class="citation_source-journal">Ann. Intern. Med.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">147</span> <span class="NLM_fpage">386</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.7326%2F0003-4819-147-6-200709180-00178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=17638715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A280%3ADC%252BD2srlsFSnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2007&pages=386-399&author=S.+Bolenauthor=L.+Feldmanauthor=J.+Vassyauthor=L.+Wilsonauthor=H.+C.+Yehauthor=S.+Marinopoulosauthor=C.+Wileyauthor=E.+Selvinauthor=R.+Wilsonauthor=E.+B.+Bassauthor=F.+L.+Brancati&title=Systematic+review%3A+comparative+effectiveness+and+safety+of+oral+medications+for+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus</span></div><div class="casAuthors">Bolen Shari; Feldman Leonard; Vassy Jason; Wilson Lisa; Yeh Hsin-Chieh; Marinopoulos Spyridon; Wiley Crystal; Selvin Elizabeth; Wilson Renee; Bass Eric B; Brancati Frederick L</div><div class="citationInfo"><span class="NLM_cas:title">Annals of internal medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">386-99</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  As newer oral diabetes agents continue to emerge on the market, comparative evidence is urgently required to guide appropriate therapy.  PURPOSE:  To summarize the English-language literature on the benefits and harms of oral agents (second-generation sulfonylureas, biguanides, thiazolidinediones, meglitinides, and alpha-glucosidase inhibitors) in the treatment of adults with type 2 diabetes mellitus.  DATA SOURCES:  The MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials databases were searched from inception through January 2006 for original articles and through November 2005 for systematic reviews.  Unpublished U.S.  Food and Drug Administration and industry data were also searched.  STUDY SELECTION:  216 controlled trials and cohort studies and 2 systematic reviews that addressed benefits and harms of oral diabetes drug classes available in the United States.  DATA EXTRACTION:  Using standardized protocols, 2 reviewers serially abstracted data for each article.  DATA SYNTHESIS:  Evidence from clinical trials was inconclusive on major clinical end points, such as cardiovascular mortality.  Therefore, the review was limited mainly to studies of intermediate end points.  Most oral agents (thiazolidinediones, metformin, and repaglinide) improved glycemic control to the same degree as sulfonylureas (absolute decrease in hemoglobin A1c level of about 1 percentage point).  Nateglinide and alpha-glucosidase inhibitors may have slightly weaker effects, on the basis of indirect comparisons of placebo-controlled trials.  Thiazolidinediones were the only class that had a beneficial effect on high-density lipoprotein cholesterol levels (mean relative increase, 0.08 to 0.13 mmol/L [3 to 5 mg/dL]) but a harmful effect on low-density lipoprotein (LDL) cholesterol levels (mean relative increase, 0.26 mmol/L [10 mg/dL]) compared with other oral agents.  Metformin decreased LDL cholesterol levels by about 0.26 mmol/L (10 mg/dL), whereas other oral agents had no obvious effects on LDL cholesterol levels.  Most agents other than metformin increased body weight by 1 to 5 kg.  Sulfonylureas and repaglinide were associated with greater risk for hypoglycemia, thiazolidinediones with greater risk for heart failure, and metformin with greater risk for gastrointestinal problems compared with other oral agents.  Lactic acidosis was no more common in metformin recipients without comorbid conditions than in recipients of other oral diabetes agents.  LIMITATIONS:  Data on major clinical end points were limited.  Studies inconsistently reported adverse events other than hypoglycemia, and definitions of adverse events varied across studies.  Some harms not assessed in trials or observational studies may have been overlooked.  CONCLUSIONS:  Compared with newer, more expensive agents (thiazolidinediones, alpha-glucosidase inhibitors, and meglitinides), older agents (second-generation sulfonylureas and metformin) have similar or superior effects on glycemic control, lipids, and other intermediate end points.  Large, long-term comparative studies are needed to determine the comparative effects of oral diabetes agents on hard clinical end points.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTL7C4f3LYdsgWRJ3OJdH_qfW6udTcc2eaHVJBy4scjKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srlsFSnsw%253D%253D&md5=ead007e4646359920b3b4fffd14e8a04</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-147-6-200709180-00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-147-6-200709180-00178%26sid%3Dliteratum%253Aachs%26aulast%3DBolen%26aufirst%3DS.%26aulast%3DFeldman%26aufirst%3DL.%26aulast%3DVassy%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DL.%26aulast%3DYeh%26aufirst%3DH.%2BC.%26aulast%3DMarinopoulos%26aufirst%3DS.%26aulast%3DWiley%26aufirst%3DC.%26aulast%3DSelvin%26aufirst%3DE.%26aulast%3DWilson%26aufirst%3DR.%26aulast%3DBass%26aufirst%3DE.%2BB.%26aulast%3DBrancati%26aufirst%3DF.%2BL.%26atitle%3DSystematic%2520review%253A%2520comparative%2520effectiveness%2520and%2520safety%2520of%2520oral%2520medications%2520for%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2007%26volume%3D147%26spage%3D386%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Ginsberg, H. N.</span><span> </span><span class="NLM_article-title">Insulin resistance and cardiovascular disease</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">106</span> <span class="NLM_fpage">453</span> <span class="NLM_lpage">458</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2000&pages=453-458&author=H.+N.+Ginsberg&title=Insulin+resistance+and+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGinsberg%26aufirst%3DH.%2BN.%26atitle%3DInsulin%2520resistance%2520and%2520cardiovascular%2520disease%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D106%26spage%3D453%26epage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Kahn, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flier, J. S.</span><span> </span><span class="NLM_article-title">Obesity and insulin resistance</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">106</span> <span class="NLM_fpage">473</span> <span class="NLM_lpage">481</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1172%2FJCI10842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=10953022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFCltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2000&pages=473-481&author=B.+B.+Kahnauthor=J.+S.+Flier&title=Obesity+and+insulin+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Obesity and insulin resistance</span></div><div class="casAuthors">Kahn, Barbara B.; Flier, Jeffrey S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">473-481</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review, with 56 refs.  The relationship of obesity to insulin resistance and type 2 diabetes is a long-recognized phenomenon with fundamentally important scientific and clin. implications.  The paradox that either absence or excess of adipose tissue causes insulin resistance highlights the complexity of this relationship and underscores the fact that adipose tissue undoubtedly subserves multiple functions.  Advances over the last decade have expanded our understanding of the role of adipocytes in biol., and this has begun to provide mechanistic insights into the causal relationship between obesity and diabetes.  It is now clear that adipocytes function as endocrine glands with wide-reaching effects on other organs including the brain.  The release of a wide variety of mols. including hormones such as leptin, cytokines such as TNF-α, and substrates such as FFAs allows the adipose organ to play a major regulatory role in energy balance and glucose homeostasis.  Current challenges on the horizon include (a) discovering addnl. adipocyte-secreted products which are central to these processes; (b) deepening our understanding of the cellular and mol. mechanisms underlying insulin sensitivity and secretion, including previously unidentified pathways such as those mediated by nuclear receptors such as PPARγ, and (c) exploring the possibility of divergence among different insulin-mediated processes, such that those driving adipogenesis and fat storage may actually be augmented, at least in some tissues, in insulin-resistant states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh3ENRAIvrwrVg90H21EOLACvtfcHk0lh5UmsIJdtAsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFCltbw%253D&md5=9b92af02bed400f248b0e84f8861115d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1172%2FJCI10842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI10842%26sid%3Dliteratum%253Aachs%26aulast%3DKahn%26aufirst%3DB.%2BB.%26aulast%3DFlier%26aufirst%3DJ.%2BS.%26atitle%3DObesity%2520and%2520insulin%2520resistance%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D106%26spage%3D473%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Ward, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streltsov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKern, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovrecz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, T.</span><span> </span><span class="NLM_article-title">Structural insights into ligand-induced activation of the insulin receptor</span> <span class="citation_source-journal">Acta Physiol. (Oxford)</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">192</span> <span class="NLM_fpage">3</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=18171424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVaju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2008&pages=3-9&author=C.+Wardauthor=M.+Lawrenceauthor=V.+Streltsovauthor=T.+Garrettauthor=N.+McKernauthor=M.+Z.+Louauthor=G.+Lovreczauthor=T.+Adams&title=Structural+insights+into+ligand-induced+activation+of+the+insulin+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into ligand-induced activation of the insulin receptor</span></div><div class="casAuthors">Ward, C.; Lawrence, M.; Streltsov, V.; Garrett, T.; McKern, N.; Lou, M.-Z.; Lovrecz, G.; Adams, T.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Physiologica</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-9</span>CODEN:
                <span class="NLM_cas:coden">APCHC4</span>;
        ISSN:<span class="NLM_cas:issn">1748-1708</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The current model for insulin binding to the insulin receptor proposes that there are two binding sites, referred to as sites 1 and 2, on each monomer in the receptor homodimer and two binding surfaces on insulin, one involving residues predominantly from the dimerization face of insulin (the classical binding surface) and the other residues from the hexamerization face.  High-affinity binding involves one insulin mol. using its two surfaces to make bridging contacts with site 1 from one receptor monomer and site 2 from the other.  While the receptor dimer has two identical site 1-site 2 pairs, insulin mols. cannot bridge both pairs simultaneously.  Our structures of the insulin receptor (IR) ectodomain dimer and the L1-CR-L2 fragments of IR and insulin-like growth factor receptor (IGF-1R) explain many of the features of ligand-receptor binding and allow the two binding sites on the receptor to be described.  The IR dimer has an unexpected folded-over conformation which places the C-terminal surface of the first fibronectin-III domain in close juxtaposition to the known L1 domain ligand-binding surface suggesting that the C-terminal surface of FnIII-1 is the second binding site involved in high-affinity binding.  This is very different from previous models based on three-dimensional reconstruction from scanning transmission electron micrographs.  Our single-mol. images indicate that IGF-1R has a morphol. similar to that of IR.  In addn., the structures of the first three domains (L1-CR-L2) of the IR and IGF-1R show that there are major differences in the two regions governing ligand specificity.  The implications of these findings for ligand-induced receptor activation will be discussed.  This review summarizes the key findings regarding the discovery and characterization of the insulin receptor, the identification and arrangement of its structural domains in the sequence and the key features assocd. with ligand binding.  The remainder of the review deals with a description of the receptor structure and how it explains much of the large body of biochem. data in the literature on insulin binding and receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOQDmwZ20mD7Vg90H21EOLACvtfcHk0lh5UmsIJdtAsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVaju7g%253D&md5=933ad1b4a204bb861d7604171509ee57</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DC.%26aulast%3DLawrence%26aufirst%3DM.%26aulast%3DStreltsov%26aufirst%3DV.%26aulast%3DGarrett%26aufirst%3DT.%26aulast%3DMcKern%26aufirst%3DN.%26aulast%3DLou%26aufirst%3DM.%2BZ.%26aulast%3DLovrecz%26aufirst%3DG.%26aulast%3DAdams%26aufirst%3DT.%26atitle%3DStructural%2520insights%2520into%2520ligand-induced%2520activation%2520of%2520the%2520insulin%2520receptor%26jtitle%3DActa%2520Physiol.%2520%2528Oxford%2529%26date%3D2008%26volume%3D192%26spage%3D3%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">White, M. F.</span><span> </span><span class="NLM_article-title">Regulating insulin signaling and beta-cell function through IRS proteins</span> <span class="citation_source-journal">Can. J. Physiol. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">84</span> <span class="NLM_fpage">725</span> <span class="NLM_lpage">737</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1139%2FY06-008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=16998536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFGqtLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2006&pages=725-737&author=M.+F.+White&title=Regulating+insulin+signaling+and+beta-cell+function+through+IRS+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Regulating insulin signaling and β-cell function through IRS proteins</span></div><div class="casAuthors">White, Morris F.</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">725-737</span>CODEN:
                <span class="NLM_cas:coden">CJPPA3</span>;
        ISSN:<span class="NLM_cas:issn">0008-4212</span>.
    
            (<span class="NLM_cas:orgname">National Research Council of Canada</span>)
        </div><div class="casAbstract">A review.  Diabetes mellitus is a complex disorder that arise from various causes, including dysregulated glucose sensing and impaired insulin secretion (maturity onset diabetes of youth, MODY), autoimmune-mediated β-cell destruction (type 1), or insufficient compensation for peripheral insulin resistance (type 2).  Type 2 diabetes is the most prevalent form that usually occurs at middle age; it afflicts more than 30 million people over the age of 65, but is appearing with greater frequency in children and adolescents.  Dysregulated insulin signaling exacerbated by chronic hyperglycemia promotes a cohort of systemic disorders-including dyslipidemia, hypertension, cardiovascular disease, and female infertility.  Understanding the mol. basis of insulin resistance can prevent these disorders and their inevitable progression to type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMi20nEly_vbVg90H21EOLACvtfcHk0lhRNc-hZq-N6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFGqtLnM&md5=0ca6c0b5faaf5659b58434114484a35c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1139%2FY06-008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252FY06-008%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DM.%2BF.%26atitle%3DRegulating%2520insulin%2520signaling%2520and%2520beta-cell%2520function%2520through%2520IRS%2520proteins%26jtitle%3DCan.%2520J.%2520Physiol.%2520Pharmacol.%26date%3D2006%26volume%3D84%26spage%3D725%26epage%3D737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Watson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessin, J. E.</span><span> </span><span class="NLM_article-title">GLUT4 translocation: the last 200 nanometers</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">19</span> <span class="NLM_fpage">2209</span> <span class="NLM_lpage">2217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1016%2Fj.cellsig.2007.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=17629673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWmtb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=2209-2217&author=R.+T.+Watsonauthor=J.+E.+Pessin&title=GLUT4+translocation%3A+the+last+200+nanometers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">GLUT4 translocation: The last 200 nanometers</span></div><div class="casAuthors">Watson, Robert T.; Pessin, Jeffrey E.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2209-2217</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Insulin regulates circulating glucose levels by suppressing hepatic glucose prodn. and increasing glucose transport into muscle and adipose tissues.  Defects in these processes are assocd. with elevated vascular glucose levels and can lead to increased risk for the development of Type 2 diabetes mellitus and its assocd. disease complications.  At the cellular level, insulin stimulates glucose uptake by inducing the translocation of the glucose transporter 4 (GLUT4) from intracellular storage sites to the plasma membrane, where the transporter facilitates the diffusion of glucose into striated muscle and adipocytes.  Although the immediate downstream mols. that function proximal to the activated insulin receptor have been relatively well-characterized, it remains unknown how the distal insulin-signaling cascade interfaces with and recruits GLUT4 to the cell surface.  New biochem. assays and imaging techniques, however, have focused attention on the plasma membrane as a potential target of insulin action leading to GLUT4 translocation.  Indeed, it now appears that insulin specifically regulates the docking and/or fusion of GLUT4-vesicles with the plasma membrane.  Future work will focus on identifying the key insulin targets that regulate the GLUT4 docking/fusion processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLBw7jPSKFiLVg90H21EOLACvtfcHk0lhRNc-hZq-N6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWmtb3I&md5=7c9dffcca713d1706d807c864fdbbfed</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2007.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2007.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DR.%2BT.%26aulast%3DPessin%26aufirst%3DJ.%2BE.%26atitle%3DGLUT4%2520translocation%253A%2520the%2520last%2520200%2520nanometers%26jtitle%3DCell.%2520Signalling%26date%3D2007%26volume%3D19%26spage%3D2209%26epage%3D2217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czech, M. P.</span><span> </span><span class="NLM_article-title">The GLUT4 glucose transporter</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">237</span> <span class="NLM_lpage">252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1016%2Fj.cmet.2007.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=17403369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslGmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=237-252&author=S.+Huangauthor=M.+P.+Czech&title=The+GLUT4+glucose+transporter"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The GLUT4 glucose transporter</span></div><div class="casAuthors">Huang, Shaohui; Czech, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">237-252</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review on the mol. and cellular regulatory mechanisms for GLUT4, its gene regulation, its trafficking pathways and their integration with insulin signaling, and its profound effects on whole-body metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfuQi6GUhMBbVg90H21EOLACvtfcHk0lhRNc-hZq-N6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslGmsLg%253D&md5=2b8c8633582d57262896144ca09a0a96</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2007.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2007.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DCzech%26aufirst%3DM.%2BP.%26atitle%3DThe%2520GLUT4%2520glucose%2520transporter%26jtitle%3DCell%2520Metab.%26date%3D2007%26volume%3D5%26spage%3D237%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalkowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Royo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diez, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelaez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruby, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calaycay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zierath, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">Discovery of a small molecule insulin mimetic with antidiabetic activity in mice</span> <span class="citation_source-journal">Science</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">284</span> <span class="NLM_fpage">974</span> <span class="NLM_lpage">977</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1126%2Fscience.284.5416.974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=10320380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVWgu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=1999&pages=974-977&author=B.+B.+Zhangauthor=G.+Salituroauthor=D.+Szalkowskiauthor=Z.+H.+Liauthor=Y.+Zhangauthor=I.+Royoauthor=D.+Vilellaauthor=M.+T.+Diezauthor=F.+Pelaezauthor=C.+Rubyauthor=R.+L.+Kendallauthor=X.+Z.+Maoauthor=P.+Griffinauthor=J.+Calaycayauthor=J.+R.+Zierathauthor=J.+V.+Heckauthor=R.+G.+Smithauthor=D.+E.+Moller&title=Discovery+of+a+small+molecule+insulin+mimetic+with+antidiabetic+activity+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a small molecule insulin mimetic with antidiabetic activity in mice</span></div><div class="casAuthors">Zhang, Bei; Salituro, Gino; Szalkowski, Deborah; Li, Zhihua; Zhang, Yan; Royo, Inmaculada; Vilella, Dolores; Diez, Maria Teresa; Pelaez, Fernando; Ruby, Caroline; Kendall, Richard L.; Mao, Xianzhi; Griffin, Patrick; Calaycay, Jimmy; Zierath, Juleen R.; Heck, Ames V.; Smith, Roy G.; Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">5416</span>),
    <span class="NLM_cas:pages">974-977</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 25 refs.  Insulin elicits a spectrum of biol. responses by binding to its cell surface receptor.  In a screen for small mols. that activate the human insulin receptor tyrosine kinase, a nonpeptidyl fungal metabolite (L-783,281) was identified that acted as an insulin mimetic in several biochem. and cellular assays.  The compd. was selective for insulin receptor vs. insulin-like growth factor I (IGFI) receptor and other receptor tyrosine kinases.  Oral administration of L-783,281 to two mouse models of diabetes resulted in significant lowering in blood glucose levels.  These results demonstrate the feasibility of discovering novel insulin receptor activators that may lead to new therapies for diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNw95zd_yRj7Vg90H21EOLACvtfcHk0lhwgTiUxEm0dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVWgu7w%253D&md5=a8daa4f742728472bc840537e6bf512d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscience.284.5416.974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.284.5416.974%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DSalituro%26aufirst%3DG.%26aulast%3DSzalkowski%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DZ.%2BH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DRoyo%26aufirst%3DI.%26aulast%3DVilella%26aufirst%3DD.%26aulast%3DDiez%26aufirst%3DM.%2BT.%26aulast%3DPelaez%26aufirst%3DF.%26aulast%3DRuby%26aufirst%3DC.%26aulast%3DKendall%26aufirst%3DR.%2BL.%26aulast%3DMao%26aufirst%3DX.%2BZ.%26aulast%3DGriffin%26aufirst%3DP.%26aulast%3DCalaycay%26aufirst%3DJ.%26aulast%3DZierath%26aufirst%3DJ.%2BR.%26aulast%3DHeck%26aufirst%3DJ.%2BV.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DDiscovery%2520of%2520a%2520small%2520molecule%2520insulin%2520mimetic%2520with%2520antidiabetic%2520activity%2520in%2520mice%26jtitle%3DScience%26date%3D1999%26volume%3D284%26spage%3D974%26epage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Liu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalkowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwei, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huskey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. B.</span><span> </span><span class="NLM_article-title">Discovery of a potent, highly selective, and orally efficacious small-molecule activator of the insulin receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">43</span> <span class="NLM_fpage">3487</span> <span class="NLM_lpage">3494</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000285q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3487-3494&author=K.+Liuauthor=L.+Xuauthor=D.+Szalkowskiauthor=Z.+Liauthor=V.+Dingauthor=G.+Kweiauthor=S.+Huskeyauthor=D.+E.+Mollerauthor=J.+V.+Heckauthor=B.+B.+Zhangauthor=A.+B.+Jones&title=Discovery+of+a+potent%2C+highly+selective%2C+and+orally+efficacious+small-molecule+activator+of+the+insulin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm000285q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000285q%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DSzalkowski%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DV.%26aulast%3DKwei%26aufirst%3DG.%26aulast%3DHuskey%26aufirst%3DS.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DHeck%26aufirst%3DJ.%2BV.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DJones%26aufirst%3DA.%2BB.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520highly%2520selective%252C%2520and%2520orally%2520efficacious%2520small-molecule%2520activator%2520of%2520the%2520insulin%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3487%26epage%3D3494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Wood, H. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalkowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. B.</span><span> </span><span class="NLM_article-title">The basal SAR of a novel insulin receptor activator</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">10</span> <span class="NLM_fpage">1189</span> <span class="NLM_lpage">1192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1189-1192&author=H.+B.+Woodauthor=R.+Blackauthor=G.+Salituroauthor=D.+Szalkowskiauthor=Z.+Liauthor=Y.+Zhangauthor=D.+E.+Mollerauthor=B.+B.+Zhangauthor=A.+B.+Jones&title=The+basal+SAR+of+a+novel+insulin+receptor+activator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DH.%2BB.%26aulast%3DBlack%26aufirst%3DR.%26aulast%3DSalituro%26aufirst%3DG.%26aulast%3DSzalkowski%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DJones%26aufirst%3DA.%2BB.%26atitle%3DThe%2520basal%2520SAR%2520of%2520a%2520novel%2520insulin%2520receptor%2520activator%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D1189%26epage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Qureshi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalkowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biazzo-Ashnault, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saperstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huskey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span> </span><span class="NLM_article-title">Activation of insulin signal transduction pathway and anti-diabetic activity of small molecule insulin receptor activators</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">275</span> <span class="NLM_fpage">36590</span> <span class="NLM_lpage">36595</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=36590-36595&author=S.+A.+Qureshiauthor=V.+Dingauthor=Z.+Liauthor=D.+Szalkowskiauthor=D.+E.+Biazzo-Ashnaultauthor=D.+Xieauthor=R.+Sapersteinauthor=E.+Bradyauthor=S.+Huskeyauthor=X.+Shenauthor=K.+Liuauthor=L.+Xuauthor=G.+M.+Salituroauthor=J.+V.+Heckauthor=D.+E.+Mollerauthor=A.+B.+Jonesauthor=B.+B.+Zhang&title=Activation+of+insulin+signal+transduction+pathway+and+anti-diabetic+activity+of+small+molecule+insulin+receptor+activators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQureshi%26aufirst%3DS.%2BA.%26aulast%3DDing%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DSzalkowski%26aufirst%3DD.%26aulast%3DBiazzo-Ashnault%26aufirst%3DD.%2BE.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DSaperstein%26aufirst%3DR.%26aulast%3DBrady%26aufirst%3DE.%26aulast%3DHuskey%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DSalituro%26aufirst%3DG.%2BM.%26aulast%3DHeck%26aufirst%3DJ.%2BV.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DJones%26aufirst%3DA.%2BB.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26atitle%3DActivation%2520of%2520insulin%2520signal%2520transduction%2520pathway%2520and%2520anti-diabetic%2520activity%2520of%2520small%2520molecule%2520insulin%2520receptor%2520activators%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D36590%26epage%3D36595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Strowski, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalkowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juttner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span> </span><span class="NLM_article-title">Small-molecule insulin mimetic reduces hyperglycemia and obesity in a nongenetic mouse model of type 2 diabetes</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">145</span> <span class="NLM_fpage">5259</span> <span class="NLM_lpage">5268</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2004&pages=5259-5268&author=M.+Z.+Strowskiauthor=Z.+Liauthor=D.+Szalkowskiauthor=X.+Shenauthor=X.+M.+Guanauthor=S.+Juttnerauthor=D.+E.+Mollerauthor=B.+B.+Zhang&title=Small-molecule+insulin+mimetic+reduces+hyperglycemia+and+obesity+in+a+nongenetic+mouse+model+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStrowski%26aufirst%3DM.%2BZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DSzalkowski%26aufirst%3DD.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DX.%2BM.%26aulast%3DJuttner%26aufirst%3DS.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26atitle%3DSmall-molecule%2520insulin%2520mimetic%2520reduces%2520hyperglycemia%2520and%2520obesity%2520in%2520a%2520nongenetic%2520mouse%2520model%2520of%2520type%25202%2520diabetes%26jtitle%3DEndocrinology%26date%3D2004%26volume%3D145%26spage%3D5259%26epage%3D5268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Beroza, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damodaran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, R. T.</span><span> </span><span class="NLM_article-title">Target-related affinity profiling: Telik’s lead discovery technology</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">371</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.2174%2F1568026053828394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm800600v&amp;key=15892680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFGht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=371-381&author=P.+Berozaauthor=K.+Damodaranauthor=R.+T.+Lum&title=Target-related+affinity+profiling%3A+Telik%E2%80%99s+lead+discovery+technology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Target-Related Affinity Profiling: Telik's lead discovery technology</span></div><div class="casAuthors">Beroza, Paul; Damodaran, Komath; Lum, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">371-381</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Target-Related Affinity Profiling (TRAP*) is a computational drug discovery technol. that is based on 'affinity fingerprints', which are mol. descriptors derived from the protein binding preferences of small mols.  The underlying concepts of TRAP are reviewed.  Affinity fingerprints are compared to mol. descriptors derived from chem. structures and shown to be a useful alternative for lead discovery.  The TRAP screening process is described and two example applications are presented: I. the discovery of novel inhibitors of human intestinal carboxylesterase, and II. the discovery of novel inhibitors of cyclooxygenase-1 through the use of the affinity fingerprints of known cyclooxygenase-1 inhibitors.  A summary of the complementary advantages of TRAP screening technol. compared to traditional approaches to drug lead discovery concludes the review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwR_tQSfq387Vg90H21EOLACvtfcHk0lhwgTiUxEm0dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFGht7g%253D&md5=923b9484010e8badee5034ebb1a7fc34</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F1568026053828394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053828394%26sid%3Dliteratum%253Aachs%26aulast%3DBeroza%26aufirst%3DP.%26aulast%3DDamodaran%26aufirst%3DK.%26aulast%3DLum%26aufirst%3DR.%2BT.%26atitle%3DTarget-related%2520affinity%2520profiling%253A%2520Telik%25E2%2580%2599s%2520lead%2520discovery%2520technology%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D371%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Manchem, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldfine, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohanski, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristobal, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schow, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spevak, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laborde, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toavs, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villar, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wick, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, M. R.</span><span> </span><span class="NLM_article-title">A novel small molecule that directly sensitizes the insulin receptor <i>in vitro</i> and <i>in vivo</i></span> <span class="citation_source-journal">Diabetes</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">50</span> <span class="NLM_fpage">824</span> <span class="NLM_lpage">830</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=824-830&author=V.+P.+Manchemauthor=I.+D.+Goldfineauthor=R.+A.+Kohanskiauthor=C.+P.+Cristobalauthor=R.+T.+Lumauthor=S.+R.+Schowauthor=S.+Shiauthor=W.+R.+Spevakauthor=E.+Labordeauthor=D.+K.+Toavsauthor=H.+O.+Villarauthor=M.+M.+Wickauthor=M.+R.+Kozlowski&title=A+novel+small+molecule+that+directly+sensitizes+the+insulin+receptor+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManchem%26aufirst%3DV.%2BP.%26aulast%3DGoldfine%26aufirst%3DI.%2BD.%26aulast%3DKohanski%26aufirst%3DR.%2BA.%26aulast%3DCristobal%26aufirst%3DC.%2BP.%26aulast%3DLum%26aufirst%3DR.%2BT.%26aulast%3DSchow%26aufirst%3DS.%2BR.%26aulast%3DShi%26aufirst%3DS.%26aulast%3DSpevak%26aufirst%3DW.%2BR.%26aulast%3DLaborde%26aufirst%3DE.%26aulast%3DToavs%26aufirst%3DD.%2BK.%26aulast%3DVillar%26aufirst%3DH.%2BO.%26aulast%3DWick%26aufirst%3DM.%2BM.%26aulast%3DKozlowski%26aufirst%3DM.%2BR.%26atitle%3DA%2520novel%2520small%2520molecule%2520that%2520directly%2520sensitizes%2520the%2520insulin%2520receptor%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DDiabetes%26date%3D2001%26volume%3D50%26spage%3D824%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youngren, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manchem, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddux, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldfine, I. D.</span><span> </span><span class="NLM_article-title">Small molecule insulin receptor activators potentiate insulin action in insulin resistant cells</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">50</span> <span class="NLM_fpage">2323</span> <span class="NLM_lpage">2328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=2323-2328&author=M.+Liauthor=J.+F.+Youngrenauthor=V.+P.+Manchemauthor=M.+R.+Kozlowskiauthor=B.+B.+Zhangauthor=B.+A.+Madduxauthor=I.+D.+Goldfine&title=Small+molecule+insulin+receptor+activators+potentiate+insulin+action+in+insulin+resistant+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DYoungren%26aufirst%3DJ.%2BF.%26aulast%3DManchem%26aufirst%3DV.%2BP.%26aulast%3DKozlowski%26aufirst%3DM.%2BR.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DMaddux%26aufirst%3DB.%2BA.%26aulast%3DGoldfine%26aufirst%3DI.%2BD.%26atitle%3DSmall%2520molecule%2520insulin%2520receptor%2520activators%2520potentiate%2520insulin%2520action%2520in%2520insulin%2520resistant%2520cells%26jtitle%3DDiabetes%26date%3D2001%26volume%3D50%26spage%3D2323%26epage%3D2328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Koguro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orita, R.</span><span> </span><span class="NLM_article-title">Novel synthesis of 5-substituted tetrazoles from nitriles</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_fpage">910</span> <span class="NLM_lpage">914</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm800600v&amp;key=10.1055%2Fs-1998-2081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADyaK1cXjslKlsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&pages=910-914&author=K.+Koguroauthor=T.+Ogaauthor=S.+Mitsuiauthor=R.+Orita&title=Novel+synthesis+of+5-substituted+tetrazoles+from+nitriles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Novel synthesis of 5-substituted tetrazoles from nitriles</span></div><div class="casAuthors">Koguro, Kiyoto; Oga, Toshikazu; Mitsui, Sunao; Orita, Ryozo</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">910-914</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A variety of 5-substituted tetrazoles were prepd. by cycloaddn. of NaN3 with appropriate nitriles in an arom. solvent in the presence of an amine salt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrirgXuLXTynrVg90H21EOLACvtfcHk0lgdGFRyM1Wy-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjslKlsro%253D&md5=954039bdf3efa904b08cfabbc98ccdf6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1055%2Fs-1998-2081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1998-2081%26sid%3Dliteratum%253Aachs%26aulast%3DKoguro%26aufirst%3DK.%26aulast%3DOga%26aufirst%3DT.%26aulast%3DMitsui%26aufirst%3DS.%26aulast%3DOrita%26aufirst%3DR.%26atitle%3DNovel%2520synthesis%2520of%25205-substituted%2520tetrazoles%2520from%2520nitriles%26jtitle%3DSynthesis%26date%3D1998%26spage%3D910%26epage%3D914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Gray, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B.</span><span> </span><span class="NLM_article-title">The preparation of 4- and 5-<i>n</i>-alkoxy-1-naphthoic and 6- and 7-<i>n</i>-alkoxy-2-naphthoic acids</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_year" style="font-weight: bold;">1954</span> <span class="NLM_volume">1954</span> <span class="NLM_fpage">678</span> <span class="NLM_lpage">682</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1954&publication_year=1954&pages=678-682&author=G.+W.+Grayauthor=B.+Jones&title=The+preparation+of+4-+and+5-n-alkoxy-1-naphthoic+and+6-+and+7-n-alkoxy-2-naphthoic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DG.%2BW.%26aulast%3DJones%26aufirst%3DB.%26atitle%3DThe%2520preparation%2520of%25204-%2520and%25205-n-alkoxy-1-naphthoic%2520and%25206-%2520and%25207-n-alkoxy-2-naphthoic%2520acids%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1954%26volume%3D1954%26spage%3D678%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Cheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schow, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manchem, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spevak, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristobal, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macsata, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldfine, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keck, J. G.</span><span> </span><span class="NLM_article-title">In vitro and in vivo prevention of HIV protease inhibitor-induced insulin resistance by a novel small molecule insulin receptor activator</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">92</span> <span class="NLM_fpage">1234</span> <span class="NLM_lpage">1245</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2004&pages=1234-1245&author=M.+Chengauthor=S.+Chenauthor=S.+R.+Schowauthor=V.+P.+Manchemauthor=W.+R.+Spevakauthor=C.+P.+Cristobalauthor=S.+Shiauthor=R.+W.+Macsataauthor=R.+T.+Lumauthor=I.+D.+Goldfineauthor=J.+G.+Keck&title=In+vitro+and+in+vivo+prevention+of+HIV+protease+inhibitor-induced+insulin+resistance+by+a+novel+small+molecule+insulin+receptor+activator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DSchow%26aufirst%3DS.%2BR.%26aulast%3DManchem%26aufirst%3DV.%2BP.%26aulast%3DSpevak%26aufirst%3DW.%2BR.%26aulast%3DCristobal%26aufirst%3DC.%2BP.%26aulast%3DShi%26aufirst%3DS.%26aulast%3DMacsata%26aufirst%3DR.%2BW.%26aulast%3DLum%26aufirst%3DR.%2BT.%26aulast%3DGoldfine%26aufirst%3DI.%2BD.%26aulast%3DKeck%26aufirst%3DJ.%2BG.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520prevention%2520of%2520HIV%2520protease%2520inhibitor-induced%2520insulin%2520resistance%2520by%2520a%2520novel%2520small%2520molecule%2520insulin%2520receptor%2520activator%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2004%26volume%3D92%26spage%3D1234%26epage%3D1245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Etter, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panunto, T. W.</span><span> </span><span class="NLM_article-title">1,3-Bis(<i>m</i>-nitrophenyl)urea: an exceptionally good complexing agent for proton acceptors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_year" style="font-weight: bold;">1988</span> <span class="NLM_volume">110</span> <span class="NLM_fpage">5896</span> <span class="NLM_lpage">5897</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00225a049" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1988&pages=5896-5897&author=M.+C.+Etterauthor=T.+W.+Panunto&title=1%2C3-Bis%28m-nitrophenyl%29urea%3A+an+exceptionally+good+complexing+agent+for+proton+acceptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fja00225a049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00225a049%26sid%3Dliteratum%253Aachs%26aulast%3DEtter%26aufirst%3DM.%2BC.%26aulast%3DPanunto%26aufirst%3DT.%2BW.%26atitle%3D1%252C3-Bis%2528m-nitrophenyl%2529urea%253A%2520an%2520exceptionally%2520good%2520complexing%2520agent%2520for%2520proton%2520acceptors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1988%26volume%3D110%26spage%3D5896%26epage%3D5897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Dannecker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rust, H.</span><span> </span><span class="NLM_article-title"><i>N</i>,<i>N</i>′-Diphenylurea, C<sub>13</sub>H<sub>12</sub>N<sub>2</sub>O</span> <span class="citation_source-journal">Cryst. Struct. Commun.</span><span class="NLM_year" style="font-weight: bold;">1979</span> <span class="NLM_volume">8</span> <span class="NLM_fpage">429</span> <span class="NLM_lpage">432</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm800600v&amp;key=1%3ACAS%3A528%3ADyaE1MXktlSqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1979&pages=429-432&author=W.+Danneckerauthor=J.+Kopfauthor=H.+Rust&title=N%2CN%E2%80%B2-Diphenylurea%2C+C13H12N2O"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">[Crystal structure of] N,N'-diphenylurea, C13H12N2O</span></div><div class="casAuthors">Dannecker, W.; Kopf, J.; Rust, H.</div><div class="citationInfo"><span class="NLM_cas:title">Crystal Structure Communications</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">429-32</span>CODEN:
                <span class="NLM_cas:coden">CSCMCS</span>;
        ISSN:<span class="NLM_cas:issn">0302-1742</span>.
    </div><div class="casAbstract">N,N'-Diphenylurea is orthorhombic, space group Pna21, with a 909.1(8), b 1053.5(9), and c 1176.8 pm; d.(exptl.) = 1.23 and d.(calcd.) = 1.25 for Z = 4.  The structure was solved by direct methods with MULTAN 74 and refined by full-matrix least-squares to R = 0.038.  Both the Ph rings and the urea moiety are planar.  However, the torsion angles between the Ph rings and the urea portion are 43.0 and 36.1°, resp.  H bonding is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIMj2WdKA3pLVg90H21EOLACvtfcHk0lhGcDI5Hshi7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXktlSqu74%253D&md5=5471af5681562cc6381b8590a7bca158</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDannecker%26aufirst%3DW.%26aulast%3DKopf%26aufirst%3DJ.%26aulast%3DRust%26aufirst%3DH.%26atitle%3DN%252CN%25E2%2580%25B2-Diphenylurea%252C%2520C13H12N2O%26jtitle%3DCryst.%2520Struct.%2520Commun.%26date%3D1979%26volume%3D8%26spage%3D429%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Ganis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avitabile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, M.</span><span> </span><span class="NLM_article-title">Crystal and molecular structure of <i>N</i>,<i>N</i>′-diethyl-<i>N</i>,<i>N</i>′-diphenylurea</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">1970</span> <span class="NLM_volume">67</span> <span class="NLM_fpage">426</span> <span class="NLM_lpage">433</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1970&pages=426-433&author=P.+Ganisauthor=G.+Avitabileauthor=E.+Benedettiauthor=C.+Pedoneauthor=M.+Goodman&title=Crystal+and+molecular+structure+of+N%2CN%E2%80%B2-diethyl-N%2CN%E2%80%B2-diphenylurea"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGanis%26aufirst%3DP.%26aulast%3DAvitabile%26aufirst%3DG.%26aulast%3DBenedetti%26aufirst%3DE.%26aulast%3DPedone%26aufirst%3DC.%26aulast%3DGoodman%26aufirst%3DM.%26atitle%3DCrystal%2520and%2520molecular%2520structure%2520of%2520N%252CN%25E2%2580%25B2-diethyl-N%252CN%25E2%2580%25B2-diphenylurea%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1970%26volume%3D67%26spage%3D426%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Lozanova, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galabov, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilieva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, G.</span><span> </span><span class="NLM_article-title">Infrared intensities and conformation of substituted thioureas</span> <span class="citation_source-journal">J. Mol. Struct.</span><span class="NLM_year" style="font-weight: bold;">1984</span> <span class="NLM_volume">115</span> <span class="NLM_fpage">427</span> <span class="NLM_lpage">430</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1984&pages=427-430&author=C.+Lozanovaauthor=B.+Galabovauthor=M.+Ilievaauthor=G.+Vassilev&title=Infrared+intensities+and+conformation+of+substituted+thioureas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLozanova%26aufirst%3DC.%26aulast%3DGalabov%26aufirst%3DB.%26aulast%3DIlieva%26aufirst%3DM.%26aulast%3DVassilev%26aufirst%3DG.%26atitle%3DInfrared%2520intensities%2520and%2520conformation%2520of%2520substituted%2520thioureas%26jtitle%3DJ.%2520Mol.%2520Struct.%26date%3D1984%26volume%3D115%26spage%3D427%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Tanatani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azumaya, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukutomi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shudo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagechika, H.</span><span> </span><span class="NLM_article-title"><i>N</i>-Methylated diphenylguanidines: conformations, propeller-type molecular chirality, and construction of water-soluble oligomers with multilayered aromatic structures</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">120</span> <span class="NLM_fpage">6433</span> <span class="NLM_lpage">6422</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9806534" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1998&pages=6433-6422&author=A.+Tanataniauthor=K.+Yamaaguchiauthor=I.+Azumayaauthor=R.+Fukutomiauthor=K.+Shudoauthor=H.+Kagechika&title=N-Methylated+diphenylguanidines%3A+conformations%2C+propeller-type+molecular+chirality%2C+and+construction+of+water-soluble+oligomers+with+multilayered+aromatic+structures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fja9806534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9806534%26sid%3Dliteratum%253Aachs%26aulast%3DTanatani%26aufirst%3DA.%26aulast%3DYamaaguchi%26aufirst%3DK.%26aulast%3DAzumaya%26aufirst%3DI.%26aulast%3DFukutomi%26aufirst%3DR.%26aulast%3DShudo%26aufirst%3DK.%26aulast%3DKagechika%26aufirst%3DH.%26atitle%3DN-Methylated%2520diphenylguanidines%253A%2520conformations%252C%2520propeller-type%2520molecular%2520chirality%252C%2520and%2520construction%2520of%2520water-soluble%2520oligomers%2520with%2520multilayered%2520aromatic%2520structures%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1998%26volume%3D120%26spage%3D6433%26epage%3D6422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Carr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samaras, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chisholm, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, D. A.</span><span> </span><span class="NLM_article-title">Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance</span> <span class="citation_source-journal">Lancet</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">351</span> <span class="NLM_fpage">1881</span> <span class="NLM_lpage">1883</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=1998&pages=1881-1883&author=A.+Carrauthor=K.+Samarasauthor=D.+J.+Chisholmauthor=D.+A.+Cooper&title=Pathogenesis+of+HIV-1-protease+inhibitor-associated+peripheral+lipodystrophy%2C+hyperlipidaemia%2C+and+insulin+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarr%26aufirst%3DA.%26aulast%3DSamaras%26aufirst%3DK.%26aulast%3DChisholm%26aufirst%3DD.%2BJ.%26aulast%3DCooper%26aufirst%3DD.%2BA.%26atitle%3DPathogenesis%2520of%2520HIV-1-protease%2520inhibitor-associated%2520peripheral%2520lipodystrophy%252C%2520hyperlipidaemia%252C%2520and%2520insulin%2520resistance%26jtitle%3DLancet%26date%3D1998%26volume%3D351%26spage%3D1881%26epage%3D1883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Carr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samaras, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chisholm, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, D. A.</span><span> </span><span class="NLM_article-title">A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors</span> <span class="citation_source-journal">AIDS</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">12</span><span class="NLM_elocation-id">F51−F58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&author=A.+Carrauthor=K.+Samarasauthor=S.+Burtonauthor=M.+Lawauthor=J.+Freundauthor=D.+J.+Chisholmauthor=D.+A.+Cooper&title=A+syndrome+of+peripheral+lipodystrophy%2C+hyperlipidaemia+and+insulin+resistance+in+patients+receiving+HIV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarr%26aufirst%3DA.%26aulast%3DSamaras%26aufirst%3DK.%26aulast%3DBurton%26aufirst%3DS.%26aulast%3DLaw%26aufirst%3DM.%26aulast%3DFreund%26aufirst%3DJ.%26aulast%3DChisholm%26aufirst%3DD.%2BJ.%26aulast%3DCooper%26aufirst%3DD.%2BA.%26atitle%3DA%2520syndrome%2520of%2520peripheral%2520lipodystrophy%252C%2520hyperlipidaemia%2520and%2520insulin%2520resistance%2520in%2520patients%2520receiving%2520HIV%2520protease%2520inhibitors%26jtitle%3DAIDS%26date%3D1998%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Frost, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, M. D.</span><span> </span><span class="NLM_article-title">Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">1985</span> <span class="NLM_volume">260</span> <span class="NLM_fpage">2646</span> <span class="NLM_lpage">2652</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1985&pages=2646-2652&author=S.+C.+Frostauthor=M.+D.+Lane&title=Evidence+for+the+involvement+of+vicinal+sulfhydryl+groups+in+insulin-activated+hexose+transport+by+3T3-L1+adipocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DS.%2BC.%26aulast%3DLane%26aufirst%3DM.%2BD.%26atitle%3DEvidence%2520for%2520the%2520involvement%2520of%2520vicinal%2520sulfhydryl%2520groups%2520in%2520insulin-activated%2520hexose%2520transport%2520by%25203T3-L1%2520adipocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1985%26volume%3D260%26spage%3D2646%26epage%3D2652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Clancy, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czech, M. P.</span><span> </span><span class="NLM_article-title">Hexose transport stimulation and membrane redistribution of glucose transporter isoforms in response to cholera toxin, dibutyryl cyclic AMP, and insulin in 3T3-L1 adipocytes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">1990</span> <span class="NLM_volume">265</span> <span class="NLM_fpage">12434</span> <span class="NLM_lpage">12443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=12434-12443&author=B.+M.+Clancyauthor=M.+P.+Czech&title=Hexose+transport+stimulation+and+membrane+redistribution+of+glucose+transporter+isoforms+in+response+to+cholera+toxin%2C+dibutyryl+cyclic+AMP%2C+and+insulin+in+3T3-L1+adipocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClancy%26aufirst%3DB.%2BM.%26aulast%3DCzech%26aufirst%3DM.%2BP.%26atitle%3DHexose%2520transport%2520stimulation%2520and%2520membrane%2520redistribution%2520of%2520glucose%2520transporter%2520isoforms%2520in%2520response%2520to%2520cholera%2520toxin%252C%2520dibutyryl%2520cyclic%2520AMP%252C%2520and%2520insulin%2520in%25203T3-L1%2520adipocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26spage%3D12434%26epage%3D12443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i41"><a href="/doi/suppl/10.1021/jm800600v">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_86480"></div></div></div></div></div><hr /></hr><p class="last">Table of purity of all target compounds along with HPLC tracings and conditions. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800600v/suppl_file/jm800600v_si_001.pdf">jm800600v_si_001.pdf (0.99 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm800600v&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-19%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm800600v%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm800600v" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                313KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992e6e6b1e1239","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
